<SEC-DOCUMENT>0001047469-18-003326.txt : 20180430
<SEC-HEADER>0001047469-18-003326.hdr.sgml : 20180430
<ACCEPTANCE-DATETIME>20180430090037
ACCESSION NUMBER:		0001047469-18-003326
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180613
FILED AS OF DATE:		20180430
DATE AS OF CHANGE:		20180430
EFFECTIVENESS DATE:		20180430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15006
		FILM NUMBER:		18786893

	BUSINESS ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827
		BUSINESS PHONE:		908-200-7500

	MAIL ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2235493zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#18ZAG41701_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B> SCHEDULE 14A</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Proxy
Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2> Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Soliciting Material under &sect;240.14a-12<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> Celldex Therapeutics, Inc.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><BR>
Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=2>Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=923822,FOLIO='blank',FILE='DISK108:[18ZAG1.18ZAG41701]BA41701A.;5',USER='CHE106204',CD='25-APR-2018;16:35' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=4><B>CELLDEX THERAPEUTICS,&nbsp;INC.<BR>  </B></FONT><FONT SIZE=2><B>Perryville III Building<BR>
53 Frontage Road, Suite&nbsp;220<BR>
Hampton, NJ 08827  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> To be held on June&nbsp;13, 2018  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>To the Stockholders of<BR>
Celldex Therapeutics,&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>NOTICE IS HEREBY GIVEN</B></FONT><FONT SIZE=2> that the Annual Meeting of Stockholders of Celldex Therapeutics,&nbsp;Inc. (the "Company" or "we" or "us") will
be held at the at the offices of Lowenstein Sandler&nbsp;LLP, One Lowenstein Drive, Roseland, NJ 07068, on June&nbsp;13, 2018 beginning at 9:00&nbsp;a.m. local time. At the meeting, stockholders
will act on the following matters to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> elect eight directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall have been duly elected
and qualified; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> ratify the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for the year ending
December&nbsp;31, 2018; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approve an amendment to our Restated Certificate of Incorporation, as amended, and grant of discretionary authority to the Board of Directors
to effect a reverse stock split; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this proxy statement; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> address any other matters that may properly come before the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only
stockholders of record at the close of business on April&nbsp;25, 2018 are entitled to receive notice of and to vote at the Annual Meeting or any postponement or adjournment
thereof. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
vote is important. Whether you plan to attend the meeting or not, you may vote your shares by marking, signing, dating and mailing the enclosed proxy card in the envelope provided.
If you attend the meeting and prefer to vote in person, you may do so even if you have already voted your shares. You may revoke your proxy in the manner described in the proxy statement at any time
before it has been voted at the meeting. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2>Sam Martin<BR></FONT> <FONT SIZE=2><I>Chief Financial Officer and Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P style="font-family:times;"><FONT SIZE=2>May&nbsp;3,
2018<BR>
Hampton, NJ </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=30872,FOLIO='blank',FILE='DISK108:[18ZAG1.18ZAG41701]BC41701A.;5',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ca41701_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>CELLDEX THERAPEUTICS,&nbsp;INC.<BR>  </B></FONT><FONT SIZE=2><B>Perryville III Building<BR>
53 Frontage Road, Suite&nbsp;220<BR>
Hampton, NJ 08827  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" >


 </I></FONT><FONT SIZE=2><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>PROXY STATEMENT  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="CENTER" >


  </I></FONT><FONT SIZE=3><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This proxy statement contains information related to the Annual Meeting of Stockholders to be held on June&nbsp;13, 2018 at 9:00&nbsp;a.m.
local time, at the at the offices of Lowenstein Sandler&nbsp;LLP, One Lowenstein Drive, Roseland, NJ&nbsp;07068 or at such other time and place to which the Annual Meeting may be adjourned or
postponed. The enclosed proxy is solicited by the Board of Directors of Celldex Therapeutics,&nbsp;Inc. The proxy materials relating to the Annual Meeting are being mailed to stockholders entitled
to vote at the meeting on or about May&nbsp;3, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Important Notice of Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on June&nbsp;13, 2018.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Our proxy materials, including our Proxy Statement for the 2018 Annual Meeting, 2017 Annual Report to Stockholders (which contains our Annual Report on
Form&nbsp;10-K) and proxy card, are available on the Internet at www.proxyvote.com.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ca41701_about_the_meeting"> </A>
<A NAME="toc_ca41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  ABOUT THE MEETING    <BR>    </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Why are we calling this Annual Meeting?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are calling the Annual Meeting to seek the approval of our stockholders to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> elect eight directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall have been duly elected
and qualified; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> ratify the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for the year ending
December&nbsp;31, 2018; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approve an amendment to our Restated Certificate of Incorporation, as amended, and grant of discretionary authority to the Board of Directors
to effect a reverse stock split; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this proxy statement; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> address any other matters that may properly come before the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What are the Board's recommendations?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board of Directors recommends that you vote:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> the election of each of the eight director nominees; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> the ratification of the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent
registered public accounting firm for the year ending December&nbsp;31, 2018; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> the approval of an amendment to our Restated Certificate of Incorporation, as amended, and
grant of discretionary authority to the Board of Directors to effect a reverse stock split; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>FOR</I></B></FONT><FONT SIZE=2> an advisory vote on the compensation of the Named Executive Officers as described in this
proxy statement. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=703081,FOLIO='1',FILE='DISK108:[18ZAG1.18ZAG41701]CA41701A.;8',USER='CHE106204',CD='25-APR-2018;16:37' -->
<A NAME="page_ca41701_1_2"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who is entitled to vote at the meeting?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only stockholders of record at the close of business on the record date, April&nbsp;25, 2018, are entitled to receive notice of the Annual
Meeting and to vote the shares of common stock that they held on that date at the meeting, or any postponement or adjournment of the meeting. Holders of our common stock are entitled to one vote per
share on each matter to be voted upon. As of the record date, we had 143,387,300 outstanding shares of common stock. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who can attend the meeting?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All stockholders as of the record date, or their duly appointed proxies, may attend the Annual Meeting. Please note that if you hold your shares
in "street name" (that is, through a broker or other nominee), you will need to bring a copy of your proxy card delivered to you by your broker or a legal proxy given to you by your broker and check
in at the registration desk at the meeting. For security reasons, you must comply with our pre-registration requirements, you must present a form of government issued photograph identification on the
day of the Annual Meeting, and you must arrive at least thirty minutes prior to the meeting in order to attend the Annual Meeting. If you are a stockholder of record and plan to attend the Annual
Meeting, please contact Kathy Reamer by email at kreamer@celldex.com or by phone at 908-200-7500 ext. 7508 to register to attend the Annual Meeting. If you hold shares through an
intermediary, such as a bank or broker, and you plan to attend, you must send a written request to attend either by regular mail or email, along with proof of share ownership, such as a bank or
brokerage firm account statement, confirming ownership to: Celldex Therapeutics,&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ 08827, Attn: Kathy Reamer or
kreamer@celldex.com. Attendance at the Annual Meeting will be limited to persons who pre-registered on or before June&nbsp;6, 2018 who present a form of government-issued photograph identification
on the day of the Annual Meeting and who arrive by 8:30&nbsp;a.m. local time. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What constitutes a quorum?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The presence at the Annual Meeting, in person or by proxy, of the holders of a majority of our common stock outstanding on the record date will
constitute a quorum for our meeting. Signed proxies received but not voted and broker non-votes will be included in the calculation of the number of shares considered to be present at the meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How do I vote?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You can vote on matters that come before the Annual Meeting by completing, dating and signing the enclosed proxy card and returning it in the
enclosed postage-paid envelope. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
shares will be voted as you indicate on your proxy card. If you vote the enclosed proxy but you do not indicate your voting preferences, and with respect to any other matter that
properly comes before the meeting, the individuals named on the proxy card will vote your shares FOR the matters submitted at the meeting, or if no recommendation is given, in their own discretion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are a stockholder of record, to submit your proxy by telephone or via the Internet, follow the instructions on the proxy card. If you hold your shares in street name, you may vote
by telephone or via the Internet as instructed by your broker, bank or other nominee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you attend the Annual Meeting and prefer to vote in person, you may do so even if you have already voted your shares by proxy. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What if I vote and then change my mind?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may revoke your proxy at any time before it is exercised by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> filing with the Secretary of the Company a notice of revocation; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=4,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=627012,FOLIO='2',FILE='DISK108:[18ZAG1.18ZAG41701]CA41701A.;8',USER='CHE106204',CD='25-APR-2018;16:37' -->
<A NAME="page_ca41701_1_3"> </A>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> sending in another duly executed proxy bearing a later date; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> attending the meeting and casting your vote in person. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
latest vote will be the vote that is counted. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What is the difference between holding shares as a stockholder of record and as a beneficial owner?  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many of our stockholders hold their shares through a stockbroker, bank or other nominee rather than directly in their own name. As summarized
below, there are some distinctions between shares held of record and those owned beneficially. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stockholder of Record  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your shares are registered directly in your name with our transfer agent, Computershare Trust Company, N.A., you are considered, with respect
to those shares, the stockholder of record. As the stockholder of record, you have the right to grant your voting proxy directly to us or to vote in person at the Annual Meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Beneficial Owner  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of shares held in
street name, and these proxy materials are being forwarded to you by your broker, bank or nominee which is considered, with respect to those shares, the stockholder of record. As the beneficial owner,
you have the right to direct your broker as to how to vote and are also invited to attend the Annual Meeting. However, because you are not the stockholder of record, you may not vote these shares in
person at the Annual Meeting unless you obtain a signed proxy from the record holder giving you the right to vote the shares. If you do not vote your shares or otherwise provide the stockholder of
record with voting instructions, your shares may constitute broker non-votes. The effect of broker non-votes is more specifically described in "What vote is required to approve each proposal?" below. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What are "broker non-votes"?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Banks and brokers acting as nominees are permitted to use discretionary voting authority to vote proxies for proposals that are deemed "routine"
by the New York Stock Exchange, but are not permitted to use discretionary voting authority to vote proxies for proposals that are deemed "non-routine" by the New York Stock Exchange. The
determination of which proposals are deemed "routine" versus "non-routine" may not be made by the New York Stock Exchange until after the date on which this proxy statement has been mailed to you. As
such, it is important that you provide voting instructions to your bank, broker or other nominee, if you wish to determine the voting of your shares. If the New York Stock Exchange determines a
proposal to be "non-routine," failure to vote, or to instruct your broker how to vote any shares held for you in your broker's names will have the same effect as a vote against such proposal. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
broker "non-vote" occurs when a proposal is deemed "non-routine" and a nominee holding shares for a beneficial owner does not have discretionary voting authority with respect to the
matter being considered and has not received instructions from the beneficial owner. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
election of directors (Proposal No.&nbsp;1) and the advisory vote on the compensation of our Named Executive Officers (Proposal No.&nbsp;4) are generally not considered to be
"routine" matters, and brokers are not permitted to vote on those matters if the broker has not received instructions from the beneficial owner. Accordingly, it is particularly important that
beneficial owners instruct their brokers how they wish to vote their shares. The ratification of our independent registered public accounting firm (Proposal No.&nbsp;2) is generally considered to be
a "routine" matter, and hence your brokerage firm </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=5,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=973139,FOLIO='3',FILE='DISK108:[18ZAG1.18ZAG41701]CA41701A.;8',USER='CHE106204',CD='25-APR-2018;16:37' -->
<A NAME="page_ca41701_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2>will
be able to vote on Proposal No.&nbsp;2 even if it does not receive instructions from you, so long as it holds your shares in its name. The proposal to approve an amendment to our Restated
Certificate of Incorporation, as amended, and grant of discretionary authority to the Board of Directors to effect a reverse stock split (Proposal No.&nbsp;3) is expected to be considered to be a
"routine" matter, and hence your brokerage firm is expected to be able to vote on Proposal No.&nbsp;3 even if it does not receive instructions from you, so long as it holds your shares in its name.
However, as discussed above, the determination of which proposals are deemed "routine" versus "non-routine" may not be made by the New York Stock Exchange until after the date on which this proxy
statement has been mailed to you. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What vote is required to approve each proposal?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of a majority of the outstanding shares entitled to vote must be present, in person or by proxy, at the Annual Meeting in order to have
the required quorum for the transaction of business. Pursuant to Delaware corporate law, abstentions and broker non-votes will be counted for the purpose of determining whether a quorum is present.
Abstentions and broker non-votes are not counted for the purpose of determining the number of votes cast and will therefore not have any effect with respect to any of the proposals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming
that a quorum is present, the following votes will be required:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> With respect to the election of directors (Proposal No.&nbsp;1), each nominee presented in Proposal 1 must be elected by a majority of the
votes cast in person or by proxy at the Annual Meeting. Nominees are elected by a majority vote for non-contested director elections. Because the number of nominees properly nominated for the Annual
Meeting is the same as the number of directors to be elected, the election of directors at this Annual Meeting is non-contested. If the number of votes "For" a nominee exceeds the number of votes
"Withheld" (among votes properly cast in person or by proxy), then the nominee will be elected. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> With respect to the ratification of the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm
(Proposal No.&nbsp;2), approval will require the affirmative vote of the holders of a majority of the total votes cast in person or by proxy at the Annual Meeting. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> With respect to the approval of an amendment to our Restated Certificate of Incorporation, as amended, and grant of discretionary authority to
the Board of Directors to effect a reverse stock split (Proposal No.&nbsp;3), approval will require the affirmative vote of the holders of a majority of the outstanding shares of common stock
entitled to vote at the Annual Meeting. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> With respect to the advisory vote on the compensation of our Named Executive Officers as disclosed in this proxy statement (Proposal
No.&nbsp;4), approval will require the affirmative vote of the holders of a majority of the total votes cast in person or by proxy at the Annual Meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of the common stock will not have any dissenters' rights of appraisal in connection with any of the matters to be voted on at the meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How are we soliciting this proxy</I></B></FONT><FONT SIZE=2>? </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are soliciting this proxy on behalf of our Board of Directors by mail and will pay all expenses associated therewith. Some of our officers and other employees also
may, but without compensation other than their regular compensation, solicit proxies by further mailing or personal
conversations, or by telephone, facsimile or other electronic means. We will also, upon request, reimburse brokers and other persons holding stock in their names, or in the names of nominees, for
their reasonable out-of-pocket expenses for forwarding proxy materials to the beneficial owners of the capital stock and to obtain proxies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=6,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=648700,FOLIO='4',FILE='DISK108:[18ZAG1.18ZAG41701]CA41701A.;8',USER='CHE106204',CD='25-APR-2018;16:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ce41701_1_5"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ce41701_proposal_1__to_elect_eight_dir__pro05580"> </A>
<A NAME="toc_ce41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 1: TO ELECT EIGHT DIRECTORS TO SERVE UNTIL THE NEXT ANNUAL MEETING<BR>  AND UNTIL THEIR SUCCESSORS HAVE BEEN DULY<BR>  ELECTED AND QUALIFIED    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ce41701_(proposal_no._1)"> </A>
<A NAME="toc_ce41701_2"> </A></FONT> <FONT SIZE=2><B>  (Proposal No.&nbsp;1)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the Annual Meeting, eight directors are to be elected. All directors of the Company hold office until the next Annual Meeting of Stockholders
or until their respective successors are duly elected and qualified or their earlier resignation or removal. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is the intention of the persons named in the proxies for the holders of common stock to vote the proxies for the election of the nominees named below, unless otherwise specified in
any particular proxy. Our management does not contemplate that the nominees will become unavailable for any reason, but if that should occur before the meeting, proxies will be voted for another
nominee, or other nominees, to be selected by our Board of Directors. In accordance with our by-laws and Delaware law, a stockholder entitled to vote for the election of directors may withhold
authority to vote for certain nominees for directors or may withhold authority to vote for all nominees for directors. Each director
nominee must be elected by a majority of the votes cast in person or by proxy at the Annual Meeting. Nominees are elected by a majority vote for non-contested director elections. Because the number of
nominees properly nominated for the Annual Meeting is the same as the number of directors to be elected, the election of directors at this Annual Meeting is non-contested. Broker non-votes will not be
treated as a vote for or against any particular director nominee and will not affect the outcome of the election. Stockholders may not vote, or submit a proxy, for a greater number of nominees than
the eight nominees named below. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nominees for Election  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The persons listed below are our current directors and have been nominated for re-election (the "Director Nominees") to fill the eight director
positions to be elected by the holders of the common stock. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Directors

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year First<BR>
Became<BR>
Director </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Larry Ellberger (Chairman of the Board)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2003</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci (Chief Executive Officer)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>56</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Keith L. Brownlie</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>65</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Herbert J. Conrad</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James J. Marino</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gerald McMahon</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Harry H. Penner, Jr.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>72</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1997</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Karen L. Shoos</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2001</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following biographical descriptions set forth certain information with respect to the Director Nominees, based on information furnished to Celldex by each Director Nominee. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Nominees  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>Larry Ellberger</B></FONT><FONT SIZE=2> was appointed Chairman of the Board of Directors in September 2009 and has been
a director of Celldex since August 2003. Mr.&nbsp;Ellberger was formerly Chairman of the Board of Omrix BioPharmaceuticals,&nbsp;Inc. until its acquisition by Johnson&nbsp;&amp; Johnson in 2008.
Mr.&nbsp;Ellberger was on the Board of Directors of NeuroDerm,&nbsp;Ltd. until its acquisition by Mitsubishi Tanabe Pharma Corporation in 2017. From 2003 to July 2012, Mr.&nbsp;Ellberger was
Founding Partner of HVA,&nbsp;Inc., a consulting firm specializing in business development, product acquisition and licensing, and mergers </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=7,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1025358,FOLIO='5',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2>and
acquisitions for pharmaceutical, biotechnology, drug delivery and medical device companies. From October 2005 to May 2006, Mr.&nbsp;Ellberger was Interim Chief Executive Officer of
PDI,&nbsp;Inc., a provider of sales and marketing services to the biopharmaceutical industry. Previously, he was a member of the Board of Directors of PDI and Chairman of the Audit Committee. From
2000 to 2003, Mr.&nbsp;Ellberger was Senior Vice President and a member of the Board of Directors of Powderject&nbsp;PLC, a U.K. vaccine company. From 1995 to 1999, Mr.&nbsp;Ellberger held
several senior executive positions at W.R. Grace&nbsp;&amp;&nbsp;Co. including Interim Chief Executive Officer, Chief Financial Officer and Senior Vice President, Strategic Planning and Development.
From 1975 to 1995, Mr.&nbsp;Ellberger held numerous senior executive positions at American Cyanamid Company, serving the last four years as Vice President, Corporate Development. He is also a
Director of The Jewish Children's Museum. Mr.&nbsp;Ellberger received a B.A. in Economics from Columbia College and a B.Sc. in Chemical Engineering from Columbia School of Engineering. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Anthony S. Marucci</B></FONT><FONT SIZE=2> was appointed President and Chief Executive Officer of Celldex in September 2008 and as a director of Celldex in
December 2008. Since May 2003, Mr.&nbsp;Marucci has held a number of roles with Celldex, including as a founder, Vice President, Chief Financial Officer, Treasurer and Secretary. In addition, he was
Treasurer of Medarex,&nbsp;Inc. (now a part of Bristol-Myers Squibb&nbsp;Co.) from December 1998 to March 2004. Mr.&nbsp;Marucci held a series of senior financial positions at Medarex from
December 1998 to May 2003. Mr.&nbsp;Marucci is a member of the Board of Trustees of BioNJ&nbsp;Inc. and also served as its Treasurer through 2010. Mr.&nbsp;Marucci is a member of the Board of
the College of Business and Public Management at Kean University. Mr.&nbsp;Marucci received his M.B.A. from Columbia University and his E.M.H.L. from Brown University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Keith L. Brownlie</B></FONT><FONT SIZE=2> became a director of Celldex in June 2017. Mr.&nbsp;Brownlie was employed by the accounting firm Ernst&nbsp;&amp;
Young&nbsp;LLP from 1974 to 2010. At Ernst&nbsp;&amp; Young, he served as audit partner for numerous public companies and was the Life Sciences Industry Leader for the New York Metro Area. Since his
retirement from Ernst&nbsp;&amp; Young in 2010, Mr.&nbsp;Brownlie has served as a member of the board of
directors and chairman of the audit committee of Soligenix,&nbsp;Inc., a publicly held biopharmaceutical company. Since 2012, Mr.&nbsp;Brownlie has served as a member of the board of directors and
served as the chairman of the audit committee of RXi Pharmaceuticals Corporation, a publicly held biopharmaceutical company. From 2011 to 2013, Mr.&nbsp;Brownlie also served as a member of the board
of directors and served as the chairman of the audit committee of EpiCept Corporation, a publicly held biopharmaceutical company. From 2013 to 2014, Mr.&nbsp;Brownlie was a member of the board of
directors and served as the chairman of the audit committee of Cancer Genetics,&nbsp;Inc., a publicly held biopharmaceutical company. Mr.&nbsp;Brownlie received a B.S. in Accounting from Lehigh
University and is a Certified Public Accountant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Herbert J. Conrad</B></FONT><FONT SIZE=2> became a director of Celldex in March 2008 upon consummation of the AVANT Merger. Mr.&nbsp;Conrad had been a director
of Celldex Research since March 2004. Mr.&nbsp;Conrad was President of the U.S. Pharmaceuticals Division of Hoffmann-La Roche,&nbsp;Inc., a pharmaceutical company, from 1982 until his retirement
in 1993. Mr.&nbsp;Conrad currently serves as Chairman of the Board of Matinas BioPharma Holdings,&nbsp;Inc., a publicly held biopharmaceutical company and a director of Arbutus Biopharma
Corporation, a publicly held biopharmaceutical company. Mr.&nbsp;Conrad serves as an Advisor to the Seaver Autism Center at Mount Sinai Hospital. In addition to serving on the board of directors of
privately held biotechnology companies, Mr.&nbsp;Conrad has served as Chairman of the Board of Directors of Pharmasset,&nbsp;Inc., GenVec,&nbsp;Inc. and Bone Care International,&nbsp;Inc.
Mr.&nbsp;Conrad has also served as director of Savient Pharmaceuticals,&nbsp;Inc. and was a director and co-founder of Reliant Pharmaceuticals,&nbsp;Inc. He received B.S. and M.S. degrees from
the Brooklyn College of Pharmacy and an honorary Doctorate in Humane Letters from Long Island University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>James J. Marino</B></FONT><FONT SIZE=2> became a director of Celldex in March 2017. Mr.&nbsp;Marino has served as a member of the board of directors of Onconova
Therapeutics,&nbsp;Inc., a publicly held biopharmaceutical company, since July 2015 and is currently a member of their Audit and Compensation Committees. Prior to July </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=8,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=761647,FOLIO='6',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_7"> </A>

<P style="font-family:times;"><FONT SIZE=2>2015,
Mr.&nbsp;Marino was a Partner at the global law firm of Dechert&nbsp;LLP for 28&nbsp;years, where he served as Managing Partner of the Princeton Office. Previously, he served on the board
of directors of Pharmacopeia&nbsp;Inc. and has worked in advisory capacities and on the boards of multiple non-profit organizations, including Robert Wood Johnson University Hospital. He currently
serves on the Board of Trustees of Wake Forest University and Wake Forest University Baptist Medical Center. Mr.&nbsp;Marino received his B.A., M.B.A., and J.D. from Rutgers University. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Gerald McMahon</B></FONT><FONT SIZE=2> became a director of Celldex in December 2016. Since December 2016, Dr.&nbsp;McMahon has been President and Chief
Executive Officer of Harpoon Therapeutics,&nbsp;Inc., a private biopharmaceutical company. From May 2012 until Celldex's acquisition of Kolltan in November 2016, Dr.&nbsp;McMahon served as
President and Chief Executive Officer and a member of the board of directors of Kolltan, a private biopharmaceutical company. Prior to joining Kolltan, Dr.&nbsp;McMahon served as Senior Vice
President of Oncology at MedImmune&nbsp;LLC, a wholly owned subsidiary of the healthcare
company AstraZeneca AB, or AstraZeneca, from October 2010 to May 2012. From 2006 to 2008, Dr.&nbsp;McMahon served as the Chairman and Chief Executive Officer of the pharmaceutical company NeoRx
Corp. From 2008 to 2011, Dr.&nbsp;McMahon served as the Chairman and Chief Executive Officer of Poniard Pharmaceuticals,&nbsp;Inc. Previously, Dr.&nbsp;McMahon served as a business executive in
the healthcare and biotechnology industries at companies such as Pfizer&nbsp;Inc., Pharmacia Corporation, and Sandoz,&nbsp;Inc. Dr.&nbsp;McMahon also previously served as President of
Sugen&nbsp;Inc., a pharmaceutical company and former subsidiary of Pfizer. Dr.&nbsp;McMahon holds a B.S. in biology and a Ph.D. in biochemistry from Rensselaer Polytechnic Institute. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Harry H. Penner, Jr.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;has been a director of Celldex since January 1997 and was Chairman of AVANT prior to the consummation of the AVANT
Merger.
Mr.&nbsp;Penner has served as Chairman and Chief Executive Officer of Nascent BioScience,&nbsp;LLC, a firm engaged in the creation and development of new life science companies since 2001. From
1993 to 2001, Mr.&nbsp;Penner was President, Chief Executive Officer and Vice Chairman of Neurogen Corporation. From 1985 to 1993, Mr.&nbsp;Penner was an Executive Vice President of Novo Nordisk
A/S, serving from 1988 to 1993 as Executive Vice President for North America and President, Novo Nordisk of North America, and from 1985 to 1988 as the company's Executive Vice President and General
Counsel in Denmark. He has served as BioScience Advisor to the Governor and the State of Connecticut, as Co-Chairman of BioCT (formerly Connecticut United for Research Excellence), and as Chairman of
the Connecticut Board of Governors of Higher Education and the Connecticut Technology Council. In addition to having served on the board of directors of several public and privately held life science
companies, Mr.&nbsp;Penner is currently Chairman of the Board of Affinimark Technologies,&nbsp;Inc., NeuroCyte Therapeutics,&nbsp;Inc. and QCDx&nbsp;LLC, and a board member of
OmaxHealth,&nbsp;Inc., all of which he is a founder. Mr.&nbsp;Penner received a B.A. from the University of Virginia, a J.D. from Fordham University, and an L.L.M. in International Law from New
York University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Karen L. Shoos</B></FONT><FONT SIZE=2> has been a director of Celldex since May 2001. Ms.&nbsp;Shoos is currently a consultant in international blood safety and
since November 2015, Ms.&nbsp;Shoos has been the Director of Operations for the Maryland Tech Council Venture Mentoring Services Program. From May 2013 to September 2016, Ms.&nbsp;Shoos was
Principal Investigator, AABB International Technical Assistance. From October 1994 to May 2013, Ms.&nbsp;Shoos was Chief Executive Officer of AABB. AABB is a professional standards setting and
accrediting organization in the fields of blood and cellular therapies. Prior to AABB, from 1984 to 1994, Ms.&nbsp;Shoos held senior positions at the American Red Cross, including Acting Senior Vice
President, Biomedical Services (1993-1994) and Secretary and General Counsel (1990-1993). Prior to the American Red Cross, Ms.&nbsp;Shoos was a lawyer in private practice. Ms.&nbsp;Shoos earned
her B.A. from Yale University and her J.D. from Case Western Reserve University. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=9,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=889673,FOLIO='7',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_8"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Family Relationships  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are no family relationships among our Director Nominees, management and other key personnel. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


The Board of Directors and Its Committees  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board of Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are currently managed by an eight member Board of Directors, a majority of whom are "independent" as that term is defined in the applicable
NASDAQ listing standards. Other than Mr.&nbsp;Marucci and Dr.&nbsp;McMahon, each of our directors is deemed "independent" as that term is defined in the applicable NASDAQ listing standards. Our
Board of Directors met six times in 2017. Each of the directors attended at least 75% of the aggregate of (i)&nbsp;the total number of meetings of our Board of Directors (held during the period for
which such directors served on the Board of Directors) and (ii)&nbsp;the total number of meetings of all committees of our Board of Directors on which the Director served (during the periods for
which the director served on such committee or committees). Our annual meeting of stockholders is generally held to coincide with one of the Board's regularly scheduled meetings. We do not have a
formal policy requiring members of the Board of Directors to attend our annual meetings, although our directors typically attend the annual meeting. Each of the then current directors attended the
2017 Annual Meeting of Stockholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established an Audit Committee currently consisting of Keith L. Brownlie, Chair, Larry Ellberger and Harry H. Penner,
Jr. The Audit Committee makes recommendations concerning the engagement of independent public accountants, reviews with the
independent public accountants the scope and results of the audit engagement, approves professional services provided by the independent public accountants, reviews the independence of the independent
public accountants, considers the range of audit and non-audit fees, and reviews the adequacy of our internal accounting controls. Each member of the Audit Committee is "independent" as that term is
defined in the rules of the SEC and the applicable NASDAQ listing standards. The Board has determined that each Audit Committee member has sufficient knowledge in financial and auditing matters to
serve on the Committee. The Board has designated Mr.&nbsp;Brownlie as an "audit committee financial expert," as defined under the applicable rules of the SEC and the applicable NASDAQ listing
standards. The Audit Committee met six times during 2017. Our Board has adopted an Audit Committee Charter, which is available for viewing at </FONT> <FONT SIZE=2><I>www.celldex.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established a Compensation Committee currently consisting of James&nbsp;J. Marino, Chair, Herbert J. Conrad and
Harry H. Penner, Jr. The primary function of the Compensation Committee is to assist the Board in the establishment of compensation for the Chief Executive Officer, to approve the compensation of
other officers and senior employees and to approve certain other personnel and employee benefit matters. Each member of the Compensation Committee is "independent" as that term is defined in the rules
of the SEC and the applicable NASDAQ listing standards. In 2017, the Compensation Committee engaged Radford, a part of Aon&nbsp;plc, to provide guidance on various aspects of the company's board and
executive compensation programs. The Compensation Committee has assessed the independence of Radford and concluded that no conflict of interests exists under applicable SEC rules. The Compensation
Committee met eight times during 2017. Our Board has adopted a Compensation Committee Charter, which is available for viewing at </FONT><FONT SIZE=2><I>www.celldex.com.</I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=10,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=197635,FOLIO='8',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_9"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nominating and Corporate Governance Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Karen L. Shoos, Chair, Herbert J.
Conrad and Larry Ellberger. The primary function of the Nominating and Corporate Governance Committee is to assist the Board in reviewing, investigating and addressing issues regarding Board
composition, policy and structure; membership on Board committees; and other matters regarding our governance. Each member of the
Nominating and Corporate Governance Committee is "independent" as that term is defined in the rules of the SEC and the applicable NASDAQ listing standards. The Nominating and Corporate Governance
Committee met four times during 2017. Our Board has adopted a Nominating and Corporate Governance Committee Charter, which is available for viewing at </FONT> <FONT SIZE=2><I>www.celldex.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director selection criteria  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Nominating and Corporate Governance Committee is responsible for reviewing, on an annual basis, the appropriate mix of professional
competencies, key attributes, skills and experiences required of board members to work together as a team to properly oversee our strategies and operations. The process followed by the Nominating and
Corporate Governance Committee to evaluate any candidates whether identified or recommended by board members, management, members of the Nominating and Corporate Governance Committee, stockholders or
other external sources, includes meetings from time to time to evaluate biographical information and background material relating to potential candidates to the Board and interviews of selected
candidates by members of the Committee and the Board. All nominees must have, at a minimum, high personal and professional integrity, exceptional ability and judgment, and be effective in collectively
serving the long-term interests of all stockholders, all as described above. Other qualifications that may be considered by the Committee are described in the Nominating and Corporate Governance
Committee Charter. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
board members are expected to possess certain key attributes necessary to creating a functional board: high personal and professional ethics, integrity and values; practical wisdom
and mature judgment; an inquisitive and objective perspective; professional experience at a policy-making level in business, government, education or medicine; time availability for in-person
participation at board and committee meetings; and a commitment to representing the long-term interests of our stockholders. We look for directors with professional competencies that include senior
management operational experience, accounting and finance capabilities, deep industry-related experience, biologic development and manufacturing expertise, business development leadership, medical and
scientific proficiencies, and government and public policy experience. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of our directors brings unique perspectives and experiences to the Board of Directors and contributes in guiding and directing our strategies to meet our business objectives and to
provide value to our stockholders. For example, Mr.&nbsp;Conrad, Mr.&nbsp;Ellberger, Mr.&nbsp;Marucci, Dr.&nbsp;McMahon, Mr.&nbsp;Penner and Ms.&nbsp;Shoos have all either currently or
formerly been chief executive officers of life sciences or healthcare-related companies and have experienced the challenges of such a position. Messrs.&nbsp;Ellberger and Marucci have formerly been
chief financial and chief corporate development officers at pharmaceutical and life sciences companies and have completed a significant number of financing and business development transactions.
Ms.&nbsp;Shoos has experience in the highly regulated blood supply and cellular therapies sectors, which are similar to our regulated biologics industry. Mr.&nbsp;Penner has been the chief legal
officer at a large public pharmaceutical company and for that company and for life sciences companies has completed a significant number of financing and business development transactions.
Mr.&nbsp;Marino, as partner at a large law firm, focused his practice on representing public and private life
sciences companies and has extensive experience advising his clients in the full range of corporate, transactional, finance, compliance and governance matters. Mr.&nbsp;Brownlie, as partner at an
international public accounting firm and leader of the firm's regional life sciences industry practice, and as chairman of the audit committees of other publicly traded biopharmaceutical companies,
has </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=11,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=640990,FOLIO='9',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2>developed
a deep knowledge of the life sciences industry and the relevant public company accounting standards and regulations and is deemed a "Financial Expert" under the Sarbanes-Oxley Act as that
term is defined by the SEC. Messrs.&nbsp;Brownlie, Conrad and Ellberger have many years of experience on the boards of directors of larger public pharmaceutical and life sciences companies. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independence
also is an important selection criterion for nomination to our Board. Independent directors should be free of any relationship with us, our management, other directors or
other parties that may impair, or appear to impair, the director's ability to make independent judgments. Independent directors must satisfy the criteria for independence established by NASDAQ.
Currently all of our directors are independent except for Dr.&nbsp;McMahon and our Chief Executive Officer, Mr.&nbsp;Marucci. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
all board members are expected to act in our best interests and the best interests of our stockholders and to avoid any conflicts of interest in accordance with our Code of
Business Conduct and Ethics. In selecting director nominees, the Nominating and Corporate Governance Committee seeks individuals who are free from conflicts of interest. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finally,
candidates should be enthusiastic and excited about their service on our Board and working collaboratively with existing board members to create value for all of our
stockholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stockholder nominations for directorships  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders may propose a potential director candidate for consideration by the Nominating and Corporate Governance Committee by submitting
their names and background to the Secretary of Celldex at Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ 08827. All such recommendations will be forwarded to the Nominating
and Corporate Governance Committee, which will review and consider only such recommendations if appropriate biographical and other information is provided, as described below, on a timely basis. All
security holder recommendations for director candidates must be submitted to us not less than 120 calendar days prior to the date on which
our proxy statement is released to stockholders in connection with our annual meeting, and must include the following information:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the name and address of record of the security holder; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a representation that the security holder is a record holder of our securities, or if the security holder is not a record holder, evidence of
ownership in accordance with Rule&nbsp;14a-8(b)(2) of the Securities Exchange Act of 1934; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the name, age, business and residential address, educational background, current principal occupation or employment, and principal occupation
or employment for the preceding five&nbsp;(5) full fiscal years of the proposed director candidate; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a description of the qualifications and background of the proposed director candidate which addresses the minimum qualifications and other
criteria for Board membership approved by the Board from time to time and set forth in the Nominating and Corporate Governance Committee Charter; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a description of any arrangements or understandings between the security holder and the proposed director candidate; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the consent of the proposed director candidate to be named in the proxy statement relating to our annual meeting of stockholders and to serve
as a director if elected at such annual meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming
that appropriate information is provided for candidates recommended by stockholders, the Nominating and Corporate Governance Committee will evaluate those candidates by
following </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=12,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=8659,FOLIO='10',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2>substantially
the same process, and applying substantially the same criteria, as for candidates submitted by Board members or other persons, as described above and as set forth in its written charter. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Leadership Structure  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board recognizes that one of its key responsibilities is to evaluate and determine its optimal leadership structure so as to provide
independent oversight of management. The Board understands that there is no single, generally accepted approach to providing Board leadership and that given the dynamic and competitive environment in
which we operate, the right Board leadership structure may vary as circumstances warrant. Consistent with this understanding, the Nominating and Corporate Governance Committee considers the Board's
leadership structure on an annual basis. This consideration includes the pros and cons of alternative leadership structures in light of the Company's operating and governance environment at the time,
with the goal of achieving the optimal model for effective oversight of management by the Board. Currently, the roles of Chief Executive Officer and Chairman of the Board are separate.
Mr.&nbsp;Marucci, our Chief Executive Officer, is a member of our Board. Mr.&nbsp;Ellberger, an independent director, serves as Chairman of the Board. The Board believes that its current
leadership structure provides independent board leadership, engagement and oversight. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, our independent committee chairs are responsible for leading committee meetings, determining committee meeting schedules, agenda and information flow, and reporting to the
full Board on the committee's actions and areas of responsibilities. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risk Oversight  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our management is responsible for assessing and managing risk and the Board of Directors oversees and reviews certain aspects of our risk
management processes. The Board of Directors is involved in risk oversight through direct decision-making authority with respect to significant matters and the oversight of management by the Board of
Directors and its committees. The Board is responsible for overseeing risks related to our overall operations and strategy, including, among others, product development, potential asset acquisitions,
financial reporting, business continuity (including succession planning) and reputational risks faced by us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
committees of the Board execute their oversight responsibility for risk management as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Audit Committee is responsible for overseeing our internal financial and accounting controls and the work performed by the independent
registered public accounting firm. As part of its oversight function, the Audit Committee regularly discusses with management and the independent registered public accounting firm our major financial
and controls-related risk exposures and steps that management has taken to monitor and control such exposures. The Audit Committee also reviews our risk management insurance programs. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Compensation Committee is responsible for overseeing risks related to our cash and equity-based compensation programs and practices. As
part of its oversight function, the Compensation Committee periodically discusses with the President and Chief Executive Officer as well as the Board of Directors, as necessary, the compensation plan
for both executive officers and the independent directors, performance goals and objectives for the period and related achievement, peer group and other relevant compensation benchmarks and practices
and other matters to ensure our compensation practices are in our best interest and that of our shareholders. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Nominating and Corporate Governance Committee is responsible for overseeing risks related to the composition and structure of the Board of
Directors and its committees and our corporate governance. In this regard, the Nominating and Corporate Governance Committee assesses the qualifications and independence of members of the Board, makes
annual recommendations regarding Board and committee membership, and reviews any transactions </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=13,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1025945,FOLIO='11',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_12"> </A>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>between
us and our officers, directors, affiliates of officers and directors or other related parties for conflicts of interest. </FONT></P>

</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Governance Matters  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the recommendation of our Nominating and Corporate Governance Committee, we adopted amended and restated by-laws to, among other things,
replace a plurality voting standard with a majority voting standard for uncontested elections of directors and eliminate the mandatory retirement age for directors. Since it is an uncontested election
at this Annual Meeting, all director nominees are required to receive a number of "FOR" votes representing at least a majority of votes cast in the election. If such a director nominee fails to
receive "FOR" votes representing at least a majority of votes cast and is an incumbent director, the by-laws require the director to promptly tender his or her resignation to the Board, subject to
acceptance by the Board. The Nominating and Corporate Governance Committee of the Board would then be charged with making a recommendation to the Board as to whether to accept or reject the tendered
resignation, or whether other action should be taken. In contested elections, where the number of nominees exceeds the number of directors to be elected, the plurality voting standard would continue
to apply. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, upon the recommendation of our Nominating and Corporate Governance Committee, we adopted corporate governance guidelines which are available for viewing at </FONT> <FONT SIZE=2><I>www.celldex.com.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stockholder Communications  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors will give appropriate attention to written communications that are submitted by stockholders, and will respond if and as
appropriate. Absent unusual circumstances or as contemplated by committee charters, and subject to advice from legal counsel, the
Secretary of Celldex is primarily responsible for monitoring communications from stockholders and for providing copies or summaries of such communications to the Board of Directors as he considers
appropriate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Communications
from stockholders will be forwarded to all directors if they relate to important substantive matters or if they include suggestions or comments that the Secretary
considers to be important for the Board of Directors to know. Communication relating to corporate governance and corporate strategy are more likely to be forwarded to the Board of Directors than
communications regarding personal grievances, ordinary business matters and matters as to which Celldex tends to receive repetitive or duplicative communications. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders
who wish to send communications to the Board of Directors should address such communications to: The Board of Directors, Celldex Therapeutics,&nbsp;Inc., Perryville III
Building, 53&nbsp;Frontage Road, Suite&nbsp;220, Hampton, NJ 08827, Attention: Secretary. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Code of Business Conduct and Ethics  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a Code of Business Conduct and Ethics that applies to our directors, officers and employees. The purpose of the Code of Business
Conduct and Ethics is to deter wrongdoing and to promote, among other things, honest and ethical conduct and to ensure to the extent possible that our business is conducted in a consistently legal and
ethical manner. Our Code of Business Conduct and Ethics is publicly available on our website at www.celldex.com. If we make any substantive amendments to the Code of Business Conduct and Ethics or
grant any waiver, including any implicit waiver from a provision of the Code of Business Conduct and Ethics to our Directors or Executive Officers, we will disclose the nature of such amendments or
waiver on our website or in a current report on Form&nbsp;8-K. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=14,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=512530,FOLIO='12',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_13"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding our current executive officers: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="187pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="351pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name of Individual

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position and Office </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>56</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>President, Chief Executive Officer and Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>59</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Executive Vice President and Chief Scientific Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sarah Cavanaugh</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>43</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Senior Vice President, Corporate Affairs and Administration</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Elizabeth Crowley</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>46</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Product Development Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Margo Heath-Chiozzi, M.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President, Regulatory Affairs</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sam Martin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>47</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Senior Vice President, Chief Financial Officer and Secretary</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ronald Pepin, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>62</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Business Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>54</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Commercial Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Anthony S. Marucci</B></FONT><FONT SIZE=2> was appointed President and Chief Executive Officer of Celldex in September 2008 and as a director of the Company in
December 2008. See Mr.&nbsp;Marucci's biography under </FONT><FONT SIZE=2><I>Director Nominees</I></FONT><FONT SIZE=2> above. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Tibor Keler, Ph.D.</B></FONT><FONT SIZE=2> became Executive Vice President and Chief Scientific Officer of Celldex in July 2014. Since May 2003, Dr.&nbsp;Keler
has held a number of positions with Celldex, including as a founder, Senior Vice President and Chief Scientific Officer of Celldex, from March 2008 to July 2014, and Vice President, Research and
Discovery and Chief Scientific Officer, from May 2003 to March 2008. In addition, he was Senior Director of Preclinical Development and Principal Scientist at Medarex from September 1993 to March
2004. Dr.&nbsp;Keler received his Ph.D. in Microbiology from the University of Pennsylvania. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Sarah Cavanaugh</B></FONT><FONT SIZE=2> became Senior Vice President, Corporate Affairs and Administration in June 2017. Ms.&nbsp;Cavanaugh served as Vice
President, Investor Relations and Corporate Communications of Celldex from August 2012 to June 2017. Prior to Celldex, she served from 2007 to 2012 as a Vice President at MacDougall Biomedical
Communications, a strategic communications and investor relations firm for the life sciences industry. Ms.&nbsp;Cavanaugh previously served as Director of Corporate Communications for Point
Therapeutics,&nbsp;Inc., an oncology-focused biotech company, and Director of Corporate Communications for Fallon Community Health Plan, a leading Massachusetts managed care organization. She began
her health care career at the American Cancer Society, holding various positions prior to completing her tenure there as Division Communications and Marketing Director for the Mid-South Division.
Ms.&nbsp;Cavanaugh received her B.A. from the University of New Hampshire. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Elizabeth Crowley</B></FONT><FONT SIZE=2> became Senior Vice President and Chief Product Development Officer in August 2016. Ms.&nbsp;Crowley served as Senior
Vice President, Product Development of Celldex from July 2014 to August 2016. Ms.&nbsp;Crowley joined Celldex in 2009 as Vice President, Clinical Development. Prior to that, she held several senior
level roles at CuraGen Corporation, most recently serving as the Vice President of Development Operations. Ms.&nbsp;Crowley started her career at Bayer Corporation in 1992, holding various positions
providing leadership of clinical research and project management prior to completing her tenure there as the Director of Global Study Audit Management. Ms.&nbsp;Crowley received her B.S. in
Chemistry with a concentration in Business from Boston College. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Margo Heath-Chiozzi, M.D.</B></FONT><FONT SIZE=2> became Senior Vice President, Regulatory Affairs in October 2017. Previously from 2003 until September 2017,
Dr.&nbsp;Heath-Chiozzi served in roles of increasing responsibility at Bristol-Myers Squibb Company including Executive Director, Global Regulatory Sciences; Vice President, Global Regulatory
Strategy; and Vice President, Global Submissions and Regulatory Policy. Prior to that, from 1995 to 2003, Dr.&nbsp;Heath-Chiozzi served in roles of increasing
responsibility at Abbott Laboratories, including Medical Director, Pharmacogenetics; Senior Director, Global Marketed Product Development and Outcomes Research; and Global Project Head,
Abbott/Millennium Obesity/Diabetes Alliance. Before joining Abbott, she was appointed to the University of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=15,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=732396,FOLIO='13',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ce41701_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2>Hawaii
John A. Burns School of Medicine, where she served as Assistant Professor, and was concurrently Director of the HIV Research Clinical at the Queen's Medical Center as well as Director of the
Women's Immunology Clinical at the Kapiolani Medical Center for Women and Children, in Honolulu. Dr.&nbsp;Heath-Chiozzi received her B.S. and M.D. from the University of Utah. She received further
medical training in internal medicine at Duke University and completed fellowships in infectious disease at Brigham&nbsp;&amp; Women's Hospital and Dana-Farber Cancer Institute in Boston. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Sam Martin</B></FONT><FONT SIZE=2> became Senior Vice President, Chief Financial Officer and Secretary in July 2017. Mr.&nbsp;Martin served as Vice President,
Finance of Celldex from January 2015 to July 2017 and Senior Director, Finance of Celldex from August 2011 to January 2015. Mr.&nbsp;Martin joined Celldex as the Director of Financial Reporting,
Planning and Analysis in 2009. Prior to joining Celldex, from 2000 to 2009, Mr.&nbsp;Martin served in roles of increasing responsibility at Alseres Pharmaceuticals,&nbsp;Inc., most recently
serving as the Director of Finance and Corporate Compliance. Mr.&nbsp;Martin began his career at Ernst&nbsp;&amp; Young&nbsp;LLP, holding various positions prior to completing his tenure as Audit
Manager. Mr.&nbsp;Martin received an M.B.A. from Boston University, a B.S. from Skidmore College and is a Certified Public Accountant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Ronald Pepin, Ph.D.</B></FONT><FONT SIZE=2> became Senior Vice President and Chief Business Officer of Celldex in July 2011. From June 2010 to April 2011,
Dr.&nbsp;Pepin served as Vice President at Shire Pharmaceuticals. From August 2000 to December 2009, Dr.&nbsp;Pepin was Senior Vice President, Business Development at Medarex. Earlier in his
career, Dr.&nbsp;Pepin was Executive Director of External Science and Technology at Bristol-Myers Squibb Company. Dr.&nbsp;Pepin received his B.A. from Tufts University and his Ph.D. in Genetics
from Georgetown University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Richard Wright, Ph.D.</B></FONT><FONT SIZE=2> became Senior Vice President and Chief Commercial Officer of Celldex in July 2015. Dr.&nbsp;Wright served as Vice
President of Commercial Operations of Celldex from April 2012 to July 2015. From November 2010 to April 2012, Dr.&nbsp;Wright was Managing Director of Navigant Consulting, a global life sciences
consulting practice. From September 2003 to October 2010, Dr.&nbsp;Wright held several senior leadership roles at Bristol-Myers Squibb including Senior Vice President of the U.S. ImmunoScience
Division. Dr.&nbsp;Wright currently serves on the Scientific Advisory Board for the Seaver Foundation, a nonprofit organization supporting the Center for Autism Treatment and Research at Mount Sinai
Hospital. Dr.&nbsp;Wright received his B.S. in Biological Sciences from Rutgers University and his M.S. and Ph.D. in Microbiology and Molecular Genetics from The University of Medicine and Dentistry
of New Jersey (Rutgers University). He received an M.B.A. in Marketing and Finance from Columbia University. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=16,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=92028,FOLIO='14',FILE='DISK108:[18ZAG1.18ZAG41701]CE41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_da41701_1_15"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


EXECUTIVE COMPENSATION  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="da41701_compensation_discussion_and_analysis"> </A>
<A NAME="toc_da41701_1"> </A></FONT> <FONT SIZE=2><B>  Compensation Discussion and Analysis    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Introduction  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Compensation Committee oversees and administers our executive compensation programs. The Committee's complete roles and responsibilities are
set forth in the written charter of the Compensation Committee adopted by our Board of Directors, which can be found at our website, </FONT><FONT SIZE=2><I>www.celldex.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation programs are designed to deliver compensation that is competitive with our peer group and that allows us to attract
and retain superior talent who can perform effectively and succeed in a demanding business environment. Our compensation programs are also designed to reward performance against pre-established goals
and align the interests of our executives with our stockholders. We believe that the compensation of our executive officers should focus executive behavior on the achievement of near-term corporate
targets as well as long-term business objectives and strategies. We believe that pay-for-performance compensation programs, which reward our executives when they achieve individual and/or corporate
goals, create stockholder value and thus have emphasized company and individual performance in setting compensation. We use a combination of base salary, annual cash incentive compensation programs, a
long-term equity incentive compensation program and a broad-based benefits program to create a competitive compensation package for our executive management team. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
describe below our compensation philosophy, policies and practices with respect to our (i)&nbsp;Chief Executive Officer, (ii)&nbsp;all individuals serving as Chief Financial
Officer during fiscal 2017, (iii)&nbsp;our three most highly compensated executive officers, other than the Chief Executive Officer and Chief Financial Officer, who were serving as executive
officers as of December&nbsp;31, 2017, and (iv)&nbsp;up to two other individuals who would have been included as the three most highly compensated executive officers but for the fact that they
were not serving as an executive officer at December&nbsp;31, 2017, who are collectively referred to as our Named Executive Officers. In 2017, our Named Executive Officers include
Mr.&nbsp;Marucci, Dr.&nbsp;Thomas Davis (our former Executive Vice President and Chief Medical Officer who resigned effective September&nbsp;29, 2017), Dr.&nbsp;Keler, Avery W. Catlin (our
former Chief Financial Officer who retired in June 2017), Ms.&nbsp;Crowley, Mr.&nbsp;Martin and Dr.&nbsp;Wright. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a biopharmaceutical company focusing on the development of a pipeline of drug candidates to treat cancer and other difficult-to-treat diseases and several immunotherapy technologies,
we establish corporate goals that are designed to contribute to the development of our lead programs and to ensure that we manage our cash effectively and have sufficient funding to complete near-term
development activities for our lead drug candidates and, where appropriate, to pursue partnerships and collaborations through which we can leverage the value of our drug candidates. We seek to link
the financial interests of our Named Executive Officers to those of our stockholders by tying compensation to the achievement of these strategic corporate goals, which we believe will drive long-term
stockholder value. Each year we establish corporate goals, the achievement of which we believe are essential to the long-term success of our business. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee has adopted a compensation philosophy of targeting our executive compensation to the 50<SUP>th</SUP>&nbsp;percentile of executive compensation of our peer
group and the Radford Global Life Sciences Survey results. Executive compensation may be above or below the 50<SUP>th</SUP>&nbsp;percentile based on an executive's experience, scope of position,
individual performance and company constraints. The Compensation Committee increased the annual base salary for Mr.&nbsp;Marucci, Dr.&nbsp;Davis, Dr.&nbsp;Keler, Ms.&nbsp;Crowley and
Dr.&nbsp;Wright by 2.0% to 3.5% in mid-2017, depending on the position. Mr.&nbsp;Martin's </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=17,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=798109,FOLIO='15',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2>annual
base salary increased 25.5% upon his promotion to Senior Vice President and Chief Financial Officer in July 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2017 and January 2018, our Compensation Committee reviewed our performance relative to our 2017 corporate goals and concluded that we had achieved 85% of our pipeline
development, business and financial operations goals, particularly with respect to progress in our lead clinical program, glembatumumab vedotin, and earlier stage clinical programs. Our Compensation
Committee approved annual bonus payments of 85.0% to 93.6% of the 2017 bonus target for Mr.&nbsp;Marucci, Dr.&nbsp;Keler, Ms.&nbsp;Crowley, Mr.&nbsp;Martin and Dr.&nbsp;Wright, depending on
the position. Further, stock options granted to our executive officers in 2017 have exercise prices equal to 100% of the fair value on the date of grant and vest over four years, beginning with 25%
vesting one year after the date of grant, then pro-rata vesting quarterly thereafter based on continued service. We believe that stock options structured in this manner encourage our executive
officers to focus on increasing stockholder value and stock price appreciation over the long term and limit unnecessary risk taking behavior, while promoting retention. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017, we (i)&nbsp;ended the year with cash, cash equivalents and marketable securities of $139.4&nbsp;million, (ii)&nbsp;amended our at-the-market agreement with Cantor
Fitzgerald to provide for the sale, from time to time, of shares of common stock having an aggregate offering price of up to $75&nbsp;million and (iii)&nbsp;accomplished the following significant
clinical and operational milestones during the year: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Completed METRIC
enrollment:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;Enrollment in our Phase&nbsp;2b randomized study (METRIC) of glembatumumab vedotin in patients with metastatic triple negative
breast cancers that overexpress gpNMB completed enrollment in August. A total of 327 patients were enrolled across the United States, Canada, Australia and the European Union.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Continued progress in Phase&nbsp;2 study of glembatumumab vedotin in metastatic
melanoma:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;Enrollment advanced in glembatumumab vedotin plus checkpoint inhibitor (Opdivo&reg; or Keytruda&reg;) cohort for
patients who failed checkpoint therapy. Additionally, enrollment was completed in the varlilumab combination cohort, and data from this portion of the study were presented at the Society for
Immunotherapy of Cancer's (SITC) Annual Meeting in November. Mature data from the single-agent cohort of this study were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in
June.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Continued progress in Phase&nbsp;2 varlilumab/Opdivo
study:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;The Phase&nbsp;2 study of varlilumab and Opdivo continued to enroll patients across multiple indications (colorectal cancer, ovarian
cancer, head and neck squamous cell carcinoma, renal cell carcinoma and glioblastoma), and we completed enrollment across all cohorts in January 2018. Data from the Phase&nbsp;1 portion of the study
were presented at the ASCO Annual Meeting. We plan to work with Bristol-Myers Squibb to present Phase&nbsp;2 data at future medical meetings in 2018.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Initiated two clinical studies in
November:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We initiated an open-label Phase&nbsp;2 study of CDX-3379 in combination with Erbitux&reg; in HPV negative,
Erbitux-resistant, advanced head and neck squamous cell carcinoma. Additionally, we filed the IND and initiated a Phase&nbsp;1 study of CDX-1140 in patients with recurrent, locally advanced or
metastatic solid tumors. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Independent Compensation Consultants  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee believes that independent advice is important in developing Celldex's director and executive compensation programs
and engages Radford as its independent compensation consultant. In 2017, Radford provided advisory services in connection with the amendment and restatement of our 2008 Stock Option and Incentive
Plan, including an increase in the number of shares reserved for issuance under the Plan. In 2016, Radford reviewed both executive and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=18,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=330908,FOLIO='16',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2>director
compensation. Radford reports directly to the Committee and provides guidance on trends in executive and non-employee director compensation, the development of specific executive compensation
programs, the composition of the Company's compensation peer group and other matters as directed by the Committee. The Company also participated in various Radford surveys in 2017 and 2016. During
2017 and 2016, the Company paid Radford approximately $14,200 and $67,700, respectively, in consulting fees directly related to these services. In 2017 and 2016, Radford did not provide any other
services to Celldex. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Data Used to Make Compensation Determinations  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In making decisions regarding the compensation of our executive officers, the Compensation Committee generally considers compensation and survey
data for similarly situated executives at a comparison group of companies it considers our peer group. These comparison data are primarily used to gauge the reasonableness and competitiveness of
executive compensation decisions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
draw upon a pool of talent that is highly sought after by large and established pharmaceutical and biotechnology companies as well as by other development-stage life science
companies, both within and outside our geographic areas. We believe that the compensation practices of our industry in general and of our select peer group in particular provide useful information to
help us establish compensation practices that allow us to attract, retain, and motivate a highly talented executive team. We believe we must offer a compensation package to all of our officers and our
other employees that is competitive with our peer group, as well as larger pharmaceutical and biotechnology companies from whom we frequently recruit. In addition, the comparator companies should be
aligned with our current stage of development and have similar short and long-term growth objectives. In 2017, the Compensation Committee set the target level of total executive compensation, as well
as the key elements of compensation, at the 50<SUP>th</SUP>&nbsp;percentile of our peer group, but then adjusted each of the elements based on an individual's performance and contribution to our
strategic objectives. The Committee may need to adjust these levels in the future to attract or retain specific individuals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
review the levels of cash, equity and total compensation for all comparable officers in our peer group relative to the elements of compensation paid to our officers. In considering
how these data relate to our existing compensation structure, we take into account our size, stage of development, performance and geographic location as compared to these peer companies, as well as
what we know about the comparable scope of responsibilities of our officers versus those of comparable executives at such peer group companies. We used two primary market frames of reference (which we
refer to as the "market") against which to compare our total executive compensation practices and levels and inform our decisions regarding compensation of our officers as
follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Select Peer Group&#151;A select group of national biotechnology companies at a similar stage of development as our company with similar
headcount, R&amp;D expense, market capitalization and in most cases, similar therapeutic targets, and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Radford Global Life Sciences Survey&#151;A national survey of executive compensation levels and practices that covers approximately
sixty executive positions in over 600 multinational life sciences organizations. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not apply a specific weighting to either data source when making compensation comparisons. Instead, we develop competitive market guidelines using these data sources. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
review our peer group each year to ensure continued relevance as we grow and develop, and the Compensation Committee approves our peer group prior to its adoption. In April 2017, the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=19,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=536271,FOLIO='17',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2>following
peer group was approved by the Compensation Committee and used to inform our decisions affecting executive compensation in 2017: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Achillion Pharmaceuticals,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Merrimack Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Aduro BioTech,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Momenta Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Agenus&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>NewLink Genetics Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Clovis Oncology,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>OncoMed Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Epizyme,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Progenics Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Five Prime Therapeutics,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>PTC Therapeutics,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>ImmunoGen,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Puma Biotechnology,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Inovio Pharmaceuticals,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Sangamo BioSciences,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Insmed Incorporated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Xencor,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Keryx Biopharmaceuticals,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>ZIOPHARM Oncology,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>MacroGenics,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
peer group consisted of public companies in the biopharmaceutical industry with product candidates generally in late-stage development, with similar employee headcount (average of
186), R&amp;D expense less than $251&nbsp;million (average of $106&nbsp;million) and market capitalization in the range of $291&nbsp;million to $3.1&nbsp;billion (average of $800&nbsp;million).
We believe that, as of April 2017, this list was representative of the companies with whom we generally compete for talent. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Administration and Objectives of Our Executive Compensation Program  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of Directors, which comprises independent, non-employee directors, is responsible for establishing and
administering the policies governing the compensation of our employees, including salary, bonus and stock option grants. The policy of the Compensation Committee is to compensate our employees with
competitive salaries based on their level of experience and job performance. All permanent employees, including executive officers, are eligible for annual bonus awards based on achievement of our
strategic corporate goals and participation in our stock option program. The stock option grants are made in accordance with our 2008 Stock Option and Incentive Plan, as amended (the "2008 Plan"). The
Compensation Committee is also responsible for the administration of our 2004 Employee Stock Purchase Plan, as amended (the "2004 Plan"), in which employees participate on a voluntary basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Compensation Committee has designed our overall executive compensation program to achieve the following objectives:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> attract and retain talented and experienced executives; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> motivate and reward executives whose knowledge, skills and performance are critical to our success; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> provide a competitive compensation package that aligns the interests of our executive officers and stockholders by including a significant
variable component which is weighted heavily towards performance-based rewards, based upon achievement of predetermined goals; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> ensure fairness among the executive management team by recognizing the contributions each executive makes to our success; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> foster a shared commitment among executives by aligning our and their individual goals; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compensate our executives to manage our business to meet our near-term and long-term objectives. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
use a mix of short-term compensation (base salaries and cash incentive bonuses) and long-term compensation (equity incentive compensation) to provide a total compensation structure
that is </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=20,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=34429,FOLIO='18',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_19"> </A>

<P style="font-family:times;"><FONT SIZE=2>designed
to achieve these objectives. We determine the percentage mix of compensation structures that we think is appropriate for each of our executive officers. In general, the Compensation Committee
believes that a substantial percentage of the compensation of our executive officers should be performance based. The Compensation Committee uses its judgment, experience and the recommendations of
the chief executive officer (except for his own compensation) to determine the appropriate mix of compensation for each executive officer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
determining whether to adjust the compensation of any of our Named Executive Officers, we annually take into account the changes, if any, in the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> market compensation levels; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the contributions made by each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the performance of each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the increases or decreases in responsibilities and roles of each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the business needs of the Company with respect to each executive officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the relevance of each executive officer's experience to other potential employers; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the readiness of each executive officer to assume a more significant role within the organization. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, with respect to new executive officers, we take into account their prior base salary and annual cash incentives, their expected contribution and our business needs. We
believe that our executive officers should be fairly compensated each year relative to market pay levels within our industry. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Compensation Components  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to both attract and retain experienced and qualified executives to manage us, the Compensation Committee's policy on executive
compensation is to (i)&nbsp;pay salaries which are competitive with the salaries of executives in comparable positions in the biotechnology industry, and (ii)&nbsp;allow for additional
incentive-based compensation through the payment of annual cash bonuses and the grant of stock-based incentive awards. This policy is designed to have a significant portion of each executive's total
compensation be tied to our progress in order to incentivize the executive to fully dedicate himself or herself to achievement of corporate goals, and to align the executive's interest with those of
our stockholders through equity incentive compensation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
executive compensation program is primarily composed of base salary, incentive cash compensation payable on an annual basis and equity compensation. In addition, we provide our
executives with benefits that are generally available to our salaried employees, including medical, dental, group life and accidental death and dismemberment insurance, short- and long-term disability
coverage and our 401(k) plan. Within the context of the overall objectives of our compensation programs, we determined the specific amounts of compensation to be paid to each of our executives in 2017
based on a number of factors including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our understanding of the amount of compensation generally paid by similarly situated companies to their executives with similar roles and
responsibilities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the roles and responsibilities of our executives; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the individual experience and skills of, and expected contributions from, our executives; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the amounts of compensation being paid to our other executives; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our executives' historical compensation. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=21,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=995059,FOLIO='19',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
discuss each of the primary elements of our executive compensation in detail below. While we have identified particular compensation objectives that each element of executive
compensation serves, our compensation programs complement each other and collectively serve all of our executive compensation objectives described above. Accordingly, whether or not specifically
mentioned below, we believe that, as a part of our overall executive compensation, each element to a greater or lesser extent serves each of our objectives. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Base Salary  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each executive officer (except the chief executive officer whose performance is reviewed by the Compensation Committee) has an annual
performance review with the chief executive officer who makes recommendations on salary increases, promotions and stock option grants to the
Compensation Committee. We have historically established base salaries for each of our executives based on many factors, including average salary increases expected in the biotechnology industry in
the Boston, Massachusetts, New Haven, Connecticut and central New Jersey areas, competition in the marketplace to hire and retain executives, experiences of our Board members and leadership team with
respect to salaries and compensation of executives in similarly situated companies in our industry and other similar industries, as well as additional factors which we believe enable us to hire and
retain our leadership team in an extremely competitive environment. Our Compensation Committee annually reviews salary ranges and individual salaries for our executive officers and approved the
following annual salaries for our Named Executive Officers: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Annual Salary </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase $ </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase % </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>608,249</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>587,680</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,569</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>442,562</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434,453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>419,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,692</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>342,413</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Elizabeth Crowley</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>343,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>331,720</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,610</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sam Martin(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>233,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>59,600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>343,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>332,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dr.&nbsp;Davis
resigned from his position as Executive Vice President and Chief Medical Officer effective September&nbsp;29, 2017. Dr.&nbsp;Davis was given a
2.0% raise in mid-2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Catlin
retired from his position as Senior Vice President and Chief Financial Officer effective June&nbsp;30, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Martin
was promoted to Senior Vice President and Chief Financial Officer in July 2017.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Annual Performance-Based Cash Bonus  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have designed our annual cash bonuses to reward our executive officers for their individual performance and their actual performance and
contributions to our corporate goals for each year, as approved in advance by our Compensation Committee and Board of Directors. The corporate goals are allocated between specific product and
financial performance targets. Achievement
of our corporate goals was, in 2017, the primary factor considered by our Compensation Committee in determining the annual bonuses for our executive officers. However, the Compensation Committee
retains discretion to adjust any individual bonus based on assessment of such individual's performance. Our performance-based bonus plan emphasizes the contributions of each of our executive officers
to the achievement of our corporate goals. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=22,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=54915,FOLIO='20',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the beginning of each calendar year, the Compensation Committee establishes annual corporate performance goals and target bonuses. In 2017, the Compensation Committee established
target bonuses for each of our Named Executive Officers including 60% of base salary for Mr.&nbsp;Marucci, 40% of base salary for Dr.&nbsp;Keler, and 35% of base salary for Ms.&nbsp;Crowley,
Mr.&nbsp;Martin and Dr.&nbsp;Wright. These target bonuses were consistent with the 2016 targets except for Mr.&nbsp;Martin who was promoted in 2017. Corporate goals are proposed by management,
reviewed and approved by the Compensation Committee and also approved by the Board of Directors on an annual basis. The Compensation Committee considers and assigns a relative weight to appropriately
focus efforts on corporate goals that are intended to enhance shareholder value. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee reviewed the 2017 corporate goals at meetings held in April, June and September 2017 to gauge our levels of achievement and to assess whether the corporate
goals approved earlier in the year remained relevant and complete. In December 2017 and January 2018, prior to approving 2017 incentive bonuses, the Compensation Committee evaluated our 2017
performance by assessing if, and the extent to which, we achieved or failed to achieve the corporate goals approved by the Board of Directors for 2017. The Compensation Committee considered the
progress in our lead clinical program, glembatumumab vedotin, our earlier stage clinical programs and our corporate development activities. Based primarily on our inability to raise sufficient
financing to have enough cash, cash equivalents and marketable securities on hand at December&nbsp;31, 2017 to provide cash runway through 2019 without including the anticipated proceeds from future
sales of common stock under our Cantor agreement, the Compensation Committee determined that we met 85% of our 2017 corporate goals for pipeline development and business and financial operations. Our
corporate </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=23,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=128025,FOLIO='21',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_22"> </A>

<P style="font-family:times;"><FONT SIZE=2>goals
for 2017 and the level at which the Compensation Committee determined they were achieved are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  COLSPAN=3 ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>2017 Corporate Goals

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Relative<BR>
Weight </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017<BR>
Achievement </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><B> Pipeline Development:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>Glembatumumab Vedotin (CDX-011) Development Activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Complete enrollment in METRIC Study in metastatic triple negative breast cancer (mTNBC) and prepare for delivery of study results</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Execute on commercial manufacturing and diagnostic development preparations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Complete enrollment in varlilumab combination cohort and advance enrollment in checkpoint inhibitor combination cohort in Phase&nbsp;2 metastatic melanoma study</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>Varlilumab (CDX-1127) Development Activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Execute on Phase&nbsp;2 Opdivo combination study, define development pathways and develop commercial strategy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Support expanded clinical development through external collaborations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>CDX-3379 Development Activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Initiate Phase&nbsp;2 Erbitux combination study in advanced head and neck squamous cell carcinoma (HNSCC)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Develop preliminary commercial assessment for HNSCC</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>CDX-0158 Development Activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Complete enrollment of Phase&nbsp;1 dose-escalation study and define next development steps</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>CDX-014 Development Activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Execute on enrollment of Phase&nbsp;1 study in renal cell carcinoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>CDX-1140 Development Activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Complete manufacturing, preclinical activities and IND submission</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Establish Phase&nbsp;1 protocol and initiate start-up site activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><B> Business and Financial Operations:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Provide sufficient cash through various mechanisms to achieve our corporate goals and extend our runway through 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#149;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Complete a substantial collaboration or licensing transaction with respect to pipeline assets, if appropriate and acceptable</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><B> Totals:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>% </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Compensation Committee's December 2017 and January 2018 meetings, Mr.&nbsp;Marucci reviewed in detail the performance of each executive officer, excluding himself, and
considered such individual's contributions to our success in 2017. Mr.&nbsp;Marucci's bonus recommendations were based on such individual performance assessments and the fact that the Company
achieved 85% of its predetermined corporate goals in 2017 and each employee, including the executive officers, contributed to our success in achieving the 2017 corporate goals. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee discussed Mr.&nbsp;Marucci's recommendations for the Named Executive Officers and reviewed Mr.&nbsp;Marucci's performance for fiscal 2017. Based on
Mr.&nbsp;Marucci's recommendations for each of the Named Executive Officers, the Compensation Committee's review of Mr.&nbsp;Marucci's performance and the Compensation Committee's determination
that 85% achievement of the corporate goals for 2017, the Compensation Committee approved annual bonus payments of 85.0% to 93.6% of the 2017 bonus target for Mr.&nbsp;Marucci, Dr.&nbsp;Keler,
Ms.&nbsp;Crowley, Mr.&nbsp;Martin and Dr.&nbsp;Wright, depending on the position </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=24,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=509159,FOLIO='22',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee determined that annual incentive bonuses paid to the Named Executive Officers for 2017, were fair, reasonable and appropriate based on the factors described
above. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We also use stock options and equity-based incentive programs to attract, retain, motivate and reward our executive officers. Through our
equity-based grants, we seek to align the interests of our executive officers with our stockholders, reward and motivate both near-term and long-term executive performance and provide an incentive for
retention. Our decisions regarding the amount and type of equity incentive compensation and relative weighting of these awards among total executive compensation have been based on our understanding
of market practices of similarly situated companies and our negotiations with our executives in connection with their initial employment or promotion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have adopted an equity grant policy that formalizes how we grant equity awards by setting a regular schedule for granting equity awards in connection with the hiring or promotion of
any of our employees, granting annual equity awards and granting equity awards to non-employee directors. Such policy also outlines grant approval requirements and specifies the vesting schedule and
exercise prices for restricted stock units and stock option awards. We believe that this policy will mitigate the risk that issues or concerns would be raised in the future regarding the timing of
grants of equity awards to our officers, directors and employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
such grants to our Named Executive Officers are subject to prior approval by the Compensation Committee at a regularly scheduled meeting during the year. The date of grant and the
fair market value of the award are based upon the date of the Compensation Committee meeting approving such grant. When granting equity-based awards, the Compensation Committee considers a number of
factors in determining the amount of equity incentive awards, if any, to grant to our executives, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the existing levels of stock ownership among the executive officers relative to each other and to our employees as a whole; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> previous grants of stock options to such executive officers; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> vesting schedules of previously granted options; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the performance of the executives and their contributions to our overall performance; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an outside survey of stock option grants and restricted common stock awards in the biotechnology industry; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an internally prepared survey of similarly situated biotechnology companies' proxy statements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> personal knowledge of the Compensation Committee members regarding executive stock options and restricted common stock awards at comparable
companies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the financial statement impact of stock option awards on our results of operations; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the amount and percentage of our total equity on a diluted basis held by our executives. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity
compensation awards to our Named Executive Officers primarily consist of stock option awards. Stock option awards provide our executive officers with the right to purchase shares
of our common stock at a fixed exercise price typically for a period of up to ten years, subject to continued employment with us. Stock options are earned on the basis of continued service to us and
generally vest over four years, beginning with 25% vesting one year after the date of grant, then pro-rata vesting quarterly thereafter. All historical option grants were made at what our Compensation
Committee and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=25,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=724392,FOLIO='23',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_da41701_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2>Board
of Directors determined to be the fair market value of our shares of our common stock on the respective grant dates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
June&nbsp;15, 2017, the Compensation Committee awarded stock options to all qualified employees, including stock options to purchase 475,000 shares, 150,000 shares, 162,000 shares,
82,000 shares, 65,000 shares and 75,000 shares of our common stock to each of Mr.&nbsp;Marucci, Dr.&nbsp;Davis, Dr.&nbsp;Keler, Ms.&nbsp;Crowley, Mr.&nbsp;Martin and Dr.&nbsp;Wright,
respectively. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Benefits  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that establishing competitive benefit packages for our employees is an important factor in attracting and retaining highly qualified
personnel. Executive officers are eligible to participate in all of our employee benefit plans, such as medical, dental, group life and accidental death and dismemberment insurance, short- and
long-term disability coverage and our 401(k) plan, in each case on the same basis as other employees. We provide a matching contribution under our 401(k) plan. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Agreements and Post-Termination Compensation and Benefits  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We depend greatly on the intellectual capabilities and experience of our key executives. Our success is dependent on our ability to attract and
retain highly skilled executives with significant experience in the biotechnology industry, particularly as we expand our activities in clinical trials, the regulatory approval process and sales and
manufacturing. Therefore we enter into employment agreements with each of our Named Executive Officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, each employment arrangement provides for cash severance, 100% acceleration of any unvested options, restricted stock and/or other equity awards and continuation of certain
employee benefits in the event that an executive's employment is terminated within a one year period immediately following a change of control either without cause or by the executive for good reason.
The cash severance consists of a single lump sum payment equal to (i)&nbsp;twenty-four (24)&nbsp;times the executive's highest monthly base compensation paid hereunder during the preceding
twenty-four month period, plus (ii)&nbsp;150% (200%, in the case of Mr.&nbsp;Marucci) of the highest one-year annual bonus actually received by the executive during the preceding two full fiscal
years prior to the date of termination. We use a "double trigger" with respect to benefits that are to be provided in connection with a change of control. A change of control does not itself trigger
benefits; rather, benefits are paid only if the employment of the executive is terminated by us other than for cause, death or disability or by the executive for good reason during the one year period
immediately following the change of control. We believe a "double trigger" benefit maximizes shareholder value because it prevents a windfall to executives in the event of a change of control in which
the executive retains significant responsibility as defined in his or her individual agreement, while still providing our executives appropriate incentives to cooperate in negotiating any change of
control that may put their jobs at risk. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the benefits that only accrue in connection with a change of control, our agreements with the Named Executive Officers provide for cash severance, 25% acceleration of
unvested options, restricted stock and/or other equity awards and continuation of certain employee benefits if we
terminate their employment with us without cause or they terminate their employment with us for good reason, as such terms are defined in the applicable agreement with the executive officer. The cash
severance consists of a lump sum cash payment equal to 100% (200% in the case of Mr.&nbsp;Marucci) of the executive's then existing base salary. A further discussion of the terms and projected
payments under each of these agreements is set forth below under the heading </FONT><FONT SIZE=2><I>Potential Payments upon Termination of Employment or Change in Control.</I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=26,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=753958,FOLIO='24',FILE='DISK108:[18ZAG1.18ZAG41701]DA41701A.;15',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dc41701_1_25"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Committee Consideration of the Company's 2017 Shareholder Advisory Vote on Executive Compensation  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At our 2017 Annual Meeting of Shareholders, approximately 93% of the shares voted at the meeting approved, on an advisory basis, the
compensation of the Named Executive Officers. Given that a majority of the shares voted approved the 'say on pay' advisory proposal, the Committee did not implement specific changes and continued with
its performance-based compensation philosophy and its balanced approach to various components of its compensation program. However, the Compensation Committee does monitor the results of the annual
advisory 'say-on-pay' proposal and refers to such results as one of many factors considered in connection with the discharge of its responsibilities, although the Committee does not assign a
quantitative weighting to any such factors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
our 2017 Annual Meeting of Shareholders, approximately 91% of the shares voted, on an advisory basis, to hold advisory votes on compensation on an annual basis. Our Board of Directors
has determined that an advisory vote should continue to be conducted on an annual basis. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc41701_summary_compensation_table"> </A>
<A NAME="toc_dc41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Summary Compensation Table    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following summary compensation table reflects certain information concerning compensation for services in all capacities awarded to, earned
by or paid during the years ended December&nbsp;31, 2017, 2016 and 2015 to each person who served as our (i)&nbsp;Chief Executive Officer, (ii)&nbsp;all individuals serving as Chief Financial
Officer during 2017, (iii)&nbsp;our three most highly compensated executive officers, other than the Chief Executive Officer and Chief Financial Officer, who were serving as executive officers as of
December&nbsp;31, 2017, and (iv)&nbsp;up to two other individuals who would have been included as the three most highly compensated executive officers but for the fact that they were not serving
as an executive officer at December&nbsp;31, 2017 (collectively, the "Named Executive Officers"). </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="26pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="34pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Principal Position


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive<BR>
Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change in<BR>
Pension<BR>
Value and<BR>
Nonqualified<BR>
Deferred<BR>
Compensation<BR>
Earnings<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($)(3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>597,569</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>310,207</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>739,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,005</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,664,024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>President and Chief</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>577,361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>282,086</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,496,440</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>14,308</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,370,195</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Executive Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>559,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>302,924</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,371,528</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>39,874</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,273,726</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><BR><FONT SIZE=1> Thomas Davis, M.D.(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>379,015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>233,445</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>7,483</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>619,943</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Former Executive Vice President</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>438,057</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>134,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>494,613</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,076,031</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>and Chief Medical Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>434,421</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>165,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,818,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,297</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,427,586</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><BR><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Tibor Keler., Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>426,825</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>147,714</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>252,121</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>4,069</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>830,729</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Executive Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>414,445</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>134,324</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>510,365</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,063,071</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Chief Scientific Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>409,996</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>159,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,818,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,800</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,391,664</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><BR><FONT SIZE=1> Avery W. Catlin(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>190,281</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>3,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>194,009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Former Senior Vice President</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>337,235</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>105,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>425,304</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,132</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>874,671</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>and Chief Financial Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>339,457</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>130,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,436,359</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6,024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,911,840</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><BR><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Elizabeth Crowley</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>337,302</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>105,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>127,617</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>4,481</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>574,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>321,970</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>97,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>255,182</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,233</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>678,385</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Chief Product Development Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><BR><FONT SIZE=1> Sam Martin(6)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>262,054</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>96,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>101,160</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>6,081</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>465,295</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Chief Financial Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><BR><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>337,586</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>102,227</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>116,723</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>6,635</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=1>563,171</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Senior Vice President and</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Chief Commercial Officer</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in the Bonus column include annual bonus amounts earned by each of our Named Executive Officers in 2017, 2016 and 2015. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=27,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=546477,FOLIO='25',FILE='DISK108:[18ZAG1.18ZAG41701]DC41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dc41701_1_26"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in the Option Awards column reflect the dollar amounts for the aggregate grant date fair value in accordance with accounting principles generally
accepted in the United States of America (U.S.&nbsp;GAAP) of stock option awards made in fiscal years ended December&nbsp;31, 2017, 2016 and 2015 for annual awards pursuant to the 2008 Plan. For a
discussion regarding the valuation of our stock option awards for financial statement reporting purposes, please refer to Note&nbsp;2 in the Notes to the Financial Statements contained in our Annual
Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017. These amounts do not represent the actual amounts paid to the Named Executive Officers or the actual value that may be realized
by the Named Executive Officers upon exercise of such stock options.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts listed in the All Other Compensation column includes our matching contribution to the 401(k) Savings Plan of each Named Executive Officer and premiums
paid for life insurance under our nondiscriminatory group plan for each Named Executive Officer. In addition, Mr.&nbsp;Marucci's compensation includes (i)&nbsp;the annual premium of $2,550 in
2017, 2016 and 2015 for a $1,000,000 term life insurance policy, (ii)&nbsp;$5,485, $3,123 and $3,948 for the personal use of a Company car in 2017, 2016 and 2015, and (iii)&nbsp;tuition
reimbursement of $24,634 in 2015 related to an executive master of healthcare leadership program.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Dr.&nbsp;Davis
resigned from his position as Executive Vice President and Chief Medical Officer effective September&nbsp;29, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Catlin
retired from his position as Senior Vice President and Chief Financial Officer effective June&nbsp;30, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>On
July&nbsp;1, 2017, Mr.&nbsp;Martin was promoted to Senior Vice President and Chief Financial Officer. The amounts included above are for the full year ended
December&nbsp;31, 2017. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc41701_grants_of_plan-based_awards"> </A>
<A NAME="toc_dc41701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Grants of Plan-Based Awards    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information on stock options and stock awards granted in 2017 to each of our Named Executive Officers. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=4 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=4 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Option<BR>
Awards:<BR>
Number of<BR>
Securities<BR>
Underlying<BR>
Options<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated Future<BR>
Payouts Under<BR>
Equity Incentive Plan Awards </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Stock<BR>
Awards:<BR>
Number of<BR>
Shares or<BR>
Units<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date<BR>
Fair Value of<BR>
Stock and<BR>
Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exercise or<BR>
Base Price of<BR>
Option<BR>
Awards<BR>
($/Sh)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Threshold<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6/15/17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>475,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>739,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6/15/17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>150,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>233,445</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6/15/17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>162,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>252,121</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Elizabeth Crowley</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6/15/17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>82,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>127,617</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sam Martin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6/15/17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>65,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>101,160</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6/15/17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>75,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>116,723</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
exercise prices reflect the closing price of our common stock on the grant date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
grant date fair values are generally the amount we would expense in our financial statements over the award's service period, but does not include a reduction
for estimated forfeitures. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=28,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=603228,FOLIO='26',FILE='DISK108:[18ZAG1.18ZAG41701]DC41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dc41701_1_27"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc41701_outstanding_equity_awards_at_fiscal_year-end"> </A>
<A NAME="toc_dc41701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Outstanding Equity Awards at Fiscal Year-End    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding the stock option grants and stock awards to our Named Executive Officers at
December&nbsp;31, 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Unearned<BR>
Options (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Exercise<BR>
Price ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares or<BR>
Units of<BR>
Stock<BR>
That<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Market<BR>
Value of<BR>
Shares or<BR>
Units of<BR>
Stock<BR>
That<BR>
Have Not<BR>
Vested ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Number of<BR>
Unearned<BR>
Shares,<BR>
Units or<BR>
Other<BR>
Rights<BR>
That<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Market or<BR>
Payout<BR>
Value of<BR>
Unearned<BR>
Shares,<BR>
Units or<BR>
Other<BR>
Rights<BR>
That<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>475,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/15/27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>178,124</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>296,876</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/8/26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>175,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>105,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/10/25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>245,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>35,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/4/24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>280,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>280,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>180,400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>164,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>129,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/6/19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>254,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/7/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>162,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/15/27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>60,749</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>101,251</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/8/26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>72,812</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>43,688</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/10/25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>101,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>14,563</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/4/24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>115,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>115,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/12/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>99,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>72,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/6/19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>254,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/7/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>33,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>46,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>69,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>84,374</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>90,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>35,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>67,153</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Avery W. Catlin(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>11,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8.52</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3/27/18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>82,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/15/27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>30,373</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>50,627</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/8/26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>46,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/10/25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>27,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/4/24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>30,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>30,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6.37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/20/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Elizabeth Crowley.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1/21/20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>65,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/15/27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,874</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13,126</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/8/26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,785</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/10/25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/4/24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6.37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9/20/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Sam Martin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/5/21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Richard Wright, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>75,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/15/27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Richard Wright, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>46,877</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/8/26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Richard Wright, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>46,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/10/25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Richard Wright, Ph.D.(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>21,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/4/24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>16.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/1/23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3.99</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/1/22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>25%
of the options vest on the first anniversary of the grant date and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>On
June&nbsp;15, 2017, the Compensation Committee approved a six month extension of Mr.&nbsp;Catlin's post-retirement option expiration date. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=29,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=319097,FOLIO='27',FILE='DISK108:[18ZAG1.18ZAG41701]DC41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dc41701_1_28"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc41701_option_exercises_and_stock_vested"> </A>
<A NAME="toc_dc41701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  Option Exercises and Stock Vested    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding the number of option exercises in fiscal 2017 and the number of shares of stock
issued under the 2008 Plan that vested in fiscal 2017 and the corresponding amounts realized by our Named Executive Officers. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Exercise<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized<BR>
on Exercise<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Vesting<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized<BR>
on Vesting<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>104,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,585</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Elizabeth Crowley</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sam Martin</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard Wright, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
the aggregate dollar amount realized by the Named Executive Officer upon exercise of the options, calculated by determining the difference between the
closing price on the date of notice to exercise and the exercise price. These amounts do not correspond to the actual value received by the Named Executive Officers.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dr.&nbsp;Davis
submitted a notice to exercise his options on December&nbsp;28, 2017. Such exercise was settled and the shares were issued in January 2018. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc41701_employment_agreements"> </A>
<A NAME="toc_dc41701_5"> </A>
<BR></FONT><FONT SIZE=2><B>  Employment Agreements    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The terms and conditions of the employment agreements of Mr.&nbsp;Marucci, Dr.&nbsp;Keler, Ms.&nbsp;Crowley, Mr.&nbsp;Martin and
Dr.&nbsp;Wright are governed by written employment contracts which became effective on January&nbsp;1, 2018. The employment agreements provide, among other things, for:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> current annual base salary ($608,249 in the case of Mr.&nbsp;Marucci, $434,453 in the case of Dr.&nbsp;Keler, $343,330 in the case of
Ms.&nbsp;Crowley, $293,000 in the case of Mr.&nbsp;Martin and $343,620 in the case of Dr.&nbsp;Wright) or such greater amount as may from time to time be determined by the Board of Directors or
the Compensation Committee thereof; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> eligibility for an annual bonus with a current bonus target (60% of base salary in the case of Mr.&nbsp;Marucci, 40% of base salary in the
case of Dr.&nbsp;Keler and 35% of base salary in the case of Ms.&nbsp;Crowley, Mr.&nbsp;Martin and Dr.&nbsp;Wright); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a lump sum severance payment equal to 100% (200% in the case of Mr.&nbsp;Marucci only) of the executive's then-existing annual base salary in
the event that the executive's employment is terminated without cause or the executive resigns "for good reason" (as defined in the employment agreement) and 25% accelerated vesting of any unvested
equity awards; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> accelerated vesting of any unvested equity awards (as defined in the employment agreement) and a lump sum cash payment equal to twenty-four
(24)&nbsp;times the executive's highest monthly base compensation (not including bonus) during the twenty-four month period preceding the date of termination plus 150% (200% in the case of
Mr.&nbsp;Marucci only) of the highest one-year annual bonus actually received by the executive during the two full fiscal years preceding the date of termination in the event of termination without
cause or resignation "for good reason" by the executive within one year immediately following a change in control (as defined in the employment agreement). </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=30,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=53265,FOLIO='28',FILE='DISK108:[18ZAG1.18ZAG41701]DC41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de41701_1_29"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
employment agreements have an initial term through December&nbsp;31, 2018 and shall automatically renew for additional one year terms unless either party gives ninety
(90)&nbsp;days prior written notice of its intent not to renew. The Company may terminate the employment agreements without cause, on 90-days' prior notice, or for cause, subject to a 30-day cure
period in certain circumstances. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms and conditions of the employment agreements for Dr.&nbsp;Davis and Mr.&nbsp;Catlin were governed by written employment contracts which became effective on January&nbsp;1,
2013. Dr.&nbsp;Davis resigned from his position as Executive Vice President and Chief Medical Officer effective September&nbsp;29, 2017. Mr.&nbsp;Catlin retired from his position as Senior Vice
President and Chief Financial Officer effective June&nbsp;30, 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_pension_benefits"> </A>
<A NAME="toc_de41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Pension Benefits    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of our Named Executive Officers participate in qualified or nonqualified defined benefit plans sponsored by us. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_nonqualified_deferred_compensation"> </A>
<A NAME="toc_de41701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Nonqualified Deferred Compensation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of our Named Executive Officers are covered by a defined contribution or other plan that provides for the deferral of compensation on a
basis that is not tax-qualified. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_potential_payments_upon_termin__pot02940"> </A>
<A NAME="toc_de41701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Potential Payments Upon Termination of Employment or Change in Control    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Named Executive Officers have provisions in their employment agreements regarding severance upon certain termination events or acceleration
of stock options in the event of our change of control or termination following a change of control. These severance and acceleration provisions are described in "Employment Agreements," and certain
estimates of these change of control benefits are provided in the tables below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table describes the potential payments and benefits upon employment termination for our Named Executive Officers as if their employment had terminated as of
December&nbsp;31, 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Executive benefits and payments<BR>
upon termination

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for no good<BR>
reason </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for good<BR>
reason(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex<BR>
without cause(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex<BR>
for cause </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary termination<BR>
by the executive<BR>
for good reason<BR>
or termination by<BR>
Celldex without<BR>
cause in connection<BR>
with or following<BR>
change of control(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Anthony S. Marucci</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base Salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,216,498</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,216,498</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,216,498</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>620,414</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61,750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61,750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>247,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,328,212</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,328,212</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,133,876 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Tibor Keler, Ph.D.</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base Salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434,453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434,453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>868,906</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>221,571</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,060</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,060</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>84,240</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>505,477</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>505,477</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,224,681 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=31,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=468061,FOLIO='29',FILE='DISK108:[18ZAG1.18ZAG41701]DE41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_de41701_1_30"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Executive benefits and payments<BR>
upon termination

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for no good<BR>
reason </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary<BR>
resignation<BR>
for good<BR>
reason(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex<BR>
without cause(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Termination<BR>
by Celldex<BR>
for cause </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voluntary termination<BR>
by the executive<BR>
for good reason<BR>
or termination by<BR>
Celldex without<BR>
cause in connection<BR>
with or following<BR>
change of control(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Elizabeth Crowley</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base Salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>343,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>343,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>686,660</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>157,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,660</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,660</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>42,640</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>353,990</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>353,990</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>886,800 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Sam Martin</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base Salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>586,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>144,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,450</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,450</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,864</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,864</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,864 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>335,314</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>335,314</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>797,664 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Richard Wright, Ph.D.</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base Salary</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>343,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>343,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>687,240</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>153,340</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity Awards Acceleration(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Continuation of Health Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49,964 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>403,334</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>403,334</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>929,544 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Upon
termination without cause or resignation for good reason, the employee is generally entitled to a lump sum payment equal to 100% (200% in the case of
Mr.&nbsp;Marucci only) of the employee's then annual base salary, continuation of certain employee benefits and 25% accelerated vesting of any unvested equity awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
employee is generally entitled to accelerated vesting of any unvested equity awards (as defined in the employment agreement) and a lump sum cash payment equal to
twenty-four (24)&nbsp;times the executive's highest monthly base compensation (not including bonus) during the twenty-four month period preceding the date of termination plus 150% (200% in the case
of Mr.&nbsp;Marucci only) of the highest one-year annual bonus actually received by the executive during the two full fiscal years preceding the date of termination in the event of termination
without cause or resignation "for good reason" by the executive within one year immediately following a change in control (as defined in the employment agreement).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
value of each share subject to an option to purchase common stock that would be accelerated in the circumstances described above equals $2.84 per share (the
closing price on the last trading day of 2017), minus the exercise price per share;  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_ceo_pay_ratio"> </A>
<A NAME="toc_de41701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  CEO Pay Ratio    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As required by Section&nbsp;953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item&nbsp;402(u) of
Regulation&nbsp;S-K, we are required to disclose the ratio of our median employee's annual total compensation to the annual total compensation of our principal executive officer. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=32,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=660255,FOLIO='30',FILE='DISK108:[18ZAG1.18ZAG41701]DE41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_de41701_1_31"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
purpose of this new disclosure is to provide a measure of the equitability of pay within our company. We believe our compensation philosophy and process yield an equitable result for
all of our employees. During fiscal 2017, the principal executive officer of Celldex was our Chief Executive Officer, Anthony S. Marucci. For 2017, the annual total compensation, using the same
methodology we use for our named executive officers as set forth in the summary compensation table, for Mr.&nbsp;Marucci was $1,664,024, and for our median employee was $132,955, resulting in an
estimated pay ratio of 13 to 1. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with Item&nbsp;402(u) of Regulation&nbsp;S-K, we identified the median employee by (i)&nbsp;determining our employee population as of December&nbsp;31, 2017
(including all full-time, part-time, salaried, hourly, and seasonal employees, but excluding Mr.&nbsp;Marucci), (ii)&nbsp;calculating the total compensation for each employee for fiscal 2017 by
aggregating (A)&nbsp;annual base salary for salaried employees (or hourly rate multiplied by expected annual work schedule, for hourly employees), (B)&nbsp;the bonus for 2017, and (C)&nbsp;the
estimated accounting value of any equity awards granted during 2017, and (iii)&nbsp;ranking this compensation measure for our employees from lowest to highest. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our internal records and the methodology described above. Because the SEC
rules for identifying the median compensated employee and calculating the pay ratio based on that employee's annual total compensation allow companies to adopt a variety of methodologies, to apply
certain exclusions, and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices, the pay ratio reported by other companies may not be comparable
to the pay ratio reported above, as other companies have different employee populations and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in
calculating their own pay ratios. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_director_compensation"> </A>
<A NAME="toc_de41701_5"> </A>
<BR></FONT><FONT SIZE=2><B>  Director Compensation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective June 2016, Directors who are not our employees are each entitled to receive a retainer fee of $45,000 each fiscal year ("Annual
Retainer"). The Chairman of the Board is entitled to receive an annual retainer fee of $40,000 in addition to his or her Annual Retainer and any retainer for committee service. The Chairperson of the
Audit Committee of the Board of Directors is entitled to receive an annual retainer fee of $30,000 in addition to his or her Annual Retainer. The Chairperson of the Compensation and Nominating and
Corporate Governance Committees of the Board of Directors is entitled to receive an annual retainer fee of $25,000 in addition to his or her Annual Retainer. Each committee member (other than the
Chairperson of a committee) will receive an annual retainer of $15,000 in addition to his or her Annual Retainer. Stipends and retainers are paid in advance on a quarterly basis. The Directors shall
be reimbursed for necessary travel and business expenses as incurred but will not receive any additional fees for attending meetings or calls of the Board of Directors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New
board members receive an initial stock option grant to purchase 8,000 shares of the Company's common stock upon joining the Board. All non-employee directors received (i)&nbsp;an
annual grant of 10,000 shares of restricted stock each year and (ii)&nbsp;an annual stock option grant to purchase 15,000 shares of the Company's common stock following the Annual Meeting of
Stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2017, our non-employee directors had the following stock options outstanding: Larry Ellberger&#151;56,300, Keith L. Brownlie&#151;23,000, Herbert
J. Conrad&#151;74,179, James J. Marino&#151;23,000, Gerald McMahon&#151;23,000, Harry H. Penner, Jr.&#151;56,300 and Karen L. Shoos&#151;56,300. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=33,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=974237,FOLIO='31',FILE='DISK108:[18ZAG1.18ZAG41701]DE41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_de41701_1_32"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the annual compensation for our non-employee directors during 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fees<BR>
Earned or<BR>
Paid in Cash<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change in<BR>
Pension<BR>
Value and<BR>
Nonqualified<BR>
Deferred<BR>
Compensation<BR>
Earnings </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Larry Ellberger</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>115,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,345</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>161,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Keith L. Brownlie</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,397</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35,795</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>112,392</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Herbert J. Conrad</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,345</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>121,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James J. Marino</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>42,538</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,738</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gerald McMahon</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>45,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,345</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>91,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Harry H. Penner, Jr.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>80,347</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,345</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>126,892</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Karen L. Shoos</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,345</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>116,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
amounts in the Stock Awards column reflect the grant date fair value in accordance with U.S.&nbsp;GAAP of restricted stock awards made in 2017 to each of our
non-employee directors for awards pursuant to the 2008 Plan subject to a vesting schedule whereby an equal number of the shares of common stock shall become vested and no longer be subject to risk of
forfeiture (so long as the director remains a member of the Board as of such date). For a discussion regarding the valuation of our stock awards for financial statement reporting purposes, please
refer to Note&nbsp;2 in the Notes to the Financial Statements contained in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017. These amounts do not represent the
actual amounts paid to the directors or the actual value that may be realized by the directors for these awards during the year ended December&nbsp;31, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
amounts in the Option Awards column reflect the grant date fair value in accordance with U.S.&nbsp;GAAP of stock option awards made in 2017 to each of our
non-employee directors for awards pursuant to the 2008 Plan subject to a vesting schedule whereby an equal number of the shares of common stock shall become vested and no longer be subject to risk of
forfeiture (so long as the director remains a member of the Board as of such date). For a discussion regarding the valuation of our stock option awards for financial statement reporting purposes,
please refer to Note&nbsp;2 in the Notes to the Financial Statements contained in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017. These amounts do not represent
the actual amounts paid to the directors or the actual value that may be realized by the directors upon exercise of such stock options.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, on November&nbsp;28, 2016, in connection with Dr.&nbsp;McMahon's employment separation with Kolltan Pharmaceuticals,&nbsp;Inc., we entered into a severance agreement
with Dr.&nbsp;McMahon whereby we agreed to pay Dr.&nbsp;McMahon up to 267,356 shares of our common stock less required tax and other withholdings. To date, 126,717 shares of common stock were
issued to Dr.&nbsp;McMahon, 73,994 shares have been withheld to satisfy tax withholdings and the remaining 66,645 shares of common stock, less applicable withholdings, are issuable to
Dr.&nbsp;McMahon in equal monthly installments through December 2018. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_compensation_committee__de402474"> </A>
<A NAME="toc_de41701_6"> </A>
<BR></FONT><FONT SIZE=2><B>  Compensation Committee Interlocks and Insider Participation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of Directors is currently composed of the following three non-employee directors: James J. Marino,
Chair, Herbert J. Conrad and Harry H. Penner, Jr. None of these Compensation Committee members was an officer or employee of us during the year. No Compensation Committee interlocks between us and
another entity existed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=34,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=661866,FOLIO='32',FILE='DISK108:[18ZAG1.18ZAG41701]DE41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_de41701_1_33"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de41701_risk_considerations"> </A>
<A NAME="toc_de41701_7"> </A>
<BR></FONT><FONT SIZE=2><B>  Risk Considerations    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not believe that our compensation practices and policies for our employees, including our executive officers, create risks or are likely
to create risks that are reasonably likely to have a material adverse effect on our results of operations or financial condition. The Compensation Committee considered our strategic goals and
operational practices and evaluated our incentive program design to assess whether these programs foster a business environment that might drive inappropriate decision-making or behavior. We are a
biopharmaceutical company that is generating a pipeline of drug candidates to treat cancer and other difficult-to-treat diseases and do not yet generate earnings. While a significant portion of our
executives' compensation is performance-based, we believe several features of our program mitigate inappropriate or excessive risk-taking that could harm shareholder value: we set performance goals
that we believe are reasonable and set targets with payouts at multiple levels of performance, rather than an "all or nothing" approach. As discussed above in our Compensation Discussion and Analysis
section we use a mix of performance goals in our annual and long-term incentive programs to align incentive compensation with a broad set of measures important to the creation of shareholder value. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=35,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1033847,FOLIO='33',FILE='DISK108:[18ZAG1.18ZAG41701]DE41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg41701_1_34"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dg41701_compensation_committee_report"> </A>
<A NAME="toc_dg41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION COMMITTEE REPORT*    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with management and based on such review and
discussion of the Compensation Discussion and Analysis, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in this proxy statement. </FONT></P>

<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>Compensation
Committee:<BR>
James J. Marino, Chair<BR>
Herbert J. Conrad<BR>
Harry H. Penner, Jr. </FONT></P>

</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>

<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
<HR NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT"> </FONT></P>

 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
foregoing report of the Compensation Committee is not to be deemed "filed" with the SEC (irrespective of any general incorporation language in any document filed
with the SEC) or subject to Regulation&nbsp;14A of the Securities Exchange Act of 1934, as amended, or to the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934, except to the
extent we specifically incorporate it by reference into a document filed with the SEC. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=36,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=70815,FOLIO='34',FILE='DISK108:[18ZAG1.18ZAG41701]DG41701A.;5',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di41701_1_35"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di41701_report_of_the_audit_committee"> </A>
<A NAME="toc_di41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE AUDIT COMMITTEE*    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned members of the Audit Committee of the Board of Directors of Celldex submit this report in connection with the committee's review
of the financial reports for the fiscal year ended December&nbsp;31, 2017 as follows: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Audit Committee has reviewed and discussed with management the audited financial statements for Celldex for the fiscal year ended December&nbsp;31, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Audit Committee has discussed with representatives of PricewaterhouseCoopers&nbsp;LLP the matters which are required to be discussed with them under the
provisions of Auditing Standard No.&nbsp;1301, </FONT><FONT SIZE=2><I>Communications with Audit Committees</I></FONT><FONT SIZE=2>. That Auditing Standard requires the auditors to ensure that the
Audit Committee received information regarding the scope and results of the audit.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>3.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Audit Committee has discussed with PricewaterhouseCoopers&nbsp;LLP, the independent registered public accounting firm, the auditors' independence from
management and Celldex including the matters in the written disclosures and the letter from the independent auditors required by PCAOB Rule&nbsp;3526. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the Audit Committee considered whether the provision of tax or other non-audit services by PricewaterhouseCoopers&nbsp;LLP is compatible with maintaining its independence.
In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors (and the Board of Directors has approved) that the audited financial statements
be included in Celldex's Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2017 for filing with the Securities and Exchange Commission. </FONT></P>

<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>Audit
Committee:<BR>
Keith L. Brownlie, Chair<BR>
Larry Ellberger<BR>
Harry H. Penner, Jr. </FONT></P>

</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
</UL>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
<HR NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT"> </FONT></P>

 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
foregoing report of the Audit Committee is not to be deemed "soliciting material" or deemed to be "filed" with the Securities and Exchange Commission (irrespective
of any general incorporation language in any document filed with the Securities and Exchange Commission) or subject to Regulation&nbsp;14A of the Securities Exchange Act of 1934, as amended, or to
the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934, except to the extent we specifically incorporate it by reference into a document filed with the Securities and Exchange
Commission. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=37,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=331315,FOLIO='35',FILE='DISK108:[18ZAG1.18ZAG41701]DI41701A.;6',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk41701_1_36"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Security Ownership of Certain Beneficial Owners and Management  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information as of April&nbsp;10, 2018 with respect to the beneficial ownership of common stock of the
Company by the following: (i)&nbsp;each of the Company's current directors; (ii)&nbsp;each of the Named Executive Officers; (iii)&nbsp;the current executive officers; (iv)&nbsp;all of the
executive officers and directors as a group; and (v)&nbsp;each person known by the Company to own beneficially more than five percent (5%) of the outstanding shares of the Company's common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of the following table, beneficial ownership is determined in accordance with the applicable SEC rules and the information is not necessarily indicative of beneficial
ownership for any other purpose. Except as otherwise noted in the footnotes to the table, we believe that each person or entity named in the table has sole voting and investment power with respect to
all shares of the Company's common stock shown as beneficially owned by that person or entity (or shares such power with his or her spouse). Under the SEC's rules, shares of the Company's common stock
issuable under options that are exercisable on or within 60&nbsp;days after April&nbsp;10, 2018 ("Presently Exercisable Options") are deemed outstanding and therefore included in the number of
shares reported as beneficially owned by a person or entity named in the table and are used to compute the percentage of the common stock beneficially owned by that person or entity. These shares are
not, however, deemed outstanding for computing the percentage of the common stock beneficially owned by any other person or entity. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=38,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=909332,FOLIO='36',FILE='DISK108:[18ZAG1.18ZAG41701]DK41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dk41701_1_37"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
percentage of the common stock beneficially owned by each person or entity named in the following table is based on 143,387,300 shares of common stock outstanding as of
April&nbsp;10, 2018 plus any shares issuable upon exercise of Presently Exercisable Options held by such person or entity. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Business Address of Beneficial Owners*

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount and Nature<BR>
of Beneficial<BR>
Ownership(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percentage of<BR>
Common Stock(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><I>5% Holders</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Columbia Wanger Asset Management,&nbsp;LLC</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,772,111</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>227 West Monroe Street, Suite&nbsp;3000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chicago, IL 60606</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 BlackRock,&nbsp;Inc.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,930,701</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 55 East 52<SUP>nd</SUP>&nbsp;Street</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 New York, NY 10055</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The Vanguard Group</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,538,175</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>100 Vanguard Blvd.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Malvern, PA 19355</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 FMR&nbsp;LLC</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,625,652</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(6)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 245 Summer Street</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Boston, MA 02210</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Directors and Executive Officers</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Keith L. Brownlie</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Avery W. Catlin</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>96,227</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(7)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Sarah Cavanaugh</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>88,882</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(8)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Herbert J. Conrad</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>61,366</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(9)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Elizabeth Crowley</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>225,382</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(10)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thomas Davis, M.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>104,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(11)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Larry Ellberger</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>96,366</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(12)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Margo Heath-Chiozzi, M.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Tibor Keler, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>787,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(13)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,801,417</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(14)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 James J. Marino</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,997</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(15)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sam Martin</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>51,359</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(16)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Gerald McMahon, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>201,362</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(17)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Harry H. Penner, Jr.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>64,782</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(18)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Ronald Pepin, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>468,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(19)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Karen L. Shoos</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>64,699</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(20)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Richard Wright, Ph.D</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>149,686</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(21)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>All Directors and Executive Officers as a group (17&nbsp;persons)</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,286,485</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(22)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Unless
otherwise indicated, the address is c/o Celldex Therapeutics,&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ 08827.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>**</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Less
than 1%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Unless
otherwise indicated, the persons shown have sole voting and investment power over the shares listed.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Common
stock includes all outstanding common stock plus, as required for the purpose of determining beneficial ownership (in accordance with Rule&nbsp;13d-3(d)(1)
of the Securities Exchange Act of 1934, as amended), all common stock subject to any right of </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=39,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=41011,FOLIO='37',FILE='DISK108:[18ZAG1.18ZAG41701]DK41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dk41701_1_38"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>acquisition,
through exercise or conversion of any security, within 60&nbsp;days of the record date.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G/A filed with the SEC by Columbia Wagner Asset Management,&nbsp;LLC (CWAM) on February&nbsp;13,
2018 reporting that CWAM beneficially owns 10,772,111 shares, of which 8,126,489 shares are held by Columbia Acorn Fund and the remaining shares are held by various other funds or accounts managed by
CWAM. CWAM does not directly own any shares of common stock of the issuer. As the investment adviser of Columbia Acorn Fund and various other investment companies and managed accounts, CWAM may be
deemed to beneficially own the shares reported herein by Columbia Acorn Fund and by various other funds or accounts managed by CWAM. CWAM disclaims beneficial ownership of any shares reported herein.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G/A filed with the SEC by BlackRock,&nbsp;Inc. on January&nbsp;29, 2018 reporting sole power to vote
or direct the vote over 9,646,161 shares and the sole power to dispose or to direct the disposition of 9,930,701 shares.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G/A filed with the SEC by The Vanguard Group on February&nbsp;9, 2018, reporting sole power to vote or
direct the vote over 138,434 shares, shared power to vote or direct the vote over 4,641 shares, sole power to dispose or to direct the disposition of 8,400,200 shares and shared dispositive power over
137,975 shares. The shares reported include 133,334 shares held by Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group,&nbsp;Inc. and 9,741 shares held by Vanguard
Investments Australia,&nbsp;Ltd., a wholly-owned subsidiary of The Vanguard Group,&nbsp;Inc.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Schedule&nbsp;13G/A filed with the SEC on February&nbsp;13, 2018 by FMR&nbsp;LLC ("FMR") reporting that FMR
beneficially owned 7,625,652 shares; (ii)&nbsp;had the sole power to dispose or direct the disposition of 7,625,652 shares; and (iii)&nbsp;had the sole power to vote or to direct the vote of
1,059,212 shares. In addition, the Schedule&nbsp;13G/A shows that the following entities beneficially own certain of the shares reported: Fidelity Management&nbsp;&amp; Research Company
("FMR&nbsp;Co."),&nbsp;Inc. (beneficially owns 5% or more) and Fidelity Institutional Asset Management Trust Company. The Schedule&nbsp;13G/A also shows that Abigail P. Johnson is a Director,
the Chairman and the Chief Executive Officer of FMR. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series&nbsp;B voting
common shares of FMR, representing 49% of the voting power of FMR. The Johnson family group and all other Series&nbsp;B shareholders have entered into a shareholders' voting agreement under which
all Series&nbsp;B voting common shares will be voted in accordance with the majority vote of Series&nbsp;B voting common shares. Accordingly, through their ownership of voting common shares and
the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form&nbsp;a controlling group with respect to FMR.
Neither FMR nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act (the
"Fidelity Funds"), advised by FMR&nbsp;Co., a wholly-owned subsidiary of FMR, which power resides with the Fidelity Funds' Board of Trustees. Fidelity Management&nbsp;&amp; Research Company carries
out the voting of the shares under written guidelines established by the Fidelity Funds' Board of Trustees. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=40,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=241134,FOLIO='38',FILE='DISK108:[18ZAG1.18ZAG41701]DK41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dk41701_1_39"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on information set forth in a Form&nbsp;4 filed with the SEC on September&nbsp;7, 2016 and Company records.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
84,122 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
36,200 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
218,060 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
solely on Company records.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
36,200 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(13)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
768,842 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(14)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,743,399 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(15)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
8,000 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(16)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
50,686 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(17)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>On
November&nbsp;28, 2016, in connection with Dr.&nbsp;McMahon's employment separation with Kolltan Pharmaceuticals,&nbsp;Inc., we entered into a severance
agreement with Dr.&nbsp;McMahon whereby we agreed to pay Dr.&nbsp;McMahon up to 267,356 shares of our common stock less required tax and other withholdings. To date, 126,717 shares of common stock
were issued to Dr.&nbsp;McMahon, 73,994 shares have been withheld to satisfy tax withholdings and the remaining 66,645 shares of common stock, less applicable withholdings, are issuable to
Dr.&nbsp;McMahon in equal monthly installments through December 2018. Includes 8,000 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or
60&nbsp;days after such date
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(18)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
36,200 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(19)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
468,750 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(20)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
36,200 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(21)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
146,561 shares of common stock underlying options which are or may be exercisable as of April&nbsp;10, 2018 or 60&nbsp;days after such date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(22)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Please
refer to footnotes 7&nbsp;-&nbsp;21.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Section&nbsp;16(a) Beneficial Ownership Reporting Compliance  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, requires Celldex's directors and executive officers, and persons who
are beneficial owners of more than 10% of a registered class of our equity securities, to file reports of ownership and changes in ownership with the Securities and Exchange Commission (the "SEC").
These persons are required by SEC regulations to furnish us with </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=41,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=850555,FOLIO='39',FILE='DISK108:[18ZAG1.18ZAG41701]DK41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dk41701_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2>copies
of all Section&nbsp;16(a) forms they file. To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were
required during the fiscal year ended December&nbsp;31, 2017, all reports required to be filed under Section&nbsp;16(a) were filed on a timely basis. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transactions with Related Persons  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is our policy that all employees and directors, as well as their family members, must avoid any activity that is or has the appearance of
conflicting with Celldex's business interest. This policy is included in our Code of Business Conduct and Ethics. All directors and officers of Celldex complete a directors and officers questionnaire
at the beginning of each year, in which they are asked to disclose family relationships and other related party transactions. Our Audit Committee must review and approve all related party
transactions, as defined in Item&nbsp;404 of Regulation&nbsp;S-K. Our Audit Committee's procedures for reviewing related party transactions are not in writing. Other than compensation arrangements
for our Named Executive Officers and directors, which are described in the section entitled "Executive Compensation," since January&nbsp;1, 2017, there have been no transactions or series of similar
transactions to which we were a party or will be a party, in which:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the amounts involved exceeded or will exceed $120,000; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of the
foregoing persons, had or will have a direct or indirect material interest. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE<BR>
FOR THE ELECTION OF THE DIRECTOR NOMINEES  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=42,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=365367,FOLIO='40',FILE='DISK108:[18ZAG1.18ZAG41701]DK41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm41701_1_41"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm41701_proposal_2__ratify_the_appoint__pro06313"> </A>
<A NAME="toc_dm41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 2: RATIFY THE APPOINTMENT OF<BR>  PRICEWATERHOUSECOOPERS&nbsp;LLP AS OUR INDEPENDENT REGISTERED<BR>  PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017<BR>  <BR>    (Proposal No.&nbsp;2)    <BR>
</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee has reappointed PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm to audit the
financial statements of the Company for the fiscal year ending December&nbsp;31, 2018, and has further directed that management submit their selection of independent registered public accounting
firm for ratification by our stockholders at the Annual Meeting of Stockholders. A representative of PricewaterhouseCoopers&nbsp;LLP is expected to attend the Annual Meeting and will have an
opportunity to make a statement, if he or she desires, and will be available to respond to appropriate questions. Neither the accounting firm nor any of its members have any direct or indirect
financial interest in or any connection with us in any capacity other than as public registered accounting firm. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Principal Accountant Fees and Services  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the fees for professional services rendered by PricewaterhouseCoopers&nbsp;LLP, our independent registered
public accounting firm, for each of the last two fiscal years: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="13pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Fee Category

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>747</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>856</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit-Related Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>42</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All Other Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>775</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>938 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Represents fees, including out of pocket expenses, for professional services provided in connection with the audit of our annual audited
financial statements and of our internal control over financial reporting, the review of our quarterly financial statements included in our Forms&nbsp;10-Q, accounting consultations or advice on
accounting matters necessary for the rendering of an opinion on our financial statements, services provided in connection with the offerings of our common stock and audit services provided in
connection with other statutory or regulatory filings. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit-Related Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit-related fees in 2017 consist of fees for services performed related to our adoption of the new revenue standard in the first quarter of
2018. Audit-related fees in 2016 are for assurance and other activities not explicitly related to the audit of our financial statements including due diligence in connection with the Kolltan
acquisition </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Tax Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax fees are associated with tax compliance and tax planning related activities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


All Other Fees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other fees consist of fees relating to an accounting research tool and disclosures database. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=43,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=294513,FOLIO='41',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dm41701_1_42"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee is responsible for appointing, setting compensation and overseeing the work of the independent auditors. The Audit Committee has established a policy regarding
pre-approval of all auditing services and the terms thereof and non-audit services (other than non-audit services prohibited under Section&nbsp;10A(g) of the Exchange Act or the applicable rules of
the SEC or the Public Company Accounting Oversight Board) to be provided to Celldex by the independent auditor. However, the pre-approval requirement may be waived with respect to the provision of
non-audit services for Celldex if the "de minimis" provisions of Section&nbsp;10A(i)(1)(B) of the Exchange Act are satisfied. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee has considered whether the provision of Audit-Related Fees, Tax Fees, and All Other Fees as described above is compatible with maintaining
PricewaterhouseCoopers&nbsp;LLP's independence and has determined that such services for fiscal years 2017 and 2016 were compatible. All such services were approved by the Audit Committee pursuant
to Rule&nbsp;2-01 of Regulation&nbsp;S-X under the Exchange Act to the extent that rule was applicable. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee is responsible for reviewing and discussing the audited financial statements with management, discussing with the independent registered public accountants the
matters required in Auditing Standards No.&nbsp;1301, receiving written disclosures from the independent registered public accountants required by the applicable requirements of the Public Company
Accounting Oversight Board regarding the independent registered public accountants' communications with the Audit Committee concerning independence and discussing with the independent registered
public accountants
their independence, and recommending to the Board of Directors that the audit financial statements be included in our annual report on Form&nbsp;10-K. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE<BR>
FOR THE RATIFICATION OF THE INDEPENDENT REGISTERED PUBLIC<BR>
ACCOUNTING FIRM  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=44,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=585603,FOLIO='42',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dm41701_1_43"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="dm41701_proposal_3__approval_of_an_ame__pro08634"> </A>
<A NAME="toc_dm41701_2"> </A>
<BR>  PROPOSAL 3: APPROVAL OF AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF<BR>  INCORPORATION AND GRANT OF DISCRETIONARY AUTHORITY TO THE BOARD OF<BR>  DIRECTORS TO EFFECT A REVERSE SPLIT OF THE COMPANY'S OUTSTANDING COMMON<BR>  STOCK.    <BR>
</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board has adopted a resolution approving and recommending to the Company's stockholders for their approval a proposal to amend our
certificate of incorporation to effect a reverse split of our outstanding shares of common stock within a range of one share of common stock for every ten shares of common stock to one share of common
stock for every fifteen shares of common stock, with the exact reverse split ratio to be decided and publicly announced by the Board prior to the effective time of the amendment to our certificate of
incorporation. If the stockholders approve this Proposal 3, the Board will have the authority to decide, at any time prior to the date of the 2019 Annual Meeting, whether to implement the reverse
stock split and the precise ratio of the reverse stock split within a range of one-for-ten shares of our common stock to one-for-fifteen shares of our common stock. If the Board decides to implement
the reverse stock split, the reverse stock split will become effective upon the filing of an amendment to our certificate of incorporation with the Secretary of State of the State of Delaware. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board reserves the right, even after stockholder approval, to abandon or postpone the filing of the amendment to effect the reverse stock split if the Board determines that it is not
in the best interests of the Company and the stockholders. If the amendment effecting the reverse stock split holders is not implemented by the Board prior to the date of the 2019 Annual Meeting, the
proposal will be deemed abandoned, without any further effect. In that case, the Board may again seek stockholder approval at a future date for a reverse stock split if it deems a reverse stock split
to be advisable at that time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
form of the certificate of amendment to accomplish the reverse stock split is attached to this Proxy Statement as Appendix&nbsp;A. The following discussion is qualified in its
entirety by the full text of the certificate of amendment, which is incorporated herein by reference. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reasons for the Reverse Stock Split  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The primary reason for the reverse stock split is to allow us to attempt to increase the bid price of our common stock by reducing the number of
outstanding shares of our common stock. To continue listing on The NASDAQ Global Market, we must comply with the applicable listing requirements under NASDAQ Marketplace Rules, which requirements
include, among others, a minimum bid price of at least $1.00 per share. On April&nbsp;16, 2018, the closing bid price of our common stock on the NASDAQ Global Market was $0.76. The Board believes
that the reverse stock split will enhance the Company's ability to maintain compliance with the applicable listing requirements under NASDAQ Marketplace Rules. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we were unable to maintain compliance with the $1.00 minimum bid price requirement and our common stock were delisted from NASDAQ, trading of our common stock would most likely take
place on an over-the-counter market established for unlisted securities, such as the Pink Sheets or the OTC Bulletin Board. An investor would likely find it less convenient to sell, or to obtain
accurate quotations in seeking to buy, our common stock on an over-the-counter market, and many investors would likely not buy or sell our common stock due to difficulty in accessing over-the-counter
markets, policies preventing them from trading in securities not listed on a national exchange or other reasons. In addition, as a delisted security, our common stock would be subject to SEC rules
regarding "penny stock," which impose additional disclosure requirements on broker-dealers. The regulations relating to penny stocks, coupled with the typically higher cost per trade to the investor
of penny stocks due to factors such as broker commissions generally representing a higher percentage of the price of a penny stock than of a higher-priced stock, would further limit the ability of
investors to trade in our common </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=45,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=443127,FOLIO='43',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dm41701_1_44"> </A>

<P style="font-family:times;"><FONT SIZE=2>stock.
For these reasons and others, delisting would adversely affect the liquidity, trading volume and price of our common stock, causing the value of an investment in us to decrease and having an
adverse effect on our business, financial condition and results of operations, including our ability to attract and retain qualified employees and to raise capital. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, among the factors considered by the Board in reaching its decision to recommend the reverse stock split, the Board considered the potential effects of having stock that
trades at a low price. Since the brokerage commissions on stock with a low trading price generally represent a higher percentage of the stock price than commissions on higher priced stock, investors
in stocks with a low trading price pay transaction costs (commissions, markups, or markdowns) at a higher percentage of their total share value, which may limit the willingness of individual investors
and institutions to purchase our common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
will be no change in our authorized shares as a result of the amendment to our certificate of incorporation and therefore, upon effectiveness of the reverse stock split, the number
of shares of our common stock that are authorized and unissued will increase relative to the number of issued and outstanding shares. Except as discussed below under the heading "Principal Effects of
the Reverse Stock Split," we currently have no plans, proposals, arrangements or understandings to issue any of our authorized but unissued shares of our common stock. However, it is possible that
some of these additional authorized shares could be used in the future for various other purposes without further stockholder approval, except as such approval may be required in particular cases by
our certificate of incorporation, applicable law or the rules of any stock exchange or other system on which our securities may then be listed. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risk Factors Associated with the Reverse Stock Split  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The primary purpose of the proposed reverse stock split is to combine the issued and outstanding shares of our common stock into a smaller
number of shares so that the shares of our common stock will trade above the $1.00 minimum bid price required to maintain the listing of our common stock on the NASDAQ Global Market. However, we
cannot assure you that the reverse stock split, if implemented, will have the desired effect of raising the price of our common stock over the long term. The history of similar stock split
combinations for companies in like circumstances is varied. There is no assurance that:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the market price per post-split share of our common stock would either exceed the required minimum bid price to maintain compliance with
applicable NASDAQ listing requirements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the trading price per share of our common stock after the reverse stock split would rise in proportion to the reduction in the number of
pre-split shares of our common stock outstanding before the reverse stock split; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the reduction in the shares outstanding and in the public float after the reverse stock split will not negatively impact the liquidity or
trading activity for our stock; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the reverse stock split would result in a per share price that would increase the level of investment by institutional investors or increase
analyst and broker interest in our company; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the reverse stock split will result in decreased transaction costs for our stockholders. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, there can be no assurance that our common stock will not be delisted due to a failure to meet other continued listing requirements even if the market price per post-split
share of our common stock remains in excess of $1.00. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
market price of our common stock will also be based on our performance and other factors, including those factors listed under the heading "Risk Factors" and elsewhere in our annual
report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017 and other reports that we file with the SEC. If the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=46,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=251657,FOLIO='44',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dm41701_1_45"> </A>

<P style="font-family:times;"><FONT SIZE=2>reverse
stock split is consummated and the trading price of our common stock declines, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be
greater than would occur in the absence of the reverse stock split. Furthermore, the liquidity of our common stock could be adversely affected by the reduced number of shares that would be outstanding
after the reverse stock split. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Principal Effects of the Reverse Stock Split  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After the effective date of the reverse stock split, each stockholder would own a reduced number of shares of common stock. However, the reverse
stock split would affect all stockholders uniformly and would not affect any stockholder's percentage ownership interest in Celldex (except to the extent that the reverse stock split would result in
some of our stockholders owning a fractional share as described below). Proportionate voting rights and other rights and preferences of the holders of common stock would not be affected by the reverse
stock split (except to the extent that the reverse stock split would result in some of our stockholders owning a fractional share as described below). For example, a holder of 2% of the voting power
of the outstanding shares of common stock immediately prior to the reverse stock split would continue to hold approximately 2% of the voting power of the outstanding shares of common stock immediately
after the reverse stock split. The number of stockholders of record also would not be affected by the reverse stock split (except to the extent that the reverse stock split would result in some of our
stockholders owning only a fractional share as described below). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table contains approximate information relating to our common stock if (i)&nbsp;the reverse stock split is implemented at a ratio of one-for-ten and (ii)&nbsp;the
reverse stock split is implemented at a ratio of one-for-fifteen based on share information as of close of business on March&nbsp;31, 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="92pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares Issued<BR>
and Outstanding(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares Authorized<BR>
and Reserved for<BR>
Issuance(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares Authorized<BR>
and Unreserved for<BR>
Issuance(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
Authorized </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>As of March&nbsp;31, 2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>143,368,784</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,353,600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,277,616</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>297,000,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>10-for-1 Reverse Split</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,336,878</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,835,360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>280,827,762</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>297,000,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>15-for-1 Reverse Split</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,557,919</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,223,573</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>286,218,508</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>297,000,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>These
estimates do not reflect the potential effect of rounding down for fractional shares that may result from the reverse stock split.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
(i)&nbsp;9,313,514 shares issuable upon the exercise of outstanding options under the 2008 Stock Option Plan at a weighted average exercise price of
$9.62, as of March&nbsp;31, 2018; (ii)&nbsp;8,879,518 shares reserved for future issuance under the 2008 Stock Option Plan and (iii)&nbsp;160,568 shares reserved for issuance under the 2004
Employee Stock Purchase Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
(i)&nbsp;931,351 shares issuable upon the exercise of outstanding options under the 2008 Stock Option Plan at a weighted average exercise price of $96.20,
as of March&nbsp;31, 2018; (ii)&nbsp;887,952 shares reserved for future issuance under the 2008 Stock Option Plan and (iii)&nbsp;16,057 shares reserved for issuance under the 2004 Employee Stock
Purchase Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
(i)&nbsp;620,901 shares issuable upon the exercise of outstanding options under the 2008 Stock Option Plan at a weighted average exercise price of
$144.30, as of March&nbsp;31, 2018; (ii)&nbsp;591,968 shares reserved for future issuance under the 2008 Stock Option Plan and (iii)&nbsp;10,705 shares reserved for issuance under the 2004
Employee Stock Purchase Plan.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
reverse stock split would reduce the number of shares of common stock available for issuance under our 2008 Stock Option Plan and our 2004 Employee Stock Purchase Plan. With respect
to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=47,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=258586,FOLIO='45',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dm41701_1_46"> </A>

<P style="font-family:times;"><FONT SIZE=2>outstanding
stock options to purchase shares of our common stock, the reverse stock split would effect a reduction in the number of shares subject to such outstanding stock options proportional to the
exchange ratio of the reverse stock split (rounded down to the nearest whole share) and would effect a proportionate increase in the exercise price of such outstanding stock options (rounded up to the
nearest whole cent). Unless required by the terms of the equity incentive compensation plan pursuant to which a stock equity award was issued, no cash payment would be made to holders of equity awards
in respect of such rounding. Under the terms of our outstanding warrants, the reverse stock split would also result in a proportionate increase in the exercise price of the warrants, as well as a
proportionate decrease in the number of shares issuable to the holders thereof upon exercise of the warrants. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the proposed reverse stock split is implemented, it may increase the number of our stockholders who own "odd lots" of less than 100 shares of common stock. Brokerage commission and
other costs of transactions in odd lots are generally higher than the costs of transactions of more than 100 shares of common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
the total number of shares of authorized common stock is not being reduced in an amount proportionate to the reverse stock split, the ability of the Board to issue authorized and
unissued shares without further stockholder action will be significantly increased. In addition to the shares reserved for future issuance under our equity incentive plans, pursuant to a Controlled
Equity Offering agreement between us and Cantor Fitzgerald&nbsp;&amp;&nbsp;Co. ("Cantor"), we have the ability to issue and sell shares of our common stock having an aggregate offering price of up to
$75.0&nbsp;million from time to time through Cantor, acting as agent. As of April&nbsp;16, 2018, we had $55.5&nbsp;million remaining in aggregate gross offering price under our agreement with
Cantor. Based on the closing price of our common stock on April&nbsp;16, 2018 of $0.76 per share, if we chose to sell all the shares available for sale under the Controlled Equity Offering agreement
with Cantor, the total amount of shares of our common stock issuable under the Controlled Equity Agreement would be 73.0&nbsp;million shares of common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
pursuant to the Agreement and Plan of Merger dated as of November&nbsp;1, 2016 pursuant to which we acquired Kolltan Pharmaceuticals,&nbsp;Inc. ("Kolltan"), we may be
required to make certain contingent milestone payments totaling $172.5&nbsp;million in the aggregate if we achieve certain preclinical and clinical development milestones related to Kolltan's
development programs and/or Celldex's development programs and certain commercial milestones related to Kolltan's product candidates. Under the terms of the merger agreement, the milestone payments
may be made, at our sole election, in cash, in shares of our common stock or a combination of both. Such milestones may not be achieved for several years, if at all. By way of illustration, assuming
all the specified milestones were achieved and we elected to satisfy our milestone payment obligations by issuing shares of our common stock, based on the price per share of our common stock as of
April&nbsp;16, 2018 of $0.76 per share, we would issue to Kolltan an aggregate of 227.0&nbsp;million shares of our common stock. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth above, we currently have no plans, arrangements or understandings, written or oral, to issue any of our authorized but unissued shares of our common stock. The
issuance in the future of additional authorized shares may have the effect of diluting the earnings per share and book value per share, as well as the stock ownership and voting rights, of the
currently outstanding shares of our common stock. The effective increase in the number of authorized but unissued shares of our common stock may be construed as having an anti-takeover effect by
permitting the issuance of shares to purchasers who might oppose a hostile takeover bid or oppose any efforts to amend or repeal certain provisions of our certificate of incorporation or bylaws. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Effective Date  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If our stockholders approve this Proposal No.&nbsp;3, the Board of Directors could decide at any time on or prior to the date of the 2019
Annual Meeting of Stockholders to effect the reverse stock split </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=48,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=283486,FOLIO='46',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dm41701_1_47"> </A>

<P style="font-family:times;"><FONT SIZE=2>based
on a determination that the reverse stock split is then advisable and in the best interests of the Company and our stockholders. Such determination would primarily be based upon consideration of
whether such reverse split would be advisable to help us meet the applicable listing requirements to maintain listing of our common stock on NASDAQ Global Market. In determining the actual timing of
the filing of the certificate of amendment and selecting an appropriate ratio within the range of specified reverse stock split ratios, the Board of Directors would examine the historical and
projected price performance of our common stock, the expected bid price and trading volume of our common stock over the short- and long-term following the effectiveness of the reverse stock split and
the potential devaluation of our market capitalization as a result of the reverse stock split. Even with stockholder approval of this Proposal No.&nbsp;3, and without the need for further action by
our stockholders, the Board of Directors may delay the implementation of the reverse stock split up until the 2019 Annual Meeting of Stockholders and may abandon the reverse stock split at any time
prior to the filing of the certificate of amendment. If the reverse stock split is not effected on or prior to the date of the 2019 Annual Meeting of stockholders, the authority granted to the Board
of Directors to effect the reverse stock split would expire and be without any further effect. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
our stockholders approve this Proposal No.&nbsp;3 and the Board of Directors determines that it is advisable and in the best interests of the Company and our stockholders to proceed
with the reverse stock split, the certificate of amendment would be filed with the Secretary of State of the State of Delaware. The reverse stock split would become effective upon the filing of the
certificate of amendment with the Secretary of State of the State of Delaware and upon the effective date the outstanding shares of our common stock would be combined and converted into a lesser
number of shares of common stock calculated in accordance with the exchange ratio set by the Board of Directors, within the specified range of potential exchange ratios, and without further action on
the part of the Company and our stockholders. For instance, if a stockholder presently holds 100 shares of our common stock, the stockholder would hold 10 shares of our common stock following a
reverse stock split affected at a ratio of ten-for-one. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Treatment of Fractional Shares  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No scrip or fractional shares would be issued if, as a result of the reverse stock split, a stockholder would otherwise become entitled to a
fractional share. Instead, we would pay to the stockholder, in cash, the value of any fractional share arising from the reverse stock split. The cash payment would be based on the closing sale price
per share of our common stock as reported on the NASDAQ Global Market on the last trading day preceding the effective date of the reverse stock split multiplied by the number of shares of pre-split
common stock held by the stockholder that would otherwise have been exchanged for such fractional share. No transaction costs would be assessed to stockholders for the cash payment. Stockholders would
not be entitled to receive interest for their fractional shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you do not hold sufficient shares of pre-split common stock to receive at least one post-split share of common stock and you want to hold our common stock after the reverse stock
split, you may do so by taking either of the following actions far enough in advance so that it is completed before the reverse stock split is effected:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> purchase a sufficient number of shares of our common stock so that you would hold at least that number of shares of common stock in your
account prior to the implementation of the reverse stock split that would entitle you to receive at least one share of common stock on a post-split basis; or </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=49,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=326772,FOLIO='47',FILE='DISK108:[18ZAG1.18ZAG41701]DM41701A.;9',USER='CHE107555',CD='19-APR-2018;08:37' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do41701_1_48"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if applicable, consolidate your accounts so that you hold at least that number of shares of our common stock in one account prior to the
reverse stock split that would entitle you to at least one share of our common stock on a post-split basis. Common stock held in registered form (that is, shares held by you in your own name on our
company's share register maintained by our transfer agent) and common stock held in "street name" (that is, shares held by you through a bank, broker or other nominee) for the same investor would be
considered held in separate accounts and would not be aggregated when implementing the reverse stock split. Also, shares of common stock held in registered form but in separate accounts by the same
investor would not be aggregated when implementing the reverse stock split. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
the reverse stock split, then-current stockholders would have no further interest in our company with respect to their fractional shares. A person otherwise entitled to a
fractional share would not have any voting, dividend or other rights in respect of his or her fractional share except to receive the cash payment as described above. Such cash payments would reduce
the number of post-split stockholders to the extent that there are stockholders holding fewer than that number of pre-split shares within the one-for-five to one-for-fifteen range of exchange ratios
described above. Reducing the number of post-split stockholders, however, is not the purpose of this proposal. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders
should be aware that, under the escheat laws of the various jurisdictions where stockholders reside, where we are domiciled and where the funds for fractional shares would
be deposited, sums due to stockholders in payment for fractional shares that are not timely claimed after the effective date may be required to be paid to the designated agent for each such
jurisdiction.
Thereafter, stockholders otherwise entitled to receive such funds may have to seek to obtain them directly from the state to which they were paid. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Effect on Non-Registered Stockholders  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-registered stockholders holding our common stock through a bank, broker or other nominee should note that such banks, brokers or other
nominees may have different procedures for processing the consolidation than those that would be put in place by us for registered stockholders, and their procedures may result, for example, in
differences in the precise cash amounts being paid by such nominees in lieu of a fractional share. If you hold your shares with such a bank, broker or other nominee and if you have questions in this
regard, you are encouraged to contact your nominee. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Book-Entry Shares and Payment for Fractional Shares  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The combination of and reduction in the number of our outstanding shares of common stock as a result of the reverse stock split would occur
automatically on the effective date without any action on the part of our stockholders. Our registered stockholders may hold some or all of their shares electronically in book-entry form. These
stockholders will not have stock certificates evidencing their ownership of common stock. They are, however, provided with a statement reflecting the number of shares of common stock registered in
their accounts. Stockholders who hold registered shares of our common stock in book-entry form do not need to take any action to receive post-reverse stock split shares of our common stock in
registered book-entry form or the cash payment in lieu of any fractional interest, if applicable. These stockholders will have their pre-reverse stock split shares exchanged automatically and a Credit
Advice will be mailed to them upon exchange indicating the number of post-reverse stock split shares owned by such stockholders. A check will also be mailed to such stockholders' registered address as
soon as practicable after the effective date of the reverse stock split. By signing and cashing this check, such stockholders will represent and warrant that they owned the shares of our common stock
for which they received the cash payment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=50,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=279197,FOLIO='48',FILE='DISK108:[18ZAG1.18ZAG41701]DO41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_do41701_1_49"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Exchange of Stock Certificates and Payment for Fractional Shares  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The combination of and reduction in the number of our outstanding shares of common stock as a result of the reverse stock split would occur
automatically on the effective date without any action on the part of our stockholders and without regard to the date that stock certificates representing pre-split shares of common stock are
physically surrendered for new stock certificates representing post-split shares of common stock. As soon as practicable after the effective date, transmittal forms will be mailed to each holder of
record of certificates for shares of our common stock to be used in forwarding such certificates for surrender in exchange for any cash payment due for fractional shares and, if so elected by the
holder, certificates representing the number of shares of our post-split common stock such stockholder is entitled to receive as a result of the reverse stock split. Our transfer agent will act as
exchange agent for purposes of implementing the payment in lieu of fractional shares and exchange of stock certificates. The transmittal forms will be accompanied by instructions specifying other
details of the exchange. Upon receipt of the transmittal form, each stockholder should surrender the certificates representing shares of our common stock prior to the reverse stock split in accordance
with the applicable instructions. Each stockholder who surrenders certificates will receive any cash payment due for fractional shares and, upon payment of the applicable fee, new certificates
representing the whole number of shares of our common stock that he or she holds as a result of the reverse stock split. No new certificates and no payments in lieu of fractional shares will be issued
to a stockholder until the stockholder has surrendered its outstanding stock certificate(s) together with the properly completed and executed transmittal form to the exchange agent. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>STOCKHOLDERS SHOULD NOT DESTROY ANY PRE-SPLIT STOCK CERTIFICATES AND SHOULD NOT SUBMIT ANY STOCK CERTIFICATES UNTIL THEY ARE REQUESTED TO DO SO.</B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accounting Consequences  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The par value per share of our common stock would remain unchanged at $0.001 per share after the reverse stock split. As a result, on the
effective date of the reverse stock split, the amount on our balance sheet attributable to our common stock would be reduced proportionally, based on the exchange ratio of the reverse stock split,
from its present amount, and the additional paid-in capital account would be credited with the amount by which the common stock is reduced. The per share common stock net loss and net book value would
be increased because there would be fewer shares of our common stock outstanding. We do not anticipate that any other accounting consequences would arise as a result of the reverse stock split. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impact of Potential Reverse Stock Split Upon Other Data Contained in this Proxy Statement  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless expressly stated otherwise, the data contained in this proxy statement does not reflect the impact of any reverse stock split that may be
effected pursuant to the terms of this Proposal No.&nbsp;3. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


No Appraisal Rights  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, stockholders are not entitled to dissenters' rights with respect to the proposed amendment to our
certificate of incorporation to effect the reverse stock split, and we will not independently provide our stockholders with any such right. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


No Going Private Transaction  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the change in the number of outstanding shares following the reverse stock split, the Board does not intend for this transaction
to be the first step in a series of plans or proposals of a "going private transaction" within the meaning of Rule&nbsp;13e-3 of the Exchange Act. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=51,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=874050,FOLIO='49',FILE='DISK108:[18ZAG1.18ZAG41701]DO41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_do41701_1_50"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Interests of Certain Persons in the Proposal  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain of our officers and directors have an interest in Proposal No.&nbsp;3 as a result of their ownership of shares of our common stock, as
set forth in the section entitled "Security Ownership of Certain Beneficial Owners and Management" above. However, we do not believe that our officers or directors have interests in Proposal
No.&nbsp;3 that are different from or greater than those of any other of our stockholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Certain U.S. Federal Income Tax Consequences of the Reverse Stock Split  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following discussion is a general summary of material U.S. federal income tax consequences of the reverse stock split that may be relevant
to U.S. Holders (as defined below) of our common stock, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift
tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on currently existing provisions of the Internal Revenue Code of 1986, as amended (the
"Code"), its legislative history, existing and proposed federal income tax regulations, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service
(the "IRS"), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied
retroactively in a manner that could adversely affect a holder of our common stock. We have not sought and will not seek an opinion of counsel or any rulings from the IRS regarding the matters
discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the reverse stock split. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
discussion is limited to holders that hold our common stock as "capital assets" within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This
discussion does not address all U.S. federal income tax consequences that may be applicable to holders in light of their particular circumstances or to holders subject to special treatment under U.S.
federal income tax law, including, without limitation:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons that are not U.S. Holders (as defined below); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons subject to the alternative minimum tax; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> U.S. Holders (as defined below) whose functional currency is not the U.S. dollar; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons holding our common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other
integrated investment; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> banks, insurance companies, and other financial institutions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> real estate investment trusts or regulated investment companies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> brokers, dealers or traders in securities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> corporations that accumulate earnings to avoid U.S. federal income tax; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors
therein); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> tax-exempt organizations or governmental organizations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons deemed to sell our common stock under the constructive sale provisions of the Code; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> tax-qualified retirement plans. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=52,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=607180,FOLIO='50',FILE='DISK108:[18ZAG1.18ZAG41701]DO41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_do41701_1_51"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>THIS DISCUSSION IS PROVIDED FOR GENERAL INFORMATION ONLY AND DOES NOT CONSTITUTE LEGAL ADVICE TO ANY HOLDER. WE STRONGLY URGE A HOLDER OF OUR COMMON STOCK TO
CONSULT ITS OWN TAX ADVISORS CONCERNING THE U.S. FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE REVERSE STOCK SPLIT IN LIGHT OF ITS PARTICULAR CIRCUMSTANCES AND ANY CONSEQUENCES ARISING UNDER STATE,
LOCAL, OR FOREIGN INCOME OR OTHER TAX LAW.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this discussion, a "U.S. Holder" is a beneficial owner of shares of our common stock that for U.S. federal income tax purposes is or is treated as: (1)&nbsp;an
individual who is a citizen or resident of the United States; (2)&nbsp;a corporation (or other entity taxable as a corporation) created or organized under the laws of the United States, any state
thereof, or the District of Columbia; (3)&nbsp;an estate the income of which is subject to U.S. federal income tax regardless of its source; or (4)&nbsp;a trust that (a)&nbsp;is subject to the
primary supervision of a U.S. court and the control of one of more "United States persons" (within the meaning of Section&nbsp;7701(a)(30) of the Code), or (b)&nbsp;has a valid election in effect
under applicable Treasury Regulations to be treated as a United States person. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
reverse stock split should constitute a "recapitalization" for U.S. federal income tax purposes. As a result, a U.S. Holder generally should not recognize gain or loss upon the
reverse stock split, except with respect to cash received in lieu of a fractional share of our common stock, as discussed below. A U.S. Holder's aggregate tax basis in the shares of our common stock
received pursuant to the reverse stock split should equal the aggregate tax basis of the shares of our common stock surrendered and such U.S. Holder's holding period in the shares of our common stock
received should include the holding period in the shares of our common stock surrendered. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of
our common stock surrendered to the shares of our common stock received pursuant to the reverse stock split. Holders of shares of our common stock acquired on different dates and at different prices
should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, a U.S. Holder that receives cash in lieu of a fractional share of our common stock pursuant to the reverse stock split will recognize gain or loss based upon the difference
between the amount of cash received and the U.S. Holder's adjusted tax basis in the shares of our common stock surrendered that is allocated to such fractional share as set forth above, as if such
fractional shares were distributed as part of the reverse stock split and then redeemed, subject to the provisions and limitations of section&nbsp;302 of the Code (including, without limitation,
certain attribution rules that could result in the cash payment being treated as a dividend). The gain or loss will constitute a capital gain or loss and will constitute long-term capital gain or loss
if the U.S. Holder's holding period is greater than one year as of the effective time of the reverse stock split. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Information Reporting and Backup Withholding  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Information reporting and backup withholding (at a rate of 24%) may apply to holders who receive cash in lieu of a fractional share of our
common stock pursuant to the reverse stock split. Backup withholding generally will not apply to (1)&nbsp;a U.S. Holder that furnishes a correct taxpayer identification number and certifies that
such holder is not subject to backup withholding on IRS Form&nbsp;W-9 or (2)&nbsp;any holder that otherwise establishes an exemption from backup withholding. Backup withholding is not an
additional tax. Any amounts withheld under the backup withholding rules may be refunded or allowed as a credit against the U.S. Holder's federal income tax liability, if any, provided the required
information is timely furnished to the IRS. U.S. Holders should consult their tax advisors regarding their qualification for an exemption from backup withholding and the procedures for obtaining such
an exemption. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=53,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=508672,FOLIO='51',FILE='DISK108:[18ZAG1.18ZAG41701]DO41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_do41701_1_52"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Vote Required  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote of a majority of the shares of common stock outstanding and entitled to vote at the meeting will be required to approve
this proposal No.&nbsp;3. Abstentions and broker non-votes with respect to this proposal will be counted for purposes of establishing a quorum and, if a quorum is present, will have the same
practical effect as a vote against this proposal. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR PROPOSAL NO. 3 TO APPROVE AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION AND GRANT OF
DISCRETIONARY AUTHORITY TO THE BOARD OF DIRECTORS TO EFFECT A REVERSE STOCK SPLIT OF THE COMPANY'S COMMON STOCK.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=54,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=854538,FOLIO='52',FILE='DISK108:[18ZAG1.18ZAG41701]DO41701A.;7',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq41701_1_53"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq41701_proposal_4__advisory_vote_on_e__pro02564"> </A>
<A NAME="toc_dq41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION    <BR>    <BR>    (Proposal No.&nbsp;4)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, and Section&nbsp;14A of the Securities Exchange
Act of 1934, as amended, or the Exchange Act, our stockholders are entitled to vote to approve, on an advisory (nonbinding) basis, the compensation of our Named Executive Officers as disclosed in this
proxy statement in accordance with the Securities and Exchange Commission's rules. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
described in detail under the heading "Compensation of Executive Officers&#151;Compensation Discussion and Analysis," our executive compensation programs are designed to retain
and incentivize the high quality executives whose efforts are key to our long-term success. Under these programs, our Named Executive Officers are rewarded on the basis of individual and corporate
performance measured against established corporate and strategic goals. Please read the section of this proxy statement under the heading "Compensation of Executive Officers&#151;Compensation
Discussion and Analysis" for additional details about our executive compensation programs, including information about the fiscal year 2017 compensation of our Named Executive Officers. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee of our Board of Directors continually reviews the compensation programs for our Named Executive Officers to ensure they achieve the desired goals of aligning
our executive compensation structure with our stockholders' interests and current market practices. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are asking our stockholders to indicate their support for our Named Executive Officer compensation as described in this proxy statement. This proposal, commonly known as a
"say-on-pay" proposal, gives our stockholders the opportunity to express their views on our Named Executive Officers' compensation. This vote is not intended to address any specific item of
compensation, but rather the overall compensation of our Named Executive Officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we are asking our
stockholders to cast a non-binding advisory vote "FOR" the following resolution at the Annual Meeting: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"RESOLVED,
that the compensation of the Named Executive Officers, as disclosed in the Company's Proxy Statement for the 2018 Annual Meeting of Stockholders pursuant to Item&nbsp;402 of
Regulation&nbsp;S-K, including the Compensation Discussion and Analysis, compensation tables and narrative disclosure is hereby APPROVED." </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
say-on-pay vote is advisory, and therefore not binding on Celldex Therapeutics, the Compensation Committee or our Board of Directors. Nevertheless, our Board of Directors and our
Compensation Committee value the opinions of our stockholders, whether expressed through this vote or otherwise, and accordingly, the Board and Compensation Committee intend to consider the results of
this vote among the many factors they consider in making determinations in the future regarding executive compensation arrangements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholder
approval of this Proposal No.&nbsp;4 will require the affirmative vote of the holders of a majority of the votes cast in person or by proxy at the Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD RECOMMENDS A VOTE FOR THIS PROPOSAL NO. 4  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=55,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=597877,FOLIO='53',FILE='DISK108:[18ZAG1.18ZAG41701]DQ41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dq41701_1_54"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="dq41701_stockholder_proposals"> </A>
<A NAME="toc_dq41701_2"> </A>
<BR>  STOCKHOLDER PROPOSALS    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stockholder Proposals for 2019 Annual Meeting  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any stockholder proposals submitted pursuant to Exchange Act Rule&nbsp;14a-8 for inclusion in Celldex's proxy statement and form of proxy for
our 2019 Annual Meeting must be received by Celldex on or before December&nbsp;28, 2018 in order to be considered for inclusion in our proxy statement and form of proxy. Such proposal must also
comply with the requirements as to form and substance established by the SEC if such proposals are to be included in the proxy statement and form of proxy. Any such proposal shall be mailed to:
Celldex Therapeutics,&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ&nbsp;08827, Attn.: Secretary. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
by-laws state that the stockholder must provide timely written notice of such nomination or proposal and supporting documentation as well as be present at such meeting, either in
person or by a representative. A stockholder's notice shall be timely received by Celldex at our principal executive office not less than seventy-five (75)&nbsp;days nor more than one hundred twenty
(120)&nbsp;days prior to the anniversary date of the immediately preceding annual meeting (the "Anniversary Date"); provided, however, that in the event the annual meeting is scheduled to be held on
a date more than thirty (30)&nbsp;days before the Anniversary Date or more than sixty (60)&nbsp;days after the Anniversary Date, a stockholder's notice shall be timely if received by Celldex at
our principal executive office not later than the close of business on the later of (i)&nbsp;the seventy-fifth (75<SUP>th</SUP>) day prior to the scheduled date of such annual meeting or
(ii)&nbsp;the fifteenth (15<SUP>th</SUP>) day following the day on which such public announcement of the date of such annual meeting is first made by Celldex. Proxies solicited by our Board of
Directors will confer discretionary voting authority with respect to these proposals, subject to SEC rules and regulations governing the exercise of this authority. Any such proposal shall be mailed
to: Celldex Therapeutics,&nbsp;Inc., Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ&nbsp;08827, Attn.: Secretary. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq41701_where_you_can_find_additional_informaiton"> </A>
<A NAME="toc_dq41701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  WHERE YOU CAN FIND ADDITIONAL INFORMAITON    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company files annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to
the public over the Internet at the SEC's website at </FONT><FONT SIZE=2><I>http://www.sec.gov</I></FONT><FONT SIZE=2>. The SEC's website contains reports, proxy statements and other information
regarding issuers, such as Celldex Therapeutics,&nbsp;Inc., that file electronically with the SEC.
You may also read and copy any document we file with the SEC at the SEC's Public Reference Room, located at 100&nbsp;F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for
further information on the operation of its Public Reference Room. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
SEC allows the Company to "incorporate by reference" certain information the Company files with it, which means that the Company can disclose important information to you by
referring you to those documents. The information incorporated by reference is considered to be part of this Proxy Statement, and information that the Company files later with the SEC will
automatically update and supersede previously filed information, including information contained in this document. We are incorporating by reference the following, which include the information
required by Item&nbsp;13(a) of Schedule&nbsp;14A in connection with Proposal 3:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Sections of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017, filed with the SEC on March&nbsp;7, 2018:
"Part&nbsp;II. Item&nbsp;7&#151;Management's Discussion and Analysis of Financial Condition and Results of Operations," "Part&nbsp;II. Item&nbsp;8&#151;Financial Statements and
Supplementary Data," "Part&nbsp;II. Item&nbsp;7A&#151;Quantitative and Qualitative Disclosure About Market Risk" and "Part&nbsp;II. Item&nbsp;9&#151;Changes in and Disagreements
With Accountants on Accounting and Financial Disclosure." </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=56,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=235116,FOLIO='54',FILE='DISK108:[18ZAG1.18ZAG41701]DQ41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dq41701_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, all documents we file under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Proxy Statement and before the date of the Annual Meeting are
incorporated by reference into and deemed a part of this Proxy Statement from the date of filing of those documents. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
person, including any beneficial owner, to whom this Proxy Statement is delivered may request copies of reports, proxy statements or other information concerning the Company
(including the documents incorporated by reference herein) without charge, by written or telephonic request directed to our Corporate Secretary at Celldex Therapeutics,&nbsp;Inc., Perryville III
Building, 53 Frontage Road, Suite&nbsp;220, Hampton, NJ&nbsp;08827. A request for copies of reports, proxy statements or other information concerning the Company (including the documents
incorporated by reference herein) must set forth a good-faith representation that the requesting party was either a holder of record or a beneficial owner of our common stock on April&nbsp;25, 2018. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=57,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=142521,FOLIO='55',FILE='DISK108:[18ZAG1.18ZAG41701]DQ41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_dq41701_1_56"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq41701_other_matters"> </A>
<A NAME="toc_dq41701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  OTHER MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this proxy statement, the Board of Directors does not intend to present at the Annual Meeting any matters other than those
described herein and does not presently know of any matters that will be presented by other parties. If any other matter requiring a vote of the stockholders should come before the meeting, it is the
intention of the persons named in the proxy to vote with respect to any such matter in accordance with the recommendation of the Board of Directors or, in the absence of such a recommendation, in
accordance with the best judgment of the proxy holder. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>/s/&nbsp;SAM MARTIN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2><I>Secretary</I></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Hampton, NJ<BR>
May&nbsp;3, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=58,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=43934,FOLIO='56',FILE='DISK108:[18ZAG1.18ZAG41701]DQ41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="ma41701_appendix_a"> </A>
<A NAME="toc_ma41701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Appendix A    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ma41701_certificate_of_amendment_of_ce__cer03328"> </A>
<A NAME="toc_ma41701_2"> </A></FONT> <FONT SIZE=2><B>  CERTIFICATE OF AMENDMENT OF    <BR>    <BR>    CERTIFICATE OF INCORPORATION    <BR>    <BR>    OF    <BR>    <BR>    CELLDEX THERAPEUTICS,&nbsp;INC.    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ma41701_(pursuant_to_section_242_of_th__(pu02374"> </A>
<A NAME="toc_ma41701_3"> </A></FONT> <FONT SIZE=2><B>  (Pursuant to Section&nbsp;242 of the Delaware General Corporation Law)    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Celldex Therapeutics,&nbsp;Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of
Delaware, does hereby certify as follows: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FIRST:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;That at a meeting of the Board of Directors of the Corporation on April&nbsp;15, 2018 resolutions were duly adopted setting
forth a proposed
amendment to the Third Restated Certificate of Incorporation, as amended, of the Corporation, declaring such amendment to be advisable and calling a meeting of stockholders of the Corporation for
consideration thereof. The resolution setting forth the proposed amendment is as follows: </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>RESOLVED</B></FONT><FONT SIZE=2>, that the Certificate of Amendment of the Corporation be amended to effect a reverse stock split of the Corporation's common
stock by adding the following paragraph to Article&nbsp;IV: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Effective
upon the effective time of this Certificate of Amendment of the Certificate of Incorporation with the Secretary of State of the State of Delaware (the "Split Effective Time"),
the shares of Common Stock issued and outstanding immediately prior to the Split Effective Time and the shares of Common Stock issued and held in the treasury of the Corporation immediately prior to
the Split Effective Time are reclassified into a smaller number of shares such that each ten to fifteen shares of issued Common Stock immediately prior to the Split Effective Time is reclassified into
one share of Common Stock, the exact ratio within the ten to fifteen range to be determined by the Board of Directors of the Corporation prior to the Split Effective Time and publicly announced by the
Corporation. Notwithstanding the foregoing, no fractional shares of Common Stock shall be issued as a result of the reclassification. In lieu of any fractional share to which the holder would
otherwise be entitled, the Corporation shall pay the holder cash equal to the product of such fraction multiplied by the Common Stock's fair market value as determined in good faith by the Board of
Directors as of the Split Effective Time. Each stock certificate that, immediately prior to the Split Effective Time, represented shares of Common Stock that were issued and outstanding immediately
prior to the Split Effective Time shall, from and after the Split Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares of
Common Stock after the Split Effective Time into which the shares of Common Stock formerly represented by such certificate shall have been reclassified, provided, however, that each person of record
holding a certificate that represented shares of Common Stock that were issued and outstanding immediately prior to the Split Effective Time shall receive, upon surrender of such certificate, a new
certificate evidencing and representing the number of whole shares of Common Stock after the Split Effective Time into which the shares of Common Stock formerly represented by such certificate shall
have been reclassified." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECOND:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The amendment of the Third Restated Certificate of Incorporation set forth herein has been duly adopted by resolution of the
Corporation's
Board of Directors and was considered and duly authorized by the stockholders of the Corporation at the Annual Meeting of Stockholders duly called and held upon notice in accordance with
Section&nbsp;222 of the General Corporation Law of the State of Delaware at which meeting the requisite number of shares as required by statute were voted in favor of the amendment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIRD:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;That said amendment was duly adopted in accordance with the applicable provisions of Section&nbsp;242 of the General Corporation
Law of the
State of Delaware. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=59,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=183522,FOLIO='blank',FILE='DISK108:[18ZAG1.18ZAG41701]MA41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<A NAME="page_ma41701_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>IN WITNESS WHEREOF</B></FONT><FONT SIZE=2>, the undersigned has executed this Certificate of Amendment this [&nbsp;&nbsp;&nbsp;&nbsp;] day of
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2018. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="47%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="38%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B> CELLDEX THERAPEUTICS,&nbsp;INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Name:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Title:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>A-2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=60,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=152915,FOLIO='A-2',FILE='DISK108:[18ZAG1.18ZAG41701]MA41701A.;8',USER='CHE107555',CD='19-APR-2018;08:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">you can consent   to receiving all future proxy statements, proxy cards and annual reports Use   any touch-tone telephone to transmit your voting instructions up until 11:59   proxy card in hand when you call and then follow the instructions. John   Sample 234567 VOTE BY MAIL 1234567 123,456,789,012.12345 TO VOTE, MARK BLOCKS   BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS   DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED   AND DATED. For All Withhold All For All Except To withhold authority to vote   for any individual nominee(s), mark &#147;For All Except&#148; and write the number(s)   of the The Board of Directors recommends you vote FOR the following:   nominee(s) on the line below. 0 0 0 1. Election of Directors Nominees 01 Larry   Ellberger 06 Gerald McMahon 02 Anthony S. Marucci 07 Harry H. Penner, Jr. 03   Keith L. Brownlie 08 Karen L. Shoos 04 Herbert J. Conrad 05 James J. Marino   The Board of Directors recommends you vote FOR proposals 2, 3 and 4. For 0 0   0 Against 0 0 0 Abstain 0 0 0 2 To ratify the appointment of   PricewaterhouseCoopers LLP as our independent registered public accounting   firm for the year ending December 31, 2018. To approve an amendment to our   Restated Certificate of Incorporation, as amended, and grant of discretionary   authority to the Board of Directors to effect a reverse stock split. To   approve, on an advisory basis, the compensation of the Company's Named   Executive Officers as disclosed in this proxy statement. 3 4 NOTE: In their   discretion, upon such other business as may properly come before the annual   meeting or any adjournment or postponement. Please sign exactly as your   name(s) appear(s) hereon. When signing as attorney, executor, administrator,   or other fiduciary, please give full title as such. Joint owners should each   sign personally. All holders must sign. If a corporation or partnership,   please sign in full corporate or partnership name, by authorized officer.   Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date 02   0000000000 1 OF 1 1 2 0000378601_1 R1.0.1.17 SHARES CUSIP # JOB #SEQUENCE #   VOTE BY INTERNET - www.proxyvote.com Use the Internet to transmit your voting   instructions and for electronic delivery of information up until 11:59 P.M.   Eastern Time the day before the cut-off date or meeting date. Have your proxy   card in hand when you access the web site and follow the instructions to   obtain your records and to create an electronic voting instruction form.   ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the   costs incurred by our company in mailing proxy materials, electronically via   e-mail or the Internet. To sign up for electronic delivery, please follow the   instructions above to vote using the Internet and, when prompted, indicate   that you agree to receive or access proxy materials electronically in future   years. VOTE BY PHONE - 1-800-690-6903 P.M. Eastern Time the day before the   cut-off date or meeting date. Have your 234567 1234567 Mark, sign and date   your proxy card and return it in the postage-paid envelope we have provided   or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood,   NY 11717. NAME THE COMPANY NAME INC. - COMMON THE COMPANY NAME INC. - CLASS A   THE COMPANY NAME INC. - CLASS B THE COMPANY NAME INC. - CLASS C THE COMPANY   NAME INC. - CLASS D THE COMPANY NAME INC. - CLASS E THE COMPANY NAME INC. -   CLASS F THE COMPA N Y NAME INC. - 401 K CONTROL # SHARES123,456,789,012.12345   123,456,789,012.12345 123,456,789,012.12345 123,456,789,012.12345   123,456,789,012.12345 123,456,789,012.12345 123,456,789,012.12345 x PAGE1 OF   2 CELLDEX THERAPEUTICS, INC. PERRYVILLE III BUILDING 53 FRONTAGE ROAD, SUITE   220 HAMPTON, NJ 08827 Investor Address Line 1 Investor Address Line 2   Investor Address Line 3 Investor Address Line 4 Investor Address Line 5 8 8 8   1 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1 234567 234567 234567 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1247" height="1611" src="g29172bii001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=61,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=661837,FOLIO='',FILE="DISK110:[18ZAG2.18ZAG41702]2917-2-BI_ZAG41702.CHC",USER="HYUNG",CD='Apr 18 07:08 2018' -->

<br clear="all" style="page-break-before:always;">
<div>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Important   Notice Regarding the Availability of Proxy Materials for the Annual Meeting:   The Notice &amp; Proxy Statement and Annual Report on Form 10-K are available   at www.proxyvote.com CELLDEX THERAPEUTICS, INC. Annual Meeting of   Stockholders June 13, 2018 9:00 a.m. This proxy is solicited by the Board of   Directors The undersigned hereby appoints Sam Martin and Anthony S. Marucci,   and each of them, as the true and lawful attorneys, agents and proxies of the   undersigned, with full power of substitution, and hereby authorizes them to   represent and to vote, as designated on the reverse side, all shares of   common stock of Celldex Therapeutics, Inc. held of record by the undersigned   on April 25, 2018 at the Annual Meeting of Stockholders to be held at the   offices of Lowenstein Sandler LLP, One Lowenstein Drive, Roseland, New Jersey   07068, on June 13, 2018 at 9:00 a.m. local time, or at any adjournment or   postponement thereof. This proxy, when properly executed, will be voted in   the manner directed herein. If no such direction is made, this proxy will be   voted in accordance with the Board of Directors' recommendations. Continued   and to be signed on reverse side 0000378601_2 R1.0.1.17 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1247" height="1611" src="g29172bii002.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=62,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=275328,FOLIO='',FILE="DISK110:[18ZAG2.18ZAG41702]2917-2-BI_ZAG41702.CHC",USER="HYUNG",CD='Apr 18 07:08 2018' -->

<BR>
<P><br><A NAME="18ZAG41701_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ca41701_1">ABOUT THE MEETING</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ce41701_1">PROPOSAL 1: TO ELECT EIGHT DIRECTORS TO SERVE UNTIL THE NEXT ANNUAL MEETING AND UNTIL THEIR SUCCESSORS HAVE BEEN DULY ELECTED AND QUALIFIED</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ce41701_2">(Proposal No. 1)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_da41701_1">Compensation Discussion and Analysis</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc41701_1">Summary Compensation Table</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc41701_2">Grants of Plan-Based Awards</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc41701_3">Outstanding Equity Awards at Fiscal Year-End</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc41701_4">Option Exercises and Stock Vested</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc41701_5">Employment Agreements</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_1">Pension Benefits</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_2">Nonqualified Deferred Compensation</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_3">Potential Payments Upon Termination of Employment or Change in Control</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_4">CEO Pay Ratio</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_5">Director Compensation</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_6">Compensation Committee Interlocks and Insider Participation</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de41701_7">Risk Considerations</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dg41701_1">COMPENSATION COMMITTEE REPORT</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di41701_1">REPORT OF THE AUDIT COMMITTEE</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm41701_1">PROPOSAL 2: RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017 (Proposal No. 2)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm41701_2">PROPOSAL 3: APPROVAL OF AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION AND GRANT OF DISCRETIONARY AUTHORITY TO THE BOARD OF DIRECTORS TO EFFECT A REVERSE SPLIT OF THE COMPANY'S OUTSTANDING COMMON
STOCK.</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq41701_1">PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION (Proposal No. 4)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq41701_2">STOCKHOLDER PROPOSALS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq41701_3">WHERE YOU CAN FIND ADDITIONAL INFORMAITON</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq41701_4">OTHER MATTERS</A></FONT><BR>

<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ma41701_1">Appendix A</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ma41701_2">CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CELLDEX THERAPEUTICS, INC.</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ma41701_3">(Pursuant to Section 242 of the Delaware General Corporation Law)</A></FONT><BR>

<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2235493",CP="CELLDEX THERAPEUTICS, INC.",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g29172bii001.gif
<DESCRIPTION>G29172BII001.GIF
<TEXT>
begin 644 g29172bii001.gif
M1TE&.#=AWP1+!G<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MBSR2;[4K2B184M=23<84HK=[*6@+( A)<#(N\TIGA*4\7GE-MLN7SO2!.)O
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M0$O!$4O5S>+?]7:)'=O7H!F4X37/8033/5F 1&+3X"+9^1+B6Y[G+PO@+6(
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M\ &2K_FP+J:=_^J6+R:S#_I+U[[2LJI ;[H$?_#:?T(Z_^XB!5 !&V  =5$
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M,%%K.08%%!!* !,X-N !02MXH,F7,-C@BIT2,$"'"G96HVBF_U+#@#ZK"E!
M!WG4L"'@!W[]##@,,AK  !LV4")H TBP 80'>)":-@]L$'0#@Z28VX $$CC"
MAHJ+/6@EP1- 3XH/%D#Z"AO(+-LOIF4UH(+R8/.@ GD^@R+R\G@CYP$;GOX-
M4@..N<*"2F)8P#@VS\8@I!7*&Z=?V6>GG2EN$+:K089T%X!WW]WZ?7?@AQ>^
M^'C=DI<N> 4@@ ,*:X<>L P1JVN?Y.7B?:[LL<^]^[JV[\Q[NL"'BWP&Q=<>
M?>Z_5S]\]M\?O_WRY3\?_O3M7S]^_-W7O_^X\I+7/O@5O<'LXD6MDT(&!K
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M6E,&@()6\,!' +A/!3*@0Y>M( A82X_+2D," YB - ))Q#W[V!0WY4@  [!
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MQ7E]!@E&(&,>]]C'/P9RD">3CP'>&"O5R?]A>KL25 Q(86>24P $:Z*%VRS
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MF!K9DKJ=3?R8G0F:2*F =[B"&(@YC@G+G@6!R-E;7:D8O]G$)5J 2I "6JF
M,6*XIPF;$5A+PQ48*]M$'1B6F4!3O1$:TKU<6=&C @ '63FZE+%9"\#9,-L
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M!P4V*)H04!  .6Q'#"@(DJ3=O@$8*Z PD""!F@4LVN4(LB !AI4&%@QX  *
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MP BX@2H$YJ. ENIA#+GT@0&@D$H#L,4)^Z<E5Z %'&B1B0!?\L I"6 $$%F
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M;/_R@5 *8 ;(K(!H/O" %>C H8O9 #;4,YK#H!B!!MB)%#:( 1*L8'\ L@L
MXF$#Z1*E0EQ4L0)B_!);Y" MTK7!=3&BAADLY@@:T:M/=H&-6FX *QQ YTUR
ME( 89.2$*=R/ 39@%\/D!@H+D &(5J24Q[HB >;5+V7*LQ7#*,$#X<TO!A*C
M(:N6Q29#D6 "-E "@E8@!I5@24.Z@I\$;#:A>MY-!7 D 'EXQ)DH3N5A;)
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MTZ_^]?/MVMI[@ 40(@5ZY(,;%9!"6*F#&\)TTP*X&<@E#8,#8=( ;D17C,
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M!LYPL9%S(01U , Z6!4Y6  ]/%UQ%( $6( ^7!A&QM"'K8,MV  *W,IG&(#
M(80%U$1VL-M?7)P%>HAM#D2-/%,!L)<=ZL0 L, "Y.%SY,09RF5XA& ROB '
M59Q36. -'O_8QB7 @D+054R@*^";.>! *2F#8\@2AV[%E+@"-G  /3S#!B0B
M7V 4C;35%+G%R"5!BO"?.5D !R3@&#J7:E 0&H976/'@+J$ ]G5F:@H "(3
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MPE0 T]3 #G"__F_!(G#"HDMJ'23V_ -?/,7HLM ^B*]^&)EA[ 8+0$,'W9<
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M,EK\V#5_L]<D  >40.(U&L WQ*@'NP911UA  0Z00Q8]!:JKP3JTL!,ZO(Q
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M[\&.!2LX(IIX<>.;'\2@IU ""H@&]&%$P>VGT*T+!GQ,8-1$@0H@;"FP@:W
M Q(FKF!(:.M[6@!'%P"P!4F!0A/L1FPP,.+@ M(*_(M! 67X^FH#+3# 0(L2
M%'#%OQ&40<& !_+;3B!YXDED 1G4P& ! FC"*($<*HAG 0\>8($<Z0Y":P E
M$DC_ (P$9J*)M <**,""> 2R 1P!0/# J@(@N4*&&2K H )_ %C@(P% :@@
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MZA@K((%L$G"J<6^,SCT)@W\ V&4!"R;L"8 /E,!A 53=:Q)V%FPQP"0%6"C
ME@UF B<!2*PR0;\/IN1V 2#B(?\3 #C]S M@!90@X6->+V,GA KHSFD=FMI.
M -D%4LN;)H4VX < <S"@$*45QJV$;1NNTM>&"@K()RI(#G72AA@J2$0_!1(0
ML)G(0$.9T]S72G 1-R4'+30Q >@4@(,$)*(A!("+!=KV-H;D900#&=>[]..>
M :0@ >XQC^$TYQ\, &X#01! K[YF@_@XA 7_P( ,^"&%Q14 ! *2 @H[1Y/K
M:45)!B"! N+AM:\MRGMZ^X#=9&63KV6@6<?X5YK@@D(26$!6RCB(!U)@F8.
M8$KQL $ ,&"!^"D@!!+SB[<*LS$!U$PV<IR,'1\CF(L9QAR6H=H? 1G(SI#&
M-+RA8]/_"'-(P2@R,(R<(\^<MK1((G(PCK0D)!.)R4IJ<I&<;*0G'SFT28XR
MDZ(L)=)(N<DX2@9J@G2E:&J7@%TD 8 ", $*!!(E90Q@  780 S^(0-><F,$
M%6#)=Q(@D5>1$$PL -*CW).KJGUD 3%X@$\X8( %].=$"H#*,PK @@(9$QP
MV$<!VM0.K@BJA"&00H(*T$$,Y  [O=P%3<JS@0V$8 0R^%A",()!2/3R 1Y(
M #0\((-\Y 5N.,*&[=00A/JPH*#>RHX4]C4_6SCD)TDRP?A,H -OZ4A37@$3
MVQ2P47/$(TP_N1L !!)  "VO3?A,@+1HVJ5AJ&$!:#+F]>*'_X%B8@D A7*/
M=YB( 0]LH"L!"ZJE,(6=9[0D8G61P@ 6ZA!VH& #B0#! &P!NVX80 H*" (4
MUO'$TM"D@P88@ FX]H$*6,!\V]2*&F;@.T>U"3N[I R^'&4#<JPC7]Q2@TTI
MN  )T*@\%<"!>* Q &5THYPT^<D*;/"2#:S ! _XV )VR8X!J,%/+(!&VCPG
M@ (\HYB#DJ%-)'BYJ?9R' Y9QT#\<U(0J"$!YP/3>Z[0$+:XR3@#($'%"+/'
ME$E&N;-9AQ(V^DKI3K=D_""!#/08&(WYYI*F5"4J3RG)\%*RD]XM+WB_*][T
MDO>3YFTO>L^KWOBR-Y3P?:]\[TM?1_]>3+DKBAIU :R7<<"EA%C3F@),$(*,
MZ*,KB/J(&D[R@0&HQ*5=0@B5:%6!LDB!(.V@"<0FQ&$#Y( B=M-"##*L@!RL
MRFXG*<!H/=<D'=9( )D50))8]9++V"01AH(()-1@-YF RH&) ,(#!$  _F5D
MG4U1  ELL0 P/"-VKP.*,9.I '"0PR9EY5("Y&%,-:!@ .-XHA(@83Y\5L#+
ME?";?AY@ 8(\( B744AF!R(OY=7% MX#D&(P$ ^0:BBG <.46;I4@:#V]!T"
MNI3>0K34+7E 4@##P%64X:%DOD,-'!%F51W50*RHP7_/(.S\>O2 '-BB31J)
M%<' 9+<D/0/_63DFG$=PN;8@Y\1U!=BF&EXBE"0<A,,@FY42[#9C.,4@"7I2
M@#YLD81G[<T 'L"@$=UJ$Y \X*L#" (0!'(%2(S@4 #C%:=&(+"'$B0!4!!(
ML)X%CI1,2,[<MMN7AO.[N\!$8B,$C&^:VUR.X?$VOC1V@!&>\-&@K# "I^]R
M(1YQB4^<XA6W^,4Q'AOA*#SA_WB #  P@NVL*5AB2I 42IB=!*6OETY>0 Z\
M%YBO^#H&8E%2UO 9,)7834=%G) ,J@F@:B8H;5[!*<&"\"$ C&,=C5)(## @
MEYD"2YL+Y0:WE*0 ;,1.!D<81D.>DR"WYNX*G!+/AHZ!C:PZ) GD_S*[.7PB
MCZM8)$F5F,XV4U[R\I#@I;-*$J9\;8 5E(@C,?KH\@*FI!#D $0<W8X)6$(.
M*)'Q(4YBQY?\D_@*J&%8"4 !J ; 16PDX A91W)>+&4HHYHC!_6IB38+\(\D
M*>E?7>)H$(B7%U97! "^^[O66? ,2!QAKNK)N0WR!I(/P*D"6A@4 0HP$,?U
M<@ Q*+TQ(X=\OH9^Y2]=4][L]@_57B1'4%-\-UR1<S?S![5W/OF_$C ,,!F@
MA.,#@1001/\!D+D\&+!%Y(8AZT3MZ4PO1K9C2M@"\<0.@/KMN&ICNQ"#X%QC
M'QSN-,Q!"0Z.XS20XPCI-"J0-1PIXT1P!/])L 1-\ 11L&5::0-9<&K 0?#0
MPE$>P,-:T#B^0NM"YG7(3<!"XXD\X!G6K@:G)OT @ A+QE%P3@BEQ@@!B0F5
MD"_\(@E@ V;X:P)G0P(%0([6P8^>L L!J0-S(P13< S)L S-\ S1, ('8^.\
ML T]X\X0I$UBS TUXP%6  -^)63@1M2*PR7:I++HT NA1#_F,! -D0Y'"+E*
M\ -EPV,R\! AL3.>@03(;0K3\!(Q,1,U<1-+<!]6,!(A,?8DPA9V$!3W(H#J
M+V0*0 T*,33@Y*MBQQ0WL$O I[9D\18WT+C^;;[J"S8DD!&S<#&4:V,N9A_Z
MZ!%Q\1;!< 2[R[[_>E&_0*D9\>L94XD7QZL:\PL;J?$:N7&]M%$:H=&]MM$;
MN]$:R1$X]N@3DW$=V;$=W?$=X=$0C4L*4Z8880,8&?&YD#$>Z?!D"BD8EPL<
MOS$:"5(<!;(<LQ$AQ]$<&3(AR?$A&W(A'3(B#Q(B)_(B)3(C]PL+8>J_^/$C
M03(D17(D2;(OJH0$L; VP($+2](+EY%CM$LP#D/@#BD$*Y(B"](9;Q(C=U(C
M<W(:>S(H?S(<=7(H!U(VV+ EE7(IF;(IG3+ $E$V#HD"[_$W%B,E%\,1G[(&
MK0N[(@,8.3$LQ7(LR;(L!2XK/+(DUP2*]&(?L,%@X$160F,7VN$#VF$=_U@1
M-,!* (A,,\!E 6C0%0=@^;!C9'A) )R0,]9$!F)L3?C0>60B%F]1M0JS9" "
M&O0"&WKIE=8$&UZI (1),OE"M1[S,_)EVHK+17@)X8P+CM0P8UJC,62#$07N
M&+>R!5^R+'5S-WFS-WE3'4LR^I3 0_3"%2[B)-*F.,!AF_*%!P#C,^1!"L1)
M,8VB%3D#%;>DMT3F(,#!%C^C/%0'GQ1 'BYO+[;)*MI1(0R \DC&.V(@+X#E
MXUY)!F+DE5!B'_>B #IK!H@C@!8@,47#;WQ-'D@'*AVPX0B#!69@03]@!@:
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M[,@D7O;)%LA%((XEQ3XB!J:-M-!)/S0"0#H*BD@$)QSE*!) >&XU?5J/*1[
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M25$!(*H ,\D!PP!X/9H '$ "XO8<5[$"W2  (%"@(H)?!'.H"F!6?@D7&K(
M)@"1[K4L*XH!,J ,%< !(; !2F #]*  2? IM;$D1\"1&8+_$"%A$-RAJO'(
M#^8P&3/ #O+@(Q5 #P37'CF0,/129Y"@(1ASIT,G !_0HTQJK(FSE5&JK,N:
M0&#I3QE(:MP'K0\%0BVH?,QTG9PU&3G FJH:& DYDA62 '\IIPT"D99X'/*@
M!<22%'3F 22Y 3\Y&7KV<L\A#Q4 !2NB "1@6!&YB?O*CQF0"-IB 3K@ 2*9
M)8W!FA@@!7^RCC37(@D0D2-II#D@),$H)/\0$@>A #XS +Y*1R/ (X:R#@4
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MH@2.87" (#9X@#X20EA@-*="Q$K84V.6>6:::[;YYEWHW'5GGBE3% SOODN
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M,J+TMC,/P,91(GC$W=KD69>30@50X!3)"06O._WMNY[)% - @3@2TD(,"K8
M=H1 "SERRK^DDI0%$"LT%S&I8$99DU .5K[SI>]@XQLKG36VL:^]P@,4@-</
M) X2%G13^6*PGD:F,WV3F=0D/70?#QSAOPI(A&MN1TM%U91/B5""%#CG#QRH
MZ&0D^,<N*". '&RH0;03C8 ,H ;_#L!Y[ESH\UJB Q0LP (>"%P^-P )&"O@
M'^8HF<E.)A2]4DP+2KA<.(OJ$AP(+@3\LP697FPP)X>V3/10 U8J-A:.;"-W
MJZT 7[__QP-UC<,<-B#(.HX@N1"H@9$%&!W__(M7P3GOKG22C@ \=H0@R%DH
M!8B6//;Q(0J#-+2[P8JD@JF$(0F '-]1$#Q?O!LP-(;0TMJI%DSP.M#8PC'*
MX!,4'A!GD'R@?!6@1P@,P"$ 2 @% /B'QV00 @PD@AU-+9_1'M,2"6+@"@%]
MG7Z-K2MNC/"&I;1AK%"YCA8>6]K'GJ%-F@W*PUC1 OWJB)]"(^/5#H#.)@M!
M4V9@$ ;=IKV09%%Z!; .94#U<['Q4X8*(AO6:"BWK/F,!=91%!8D*#C=N8D%
M-&2R 2C*,T<TQWT%X"S5;(<D KUL=QKFF140O")":JE8,# ,_S5<IV(B2D0"
M0& P.EN 0?N85(0, +: &?8OUZX)S4UB\XW@'%4SYWD*>]X7G0?]YZH:>EY@
MY?#"FB2_TV[E3OO$&I+,LJX15 W4$W 0Q4JF'<&<GEM?$L&!8&EH&";3GI10
M9!NDH *V(*(!0B !$IQU,@)@:06P86)\&60W*ZCZVRHPK]?%!PP_V65NZ[0
M<N23/^-I"=5UDP@3F%A."EJ!"?A:)"TFP$,=O:Q#.T,;^;TNK0-1C0'H7@&Z
M3JDZ#?(H2!LFEP+LHJ0FP!%,=F. <B8 "/RIDT'9R0'6<*< -?( !$D !->8
MHT6-EA-2^D<1SASQ=?13$?/.-$GTY/]&0FTRD)$QP,"[K35.9..3AK0PI ]P
M8RFV]P!'#X4ZB#QCM1SHGO'HNC0,)@4]("  T_WO*5'I%Z +#)TKE52BE:S[
M/P6$H6J#F?HZ#(QYP%.*0 ET-L(0.I_+P '40*+C0*,KNJ+ P T<P0XDP;QX
M+YM '=E9P!=Z+6Q8FJ&I %\K,!N0NX/R "F9#'!XH'@X'0&X AY9@$HK";6)
M@1%XC"0 #;@: 0L0#D8!@;'SK^<I-L@8!Q-0L4F+#RA8&5XZ&L*9/CXIE (H
M'R!!)X>0'!O<A;2J  &8,BU@OOS!@".(/<AH"1)0%\?(!Z0PF$I8 =>9C-CY
MCH7: '*YL ;_(3-)"0(T*X!Q(( C( APL)$/R T#\([-6)['D+Q_RJGOJ #A
M&X8,&(I]B!9WN@\,2)\/6!02B(%(:2-]Z"#'< 4!:(M@VHV/2H3&4  .2!-C
MT8'[<PS0  ''D $H(($CA QL4)X$4(9$ ()X\([OFYZ_,Q9C69#;2(0,L+Y$
M:4+<X0<6_$;*$"$JL@F'P[;Y*L"^&)9H T=VW)4&] M70<$*G$=ZK,>9$<$2
MS,</], 0!$%K\\>: \B;$\B<(TB_6*5V[)F=@J6ED;K3," ;I)C+F2FJ,8!&
M:Z.N6P?\> !SR $RL8T/. +S.1V<D):*&(L!*$:U2X!9,H&A(9*6_W@+5Q"G
MEJ(1"SB[=#*HKHF!=@H\SD @K=F-B<FG+>2GRP$ ;, /&VB(!!H&<+@\<4H.
MK!B'!] 0&=BI#7 RR*A*&V@>L5B.HR !%% H!1@&D)J4Z@,/&V 6T# !<@ !
MD5R.!- ;;0P@F8J,DL**))06BOB,Z[B-\+D/)<BX\^LZI\%!*BP *=@  T&/
M/=J.&M&C 9"_,B(5IOJJ1.&3I3H:L_(1U; >"=FV7",)@] 1&;"<K#P-BW@;
M"U"18TQ(<!0A =0+P4!' CR,^THZDU@')1 UV/S-3WD&R$J,4=H+AQN J_NO
MGY@!EGR+Y#()E @"!9#.1IH!J5" _QH!%O^H"AQ8#R9!3M.AL_\* 04@3P60
MAY)@ 1F@EXG83I94 Q/H!F() NF43M<A1W-HF/($@8NALP>@!WE D8 +@@7X
M@(TP@3MCEL$(N*L+@JCPSP_PSXO13X-9&070!^S$,GZ0APQ]B[Q@ >:D3WOQ
MSR"X"VT)"0"-+'M<41:M+Q34PQ4$SEQ1E!+HK_\"HJ>P,S6@AQ%(@O*1@CA[
M /Z<D]RB!Q9IBO=PIIIJ!SG9L0=8A[* -%N@,Z$P 'J0#5;$RA&X#3NYJ[$#
MB5=;$3K!HDD#@'W(&SN[ J' $K7  !38496)#1TH&/]B21LH = Y4W@*$UD<
M "8#LCIM&+UQ#!/_**/ (50Y+(!#JT-]$(K_\L0.68!A6('KF(S0BE%Q4D*,
MF**[040Y&0 V6Q'4(XX">$30:8GD6 !YT)$7"]0BH0]._!!/M)XY*9^WF3(Q
M'88CX$_4&)+>PH!/NT'#_ XH*#FDF"(*2P34.*)_(A( ^ QAK+$5>0!]4 ,9
M(YU"N0_2F0&^DX IDP*%JI@2L 5*61 X78#86)!X(,58DE'_&P =^#3"D,?;
MC)EX_ L62D!WW5>?\154HA0(J@UP.,FU(*&:$,(C@0F3&8'10(\*2S@4$,ES
MZJT-.#<#:*T(JBHI()5T<HV3 (%H>1(>0H']08]Q-(EN< DE0)*$2@(+__@^
M+2 X*W(.<@E9O4FO<BR* 5 #"5&-'-N*+C( ()"!K=,-?5JMC+44BT0*]-"2
MO)"*GAT*.H.$\L& 'D&):#$?"FQ1KNU:^EHZ?OT4@V -$5&-!# !#2F?\@$!
MCP2-\],"HAJB%M$"BY2H=@@*>7@/?UD #PD;J^6:V/ ,+2"2:B&G<1BBVEB
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MI@20 !VP"W%C#AM0')!8 ,F93J; X>]:@"W-BQ&  ATXN0,AQ0?PF"/FDV'
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M_Y89A!QFF(YIF9YIFJ[IOYK@F+'-@1P,7O8+!+1IX!1.%4U'"_1@OMB,!7D
M% D).O&DH@ '>G@2['S0^$"^,'74B0BF$'"1U@@-*7'FCP$E7<( )>">BJF
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M!0.@QPK:H4W1I35:),A!@\7SX)SLPQR^)3'1BYZ0+OI$70R&BCR0.C7-7,0
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MD,!8D,"!1-4 (!!S=$^%\,QMQ%=5Q!< D(.$* #_.2 0663,U=S&!G! $.2
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M$NPBZ(@$QJA0CQ#=.."5C+Q3[EG&_T881=6MHH3ZA4"/Q+0(;N3!BX-B7G=
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MK^/&"FN!*$<E9Q@HS4Q !@56V.#6$( "H!UY*MF @PI, *DM$G8%H (/M+#
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M!!RKP#XH\D1PI0E !HA!N/PGO@K\XXW?&9<!DC "_P^<+ DG4<"[9F*2HN7
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M$ (=8X1,$3&(E@)H P](@4'/QL"SR2.#(4O '.?SW\UX:RJEYT","R :"A)
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M7D\?J*IHE.$O%& #2N#UFHK'&,4<CI##%$ >^L0+-X!6E(D$/ !0[JF'\&D
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MX5WL1:$6U64$>-%+ :30GH?LHWN#4L!1#..< CQC*0H(00)V\;($Y",F$GB
M# :@!?4E(E*^P<A#UE$!*? ,.>20QTV4J,'5#&1X PB+7>!G"Q)^X!\7:<<
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M7P[<4M,1/.4(($HE</C3&</,1 T8(<?_3B2 ' FIP2CCW9H:4/ ,"/71+@,
MPN@&H 0._$YRW$B!3F]DSQI9J<%H\IR/:,2"T9GSPAC.\)-8=\\.>_C#( ZQ
MB&6W)DJ-^$UQ:I$Y$G $#(R%&VK( 38&( 4,I#*.SX"@HP3075N8X#/-L@%'
M-0(4 ;1E)0F0AV-T+ ,9G <#\7B %!-@ A,D8##GF=!<0&*#TLI@*_*HL:<
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MD.7Q'0.7K-R! 2F 'D%P*7HQ ,N% 1( !G3C 1; #G_D 2300 .@+:\!$_G
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M0RVJ 0 C0!!E8P'/,!,0M2 KQ!YNP1U P10D,2$Q$ __MM ?.-$J"I!H#)$
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M7QQ-_6%E"B /T) =A64!)QD=_P5Q*.%#'GJ59./6#AZ@RH;1'ULZ%#D1 O_
MQ.SAQ./S<-P!&,C!'D T &X\%DD0!-Y!(75!CYZR)CYA"\/0S(9)$H;Y))N8
M)=*'AN8[JE$9G<J7O)5(@3AYO5M2B]UKB/E+J6,RT)S(O8C*A[9ZONLKJMKK
M)3'XO@$]O_%;T0U-T1<-OQD=CO8,E6V232#MT/8<BKQ*%\^1G.30I>KA:\T*
M FS,/@KP#K]S' 01. ^0 ^:PK3_A*;M $OK@2 J  @NQ2QSQ$^2!IUW+ C-A
M HFP%3/ PMU%IWHV% H !L^1$\+46=4, .E1N'91QO5:$E:Z$^&##<\R *X
MRD626/_S,68%\3LS0""4D0//$-:#5BC-IE  H-2^HE!*-!0P'0]*I@9*U%D[
M5 $NG692]&9L40!KL;3CH1M^0U?EH7+QLPX=L3=/* \84 D@H@57, (EP'YY
MP7YW/!V0 QA%+ _P56=4#01*A!F-=BC'(3%)\ ZV<'DRIU!CT=FA81?Y,%5M
M*];JPQCM4!?#=D3C5@#!K0#^6B@PHC$OIUD5\&.ZD1$*( '@H%[Y  7OL ")
M4"H5P%$*-1.02Q<A\ Z7QP(+  7'80/R"0E<G! 5  4"H 0/XRL9(3&-E@ B
M<W)Z<\<GL@$-1=9^0UNNP!^YXI!K4C#^NBPQ 1A+JQXQHA#_,T'3 K"[3Y)@
M"_8E]1L[S.N%C:K/50B;7**;82)] *W0&FW0">U.*+Z!+ZB+OUGC-(@!'[[1
MJ"F5><CC$UV<DK@3$0,O+^LI04 W6K "*X".#W' L;0 NR!EMF$!E5"U_  4
M*60!VNJE%;Q'4R2/G54 :@ $^9( W!E%MBL//K4!A)4M[:8 :/9'@(&T#R /
M73E)@AQ7U 4;)@%!*PO"@UNU#?0W05VXD4(.[LS&'.5BVXH<4_P; 9X"0"#H
M[#=&4% )47598;9<A?WD^P%( ;QFCG)3=!H@ %!L&Q#)'J#DB6"Q@NH2P_ ,
M3XM 4A;#6C#I=:L/,@ &\:$#=Z$,_P.! CJP 8GP:GN#'&C&8WV$K=FR .M&
ML 4# !^"L'J6'2%W%&0S#A>"$$?# QE0M2[+'[D=6^\<51L0 @) #E @P!O@
M&>#R#"ZJ1,#E)P\PKA\ &'%[!2 S$TFP 4G@%AZ0Y*_,/EQ=$&SG/](Q(=AA
M%QU$*0P!)^H#"3.2/:@KL4N[ - 0Z(D@R>VP$QSR 6I $0"@!EX!RJG[K F0
M"%"ESKKQ,.$RROY1A#F- N7>)/$<JQ!]);"8XSIRBB-.XDLH)9%JX]SDD_)+
M]+"CJY,:OK+*]$Z_]%!?ST\O]5$OTEW"=--'O25-$E>-78Z\1$BU03 = H*D
M,UQ7VL[S'/]>^F;T""\*\ 'CL1?.<>#HL6H+81=:@ ,*L0(@\!GQO@$%(%]P
M@ARVJP#^X%$Q%"(&(-@.HB@\9F-"D>9K&3Y[M"(P>G9X6:^P,A.A16\S<+#
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M01H-&H"$9Q*H8 0!3&!*'B@P0&B8[/0)BH0%%M)AS05XDT%!CV;*8<S" "!
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ME;8H@!C8@/+[) D8A@= P)';#!53F.O00'AB@6? @"/P0(O3#--@ 1.H  \
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M0'-XA^@8 9+@$B_ADHPH,P#0B+ I#KK9&D4!@21 @880"5<@CK" )1"@G0<
M O=Q$/S<R<#XBOI3F;00-\PXMR@]K/^3L<A8!V50$%(<BS\ICB!("/JDBQP@
M"@%+@.@XKP*0AWB !%84L+28 3);TADX+X&S 50\#X*C"WFX"/>H.:N1N8M
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MS^_QD ?  8K@N6JLD2Z)B/9(M01X!Z#PO@< @ZE@6)J5@1!A"4'= !95@'A
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M!6A,#^ ^6["!', &6:T1C\8)X'P @RT1)7 /W',0&\K-]%1MX%R "Q$ <"@
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M1]$9# $#$E"">+R.;!^5 M"7Y,AHDUAZA;AP &#FH<.&&*QI; @"#E@*4)E
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M_G$JA0SFU+D!<>AQ8$ 26F'PYTX#;!##01HYM$$(">1PJ&@"?#!L @J<>I8
M+ R0 S0F)%3! FX*!-,^)BAT5@$L6/MF$ IEM$X%%8 @T /#*,!:"%I8D, "
M\):9D4XL/1#AIVB:21)0&_6KT;_TSC0POU4:O)$"*SRI[\$-RW144DBZHD ,
M!B1T4)@9:[PQQTD^$$-;7RZ0Z'(=FWPRRD06\  &"127LI<K'Z' .C#;?'/'
MW)#0*TE4.OQS2#Z#9 ZL.!M]-,["S=NPOC,D4 $&!N0W4 (;0+%5$A5LP*Q
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M-@X@O;*68=J'+97"%5KFLI=;8I(9-W)*5"IRDRPI0-%\J<R3*8U@ GM2 1(
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MD() /+ -!N"?HD%;#I3)!]S- (# WFC3W[3:X!1.K8[ \"U.BU2$ M BZ0Q
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M6JJR8AW,8[T)9$G*1D0*.!A(/O%32.2(RVF%Z.ZDA"V6K\&L0"CIW^UI*A7
M.N0(,L_9!N^L!A>M!SNS/>YCPFP73SUJ."T:#G@(6YC  _@>-#O'/^*$!<A)
M9ZR<3.8 MUG,N?*F&B3*X66=P7F ?69=/+ Q (@C,1H !PQ#$G3#'5V!5!B
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MD&D$AA\7FCQO,VK$2JO?0(2X "BW!>" !>B .BD &+C,4J2K -&QKIF 4BP
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M(0$ GS]]#JC@P<.*&#H5>%#3S16  A4V)!  8( -#"9\+L" X0-0K[82Q2@
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ME;IL)0C=FTP(* B=IR1B XFP@#+V,8(8 "\1+]&*<ZSS/(C-D(8UM.$-Y3,
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M;"$'Y$QD1B#W7D)V/J.S6%*81N '*<H-=6($V ^XH"%*Q'(O^(YB1F8$<K(
M/N ?<J[-Q)*<%F  <N*A &\!ZE)!R.D.U5+<"D):RFH!.%.8+K,@:J/]0L9
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M5>YZ69)-"UT#?(9$;']B/&T@FC%@FADY.M"B0VDB!YRB K;9 UJ+E(AEDRO
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MR"0#1ODG$(5[U$ +C@DV*JH"0$(+!X #>>KVTOHF@@M-GCC9/#XZN@)I8ML
MZHVKZ2$& FT#GL/_C*FCK4TL:SA07%BT5$+CB351!P"$:V0C"$)@(,(YN R@
M*3J%U4_+*=YEQP(M$;1 "HZ2V#A%+PYB\NEA,C2L-I*-!=H!6NI"3I3A 3:@
M %SA&6XJ"6) "X1%$]L<T/D&E9(@$?BA5>3!<^E;2$9C1EP#)*[&!$Y; &"G
M:Z1\6BT#-P"BP ,#"03D6[#!A!J"(PPH$+ A!#@!#X*$J/#@0[X!&QX ^%A
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MDB-)DB5IDMNS&;D'?#:'</NP3IAXDC%Y&?+WB<!!:D3GB\%4%)JB)!/! LJ
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M(D<Z@Q$9_\&0+#HG6&(#H(2F'^=+6!2 6.=*GH(1^#8 '@ %R*F<A1I2SF(
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M 5NQ)!C@ =/&U!D !AO %981?K'$#PS4E#J@ Z:T 4R4 ,-A TL-("SR &!
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M!O^0!,GV#!; %'FA%]%L(][%LL-B5)FN!B>(G@F@!?1@ F&B/C6B $GP ._
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ME@$;5B@ 4:&" A08)BK8H&  _XB& U(HW)!#P (##PS$DP?@Y :2  04J&"
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M"=$"#K)&PW+C 4TEC.V.4AW-#& !V.B380>@#"850 9)L%287-$-A5S!IBP
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M/E$ (*@ \%: 6J(K#P #BQ@8#^ 8O&"L&-B;> T?MQ"Y[NP&_V6P3F+*D@>
M.Y[(E".Y"R#X;] I"?<)&2$Y'Q:>[IX@7J$3B<Q &Q+0 0NH#A0D@?PN@'3*
M8_SBB>E^!^,H@5/!\22@#N[,  SH8R3Z<1(P@)S8 ## B^21;@M/G@.'EO,Y
M%A(B ;P F?+&TP&0@KH+@1 8;RU(\1@($?X: !O0GQ>Z"#@1<O4)*3#0@A
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MB)L"! 1!:@,#E(08#)AL!P*%40])!W  \0 *S@=)!.10(P\ !BD#  114'*
M B@)#( X:VL!Q@0+/'HT  XP%! &#-@",(*EC)LU<Q0PJ7HUZ]:N7\..+7LV
M[=48<YS-K7LW;]WY>._K??;W<.'%C2//O<_<A@>UGT./+GTZ=>@+2  %OCMX
M\NV]"\PHT#UW@0<)L@L@/CXYBP(#<O KP/]B/7W=W,\.0+% ?/W^]_L#&*"
M ZZWCWKT_4>@<LDEJ!UR#?)V('T23IB;A I@L$MO$(['87T)>FA< 1XDT)HM
M"@E@S@,D$@7 !Y\]-)H!ZPQ@@ </I"; 3C8^,XY)&!;P&S@%+!"$ 1@H0=,
M%7RUI', >#350P54\(!>!HAW74D/?=#8+@ D8,,".;B5I $+0/+D%0K=:(X
M\D!FD@!XV7"3!QC$ ,4"+0+ D@E*>,#!!H.>B4%).CXP@TD$/+;3 V7!)9H"
M$B16X@P55&!2>8KE0\Y& X!D@Q(DZ 7)0B'@(*= =F94F4L*A,!29 (D0 (_
MJMFRP0?_A/# . +_*+#!"!AX,.@&5>X9PD,L'294FO(D=)@ %NBC0 P+&1F#
M/C)0I0 DS\0 207'5C#3!ZH]9ID%"CST0 4R;%#L!HG0I*E'1FF1V@ ;)#""
M/$=HD4@% X"@@#^$*1 45R7EP-(#%BQ SBX%@%/9"$%8\$ ((02U9T+ZC2,#
M5[2."X0-)5:7LLHKRX;17\<]:&%O%"JHX#I*A,:RSCOSW/-#RI P@G 2TNR@
M< NL.]]X'V  B0D?&G<?._)@4,(&*& C7(@ %B"/#A?5'+:"]VTM-M1B:QAV
MVL85+3-R;<.,X(+=K;UV@ JL8+9O H0(]WIMCXCR:@GL-*<"-C1L 0#@_QB0
MR #DY+ 3-@\<$4,%4^WB+@85I&82X0\8;L"Q23T0@P%+.E1 (E@.!<D_)JU3
M)4(69$F2O160 Z8-.EU.#@CA@OLD2SF\Q0^P%1PLY[@8/" J!CCLR2X (9R)
MTPCDY . .0O8,)6.(9E$#M,>(,61XP+\8WI"'"]PA UR<H\CE40EHDQY!]F4
M@#P*Y Q  5>X3D5*(L%7@*4Q"YQN!@JPG4D>L($!+$ !#PA.L#@"A0\(P!6_
M&4 ,Z+&LTWV)*D19" 82X!X;H&!25HI58YQ#)1L,@'*KPQ 0*M .U< I ?RP
M0#S:%8,E04R#V#,). H&@@2LX%P?X%<!QB&QS_\YA3 MF=Y8H 0%2"P )^+9
M20)28!G,W*0 <F&> 2"VCU6!10 +>(O/VNC&V'"#!+B)$-_HJ#< V:T[!6C.
M&_OHQS\"X#KH$1!WU%,T=[5D/0/87%)BUA\02*$"%JA #$("(+]):!VVX '8
M[+.A NT&DP3RVQUG%J"RU:=MI"PE*^W82MY@Z%>N5%MW^M:?P+7&7<.HQ#"N
MD(-GK L ^R#<"FQP! O( #.,><  7)'%%8!.-1]HGC$-, (+8$!@F+(FDZC2
M/ R TP!2 @ VJ@2M>-1N2P!@#"3",HP(SJ0"4)" -0V@AF598 2$VYP-NBFG
M8"$E6!@80%F"\$$9K 3_4S90PS^(=Z@*!.%<<A*=!0RTS\V=*3\8W<#[(/*2
M"H03!"!0PELJP &-*>1><GI P'"RE0%XT24H, _A,(4!!H;E3@H(P@-^$RQ:
MQ<!]4E"##$ISSSZ=SA4/,8<!0O",2X&SGPM8P+5PX)$%H* 2X*R +01@@F.L
M( @)P, &(J,::%0@$0D 2;L&EE#WJ:%9_KL7"#:@KPW(0RPV-8!$@KH FH C
MD*+#%$[0 M*W4(8#*S  Q@8PUJV&9&&!9)8"RG6LIS')'(#<+,M@VDA6HI)O
MJP20.93P),ZB-K71X0=VW/9*>6!J-P60@?X2( .E[8-I._&'/$:P#O*8( >U
M_T7-WL[2H,,I1BP*4)I+_B$/WLJ /P+H1E[SJK\<S. L,Z#M<.5#G@>0  6#
M/ L+:,O;_;RRN*$4T&]0F<<\5FB6  IMS;9F7P9%S;7R-6YZ!; +#%V2ONQU
MI-%&U#]T20&!YAG25*>4! 7$XP%)F>IA(%CA& P4+!!AAT<&,B=;<&4B.3#'
M>::D7+^P0TXF>,8 !O"T5W6.*@M &3=,.  0*V0B!;#M0Z:ZD0=+L,0FR4<,
M$\""$9A'  0PP98<FR6/Q$,> ]AQYRRC81%6:4H1E& CGX$9-0CN(3=>V$:X
MXA0(GH>@<IW3 ^*AAL#LYR(RWL^.=PKB&+OHJB-8P/\XG-G3)<<CQ%.V3(_W
M(Z=_1-?/7('&1M*\9P$@.<2IT20S)<+,*]?Y TEHL@G5"&5FJHHR,0P*.)A)
ML$"K(2D[#L( @O 7 +#@P?%( )/7J=PDB <'"@#!5%URXI+(8 &**L (4+,2
M,@-+!@10+;.?$\<7L]*0H86OW'2S#CXV.]O:5HT@!S3:W#R@$C'0#0OVM$N<
MH&< *T@$.+60D]P0SZ9X6@!SD<."(UU$S;EA00(@@8$C8(!3*4H 20.F5<B<
M)0>-&\:_8T#<L]PO!.,U',/?,L?N?#O:_9W;@!=4M+8)N(ZF?%MR1$ERHX%R
M/&L++8#UF_*,VP?F(R</B7+_J9_<4:<\.]DVSZDSIX#+M>="GXY2AV[THV\;
M(Y\=&G[Y6^WD4/LLU#Y0 4Z*]*NW\3HRJ*4G3^FN"C"72L.P19<PA4$!S("L
M,7C86Y26@'AUY %*.--ZL@@&&UR:/)^QK1HJ@ *(@[>R,_0[WTQ0 1)T)"U(
M(4^M.JD;;UVA8/WTKM.]S?6-8[Z5JH20R=E6\L_/M[_J@5#+2QYR K\2EZQ)
MUY6A(\#+83WV)EF #CCP%=GC/O>ZW_W./-OU#F5^/#1;#K9Y;WS9=-L[<4O/
MV< ]C$3Z.N!9$MT(Q#, @3'3@:Q[$T=-0*0-.'P]1*KL6Z"M1C7LU-\*((=+
MP*O+_X[$X J_(MP&*!-!#,PJ18$?;P&&H87-C4LBH-?3U9',K5?P <>WG5[E
M^0<"8MXJ2<@")@>&4(7R8=S)J5?*B=SHB4C-L<9&L$!UC,-L<4/K'9^VJ=&4
MG> *LF +XI[2C9++&<?:&&!]W,QIN2 +/D-KI1<+#,#6?1UY@ #S0)P% $&G
M+5(%C-C;2<'9C=7 N,3F%!!OY%$!?,![E,L[\$<!% Q7X!O@D4 (!-5,Q< [
MG 55G0\7TH1X[$,!^ ,).)X M,>Z[83EQ,!^&-+O96!_D%+&-0@JJ1(&<ASH
M4:'>W!?J?5)^):)+Y,"8%-N8.&(C2F(D%ELEYH E/J(D9O\B)5YB(TZ5M]R1
M! Y'@AB@ZN7@*:)B*JKB*C);'$VA;T"(**)-?8!#\;&B[B6?#%Z>R.E&J]%.
M"%1"!7Q7P.''.VR "<S'(L7 /W0-^/%' JP.4"CC*W((OW5: F"8>/C@Y@Q$
M92G ;]R/YDA0)9W%/@V .0B$$H0  8#A1=2;NC'/1.B8YQ'2+BHB ]*C;D2=
MV$2@V8 <TPGBS %D/AJ'#%A KW#%Q@1!""PD"S%DK[ 0K"RDQG"%1$*D0TYD
M0DK00TJ0 XH>Q'G@+8KD2))D29JDF*7 9Q5-(7FD@E0=#I[DT0&-T)R2*ZF'
M3M2? @R#,)+7 JS XE'5"I1@%#+_R8YI >>48S02Y2N*R+A(G.;PAS)X@ %$
M%S8E4GE\S9%8 .$D$N$<1+ =R126VU1ZWVZ81HL%%P&FDBC"30WRX>G!C2PN
MWR)J3=/=XP7B!_B80Q*@AC"-PS@L&7I1Q>(THG@,)F (YC[\"I.EAL2H1%)\
M2<> SM! R#[B4<WD0X.88DQR9F=ZYF?VW&UH'-FL1]W4#'/ )&AJ6RXB(O.-
M!PL\ %EQU&1"7 B4RY%<B]+LRQTV(Q0\XP90)=HU30)8YEFH2 6L %EEUEET
M Q1@%%E]8_N%804,@P3AQ&\DP#!X0'*"4]Z=A3(<"6*9 W>80'AN3E>9#4OB
M97RU9'NF_Z==UF5-\H;(!,4Z^)AJJ)&AF42Y)8%F$=$"F(!_"L68Q!B1) 6W
M!8$>G@V%R*6 ;*9J0FB$2NB$2H?+?&1K:B"'W""%9AMK3=Q  @C!0,&N;5TO
M[H\";.50MA\S$0 _J $.\(<,"(9XE(=WNB9P.-9G6( M=(-NF,##;.17+,>>
MS)AYS%@!)8%)?091#$"]V2?UY,1O05S#&( 4A,#%K><>CHT&#B)\_@=]"5B#
M?!R'9"9="N29[M=N%.=N,$90>)5^"D5AJ@8X-.(ZJ$:Y+8"=RHF<:AEN(&CF
MP9R8XN-WA"2'&NJA(JIJQA&6HJG479* [..!E"EYV&*B_A%KQO^<WFR$<!
M 10 .\J6.8!J 8QG;JQ#.Y"'F]3'1DB7;GAJJYZ%I[J$J!IG<)CCI@K'.N"J
M;(&@F?HJEQZ@V)!IL$H(M:FGQX%6ENHB?_UCLQ+B;H@,C5I&J^Y863)>$GP
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MO%3R>.Q8#  !<+YQ ?@;)F-R!<RQ $Q--F%R<.9&%I%R(HA)*S<.*0_4?!"
M!1S#*U< #J@J@4S;7>IC P[J&J.<@D!L4!  GSX$G2Z @%+%M-XI-*L8G'Y
MK_TI%<-GZ 9S]A8SS879$X-S.+^K*U[HC88-YRE'OHHS\O$@WJHEN35/#) /
MEEHC9=@F]!'; L#6G;QBN>W$A\(-]ZR."7#'D6V $ES!;UD+$BK $<A#C4G?
M600!!H2 >$P33: J1]@ Q90%& S@ XA+0M(FQ.()BD:TKY4 3G"%M79'#EC
M$4#%3FRA1T#"!AQ#1QB/X9 /5*R XXV5 :3_D#YXISQ(075R11#P!Z.PA!<S
MEAT7X(8$HM%L#8/:8P\;R(/$I=]PB L3  QKF0P;J W+< UK"H#J,,=D,Q_Z
M8[ V;A"O\UO#]6="+P\W\-UJ+GNVS8;&M6O\;0QV1T*\W1&8GTL\(Z9(5SYT
M@RVLQ0.<'<1Y(ZQV!P'( T<-LFY()3\?3P*@:KD=04=@4P*H*B*%J]Q5M$LL
M<I/6B!RY"6P2A0S\('HH4,#) #_,&]^0& GHPPBX]@ D+>;FABU@RC.L!);H
MY@"H 9Z<!W]\@!IXP!4 J,7!6R(4Q0_Z5FX\QIFXMA3/20P)# CD+S<3I%V[
MK5^'=X2\+!LG#&$V_S-^*C-5M+< \"6>@<,-?[4.TZ8Y(Z_,N:PV$V^[[O5_
M _@MBB; KK!P-'& KP;V^K#3J8<Y\$,",(VA] 8+<(,!5.=N*/94+MV<<%%X
M,/ @OL165, 5D,<">(!.?921G44[D!_0@1NZ]:X#3>8'2,% N9@!D  T2"E+
M: 2KBNZ1R,].-)(F'<24D2I]I 5?$=2&OXD6G$XO+I"I00**)&405-^NOLEG
M&#EDYP!P:K='#JLA3FVT^MK#0=RX M<"9&N:K_FV@JM+S F3]?:/"G,WJS5X
M9Z!_(_B>\_GQ6>@P8_/O+7%ZJ3.?1W$V1W5O# D&G$SC4M4&0,$;TS%9D?_
MY>3&U(#!3$$4X+K6_;7/,)2H#RJ!#<S$"*! 48IN!5A-$DCI/I0G3GQ&"*S
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M( E2?  4QAC&+**E&PHHCPIAAI(*T<YUE-1D'C,4/N+U!!S^VITH?Y*[W2U
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M0DEX0@0W00F54 0;4 GV(I+BGG+=CC-V4L(B_R\RP%ZR)URA-M5 Y=1@8 0
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MB$1V@RC6A)#K8I&3Q$XXL7@:N2J, Y*5Q#@ &2L(UWD^CS6U.%$=5G$5N"@
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ME<0@40S0?%#_@56]%5> !1N8@]!J*RA0@!(AK ;$ P5 Q(\%!NQU14@ N"+
M &+*"0*8"GP@5PCL\/: E";$,)H-"V 3Q 8G>E"   ]X,((!8UGV@%&@*L A
MIV158$(!(&R0@$85K E  A8$48 6=D(T@@(A%)  ),&!,P"G'R0UF <A#&""
M!WSV)D ^!12D56X+K$"L$K,^0,("O,E :@$+H #%H00)H  *CPZ@;A!JH)";
M7#$\(X-1?4($@FJJCL#; %X94($\;P)EV6B:N:J11 8$8<ZO7@(@< ("&*#
M9DZ-0)D",1A0P#XSQ:!&O@(48"8(08PU  J)* !H/A<:0 Y$Q2'T_]6:#PD
MC@G?EE6Q5P5  A1$,SR J;##+!!J$B.@P &M8%V<Y& 2+=!EDGO5&FNS5-D2
MZU>QN@O1Q0] TN0#.B#I*I=^/20L9F1Y!=$^_(2PD60%/& !09D5$ *;W@U
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MF[\6FD%G9G.:U\,YIF;'%E):C#AQ90%;',,6.4B)+>2A@SY="012V%\!S$$
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M9($!G2@YH*(/] 0YV$ /F#1^=3JH";D+%L-( O4V+O-&@MH;Y&!7TT:HWU$
MMH!'W)&@DAH>8U9FJW.DBK,.UY&IHDJH"UFD*+I1Q\&CJ/I1#?6CB>.JK.J0
M.8J3#^FI$?(KYE R(T)#PR$L.2!1PB$LKY*F"3"LO6H"21!"N>HL"Y"KP[$A
M."H?(86FJYI]ZJ&FA+IZ31)FH\H=.  %*$">D4,.,A4Y7 H%'M.MZAIGY# 1
MC2HYD7%(!>"(VU$M+;JNY-<K^$K_'H)CHD-Z9PW2I-MG.C?9JQQ@"_N:L')V
M)<9GK?^JI!FY.M S?0V"D4A:DT*:I$MZJAIIHPX[L-&Z. N25 T"(; J'P/P
M#B3R.SA2(\@#(C8R(B6R $D  C'R(21"0E(W$;FC(JMQ(BIJ(/-GJQ72JQZ
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M  @/M"@JN2 JD*&I&'+:H#H%P,BA@B-D6( YGF+:H *+8F(-@ %B *HQFS9
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M. 7%'T[W\R=>^>@'+ABY*@'FP('=:%, </2$@18Q 3L8XQ%!:0<$[1@!4!8
MAJRT1U#8*,""/!>2<3T@,\@! 0^\YBP61.XZSUC  K 1@F/ERC(>:L@#KE2[
MB.CP,!S)E3E8\I<'T'  X%!1KS(2.11\[".HH<C&Z/,L#G30/<"93(QH*("F
M)&( YOA'5"3"11!  1*LB>$ VD$59: &!-P8 $%NIYR!A0  -[' N/2QC@&X
M;D :B5 !;K*>!7## VO3C&$TH@3I+:!1(5 "%P5%F5'_&8 L72&+9]B!#0P$
MH3*9T8E\*,*7(!1&!N1H2Z44H(P8:@LDXY!! E;B%X+!IVMWD4'4:,*!"HS
M D<0"VUBB V>V**%8/ '6"QPDPW(,HUHR0X&I& "VB6AE5Q< %\&Q1(#>. (
M+&C' TK0* +(P 8/L 7"$L"B%=#NCR'1CA(!4 !(C: I$LB)%F;@ET;%  /.
M?$H%.C2N#=A@!/*(!Y(&8(#2&, R"TA$<CC0G@>H4$HRHI'^NA<_\7GO>F:2
M7XW6H01;/,^D)T5I2IWT#.'HSZ5GLA_\B!13&W&41^\#X$OUEU/CN8]Z'?VH
M3N^'/J'ZJ*@UHJE.VZ0G]_'O_ZCE>^IE&%72%W5% FJPR "0PXU=E,0 -'S
M# 10 2#\,R(8,(=$]#&A(!0@-@JP15GX8I$*&-0N%2E,21Z0 Q[( )=_<4\2
M5O> !#1H(TD(0FRZ @EG02L(EHF:BQ( ! '0D!YW14U,D",1*'A- "; @!;L
M*")]0.$!*+B"/)+PCL;$0&AE80EH72FBT+EG 1BX@D0J,(!TYBHV,"'B4WB+
M@RO8*@GK4< 14H2Q7(DH5P1  104H(:(O>0IQ'%MKBJ0HI,80+H&=*6*KO
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M!+5)@'RJ^%%-'!DIJE+0O^2'EK(106(!L=R2&3@)&Y$!L>I*'6&!!B&2 ?@
M'#'- AB!#-50(O^9 <FLD0]=$QE=QG5C432A4:3*T18%*C#9!1EH2 %@@1$
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MG%%R1&.0(W+4VIX6L="A8_$(IQA'8G8$)G7)*8 ! /@=B5^<)/&':5LS>9#
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MG[4 .U^+*=%:-T=^<D9__3[\\<L_/_VGMCJUT%AWK+[^_..T0=?J)T""/,-
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M/H ^2.$45J$57F$6!@$5;J$63J$"9&$7BF$86N$#E*$7IN$6GJ$'/!V-%<
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MVDI;RP&-\#;QG**>!_.R.J]SXE8 .7@>.X>0 80A/8> /H1 /=]S/N-S$"B
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MQRX7+V0S]F-C]BHO'?1B!$>3,9Z@KF,?MF8;\K"M3]#8=>72=?_!*8U)@03
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MW&RJIX>ZSG]OJ8XMIERN2:OX7;LXT1?]?>1R97-V=@Q  BB  ORX LA#;!1
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MP&P"T(<V(-<*6(U*#=EZGJU&E0@.T&-:O0*!%K91@&$<ASW\D-8&:K6[R&W
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M$'!P8XD/X(85"39(A7 M"4U*@#QP%E,!$!0R[77O>]M[*OC:0BY;L<!% R4
M!)&K(.;H#'2NJ\D M<("W%C'X43T@%051!\D4, P/+!)SK0B! JV%4M@^1H1
M%>0!B5B/ 38@!4W9P#'/(^(,2E"";I(@>@6)03.:E9E;R<H #Y!": 7  N6(
M35R6.I<:G+.!@K #K0G0AP=:T4,M508$RIG/.!20" SDHP*P 6VF"M#-W))$
MG1TAZ&GAUY#Y960=[83MF=&\(BE(8,P"80B8MQQG.<__F<YU#M(^9)N0D T
M!#2)+E\(RU %7,Y\7IS+!Y31I00H,2;U!4M!\@$5CR*T &I0J1K,\@[KCJHM
MWIP73$#PTDX30"\(,>).H&$+F22!:&=;2VM(3=A7FX, + "'K8>2XW:L8Z9&
MB8>VS,B7O1V&Q:-IS+TBDQT%VP"Y&]C ?+!QR,] +DL)0"4T9B"K!Q"@ /X
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MG CP_@;0  N0_PY0 1/P_Q:PA6CHXPSB)-HL(6:FQBQE!DS@);)#:@(I4%C
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MF321N5W/56]KN(#1#HAGV9(]&5>A>8ISN9N]^9]JF67\=SXWXE8])(P!&65
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M]* :05"0O-&R!HRK^EN80="2._.G!RR8^X A'M&<0?@OWBFZ/OL2:4A_%6H
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M\<""@HD7L44TL* BOQ &0N0(0M" A0<)%"@P\?"!@7CR$BP8,2"E@ 4<#2A
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M *46( ];Y"0F.W'@^+[R !ZR) &GC-KY>C8M 2S33;I+ESZVZ! ",L5Z!'J
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M-EEYOT!]5$B-5$F=U.BL1TJ]U*S\0QSM304<J<C$L9K*"!5L*2,\BO8P0)(
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M"4YMI>(H0TY2[NM1R=BSU:T;;K65>9H0^#M7EF>VB^6)"0(2)N$1>$+@.0O
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M"%RQ@ 'R;,IP5$'V%?#>1/D(J%9FG($P46,1^572 @8.55EG)E!WFW*@C?:
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M%262#_F41!DARU!H,%(HK-&01RS Q@* <C/DZ(DS9.O;_U]DL+U^V<( *QM
M&6<VD1F88"]'@Y-09I"$5UU!//&01]-FT))X& I3"I 55!R8N%?"$G&;LZ.-
MBD(N(HGN7)B+95)<V2-?ZFB6C./<1!:8N"D]SI0".5_!UJB1I@W %J[92,"\
M& )"&K @'SC3K1) * LDP4SY4>4!DS0 '%A #=UP$/$>T#HBS@4XH[E"26(U
ME'V8 S07(8">3&@8?WFI0I%*P %711QJ.LB+&>%&H/3D1\_8YU6*<<U)/#+'
M0J;/ G7DY;/*E3ASK8,#$K0@24M*4BA(8!P'VF"6Z/(.F!C$726Y#C<^P"IZ
M]05[-QL 3U<2*&7^\#"J :2DN/^'JK<4H"'_*HY%@F +]1&$BS8)C"V @C8!
M0,,RZGO535H()F[4) '@ (U%\N6/B9@@".E,GDP$!A@6Z),S9AP!9]170HBL
M WQ37=[#]"(0]SQC/"^:P0 ^P-/D^4<R]K%9]T2S-JQ)TE$&,>5SEJ*KC-@%
MD;BSI$P*Z4AVS$<G1(GC13+BQK8.0 8]78 7 3,"PHY@M9OR3*!B YR+U.0A
M'[ =1WOK6Q\M<(&4 R:.RF),QR60N+3<I9%NA*2UN/)Q#E2N6O9!W00&3!Y7
M"*A$!F41$]2P+S.@"0J"P(XOQ56?@#D.;KKQ 6P4 )-K&\'R"-HQ"W2#MT4Q
M 3TTLKW_#R3!)Y]1% $(P X3J &SCR7*.O39(#/=!#M]Z1(S9ZB1\'XIK0J0
M!_LFJ\\7Z=<@+&"))!?0C4C9Y;8@8)II>/J!=GS 'TMCJT&."\OI+N6X3;I1
M 41JTA\#V5L8A*6Y.DA0@[2#+DA%H0%T%B&3/+)O,NCJ9%@@@U>9("+*7')!
M3*G(N3@D! (;#\GJ.Z*'J*:P!9K3=O(6RI+<:GXBH8[3DF9&@T J(S3.(F#(
M,1*Y!F<F9(8ST@BZIO'(@Q]*$Y,W:9B;FV"F(.1X7#1M\HP]OJ4_?BS)$L_X
M%KXMB%A*R4S%/ 1" 0S0C09*E*$WM0!6BC@);MD.WAZ29=.P_Q8H?;E/"-CC
M#WE45 ;A(:*ICLJ=DOCDU *PL8Z"6\QGDR[:-8;VM*7=46LOF]K7KC:WM_U;
M="%E%U<H4HZN2Q1AKG2YS 4WC31WEESF^)7H1NZ._ +5B;##AS<S%6OVIFG=
M6BIN*H,S"#KE$67,H!V(JF="%"4 ;$1& <IPED&LJ4>)<.,_MT(4H>@!(5:9
M( >V$,\B)3(7$C8Q ?F2L #8D3J L2#?&=GW4N#W*EO .DSFBQ%A%7)&<#K1
M '6ZB8!-HUJA_.7(4&(VLUMY8Y-',,A2G[I7I""!IFOPW411UUMN,Q>;*#U"
MWF'R<1ICCG4TID+%*3ND'I* 4^6-5/\/*J.7TM-"3:Y8GQ$;F#G,Z9#.J"%9
M[8R(.;K!H(*@R@+0:Y!$<N B&H?,18AW;'#<:@%]N%,-[WS >TEB@7\, -D:
MR62P!K .NA9J)04X>P' 8:G$&F  1;N: #"D-++9/<N9^?L">#OB-9LJ,SGX
MSE4[$BEY<,,CK6WA:0QPA07 MT!KMCP+W2E'.27R(@^2V4\L\X 9-*8RP3I?
MI2]/,>*@"</TAO>WV^_^7AIDWD,9\BL_Y]$=;>YRYJYE!M^/W2,-EX_XQ\(
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MH$Q>$$2NU="IKAA/':KL%=*6B$0A'=DQRH,T>=.QKJ6#L)8MY%<W_,2%_R[
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M@:08]!=#2B1/?Z%*(Y>X@'^%8),,80A<"+.I!X  !/%AIY-T-H*Y8.<I#'L
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M^@K!,\))2 ,PASK^_Z .1:LC,WUMKT+A:4X.H)$#3#8R?4==350L.I$\:VD
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M45Q#O5@+0$*@-*H'H6B(D9"DP]9KP8ZN(<9*#8+@,.9M "@C+MS/:F"C?W
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M8&QU>Y-6CZUD,<16A5'8+B@Z"?1(^*RV(&4[NVFMQ,X E $G6. BE51Q!R9
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M@0 RX]$8I9J%>+3:S02 II')6!X2=H-[=BDT+Y!."#3N UX!T1;6Y!FFF1\
M\:H.>2*F<I$99:R0V3V7<8!E*H&ABU4QI !0$H(36B:D0 +B9E>/JT9TA3*L
M<[1Z5@//9QW^HV2^!4" \E8ZVGA:SY/ A2@H^B*_@Z3#I>B@"9':LZ+-,C2-
M!XO  J6MDT) FB_0^:1AF*19 !NZ 30YVJ,OBJ)+^J4QHJA7(Z9Y)&U@^*4Y
MNC;]-:D?H_\ 1.LB!V"/8+I^<--;H=ISD_&".GF!<W.L?;&LQ9JLTSJ5+\0
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M,(8"(,P->&"@8((/ E@D*&A @0D!!0@:>'>%X0,3ZP1HC,AP00&-$!<45)!
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M%9H"$2E8N!'6$AIRG,]3BU3-& !7,!_PJS":%I[T?&[7%IZA31]A#C'"<VI
M%($TM]@'&&M!/GZ] !G+?G9JB&VZ:(<Y&N8PO,*<VIJ#O,6L?_/(09KV0VU4
MR3H*%2 @0*WFCW[T !KY /X@#]FY$6U8HCX5J9R2!)5\+\"-8!L!#6Q&%DGP
MVUUA(387$FQVRR !#B7_>E@Z%-LSP VW/2\SD ,:>74#@-RX.QK2@@/B_0]]
MQ"#^R&1>9PL@<%CQ(4#.NTL)0  ?$-^W@@.:9@LXT-O^(%7BM #E+0#L\-M4
M;57U35Y6)0^VP$NSM-U&4AX^Q68YP,(@<1(::0N[3=\K8@).NB.QW3[Z ^+6
M.P"D;(H1/!A#@N&:YE2L&M4^+3)C"K94W-I]N8B[@1SQ$,7&#!MADC*A?>-(
MWH@B@^$&OHG*$.!2.N!M8EV7F=P+$MF)Q<>P?4VC\@Q]M'%)T TY9 Y>?B]U
M!'UKD4B! MQS(1#._0!LMED<8N4CH(E+NYY63M/<XU.WC.&W#>() ."(HG8)
M_S< U3:K@>)'4KKH%3SG]V(+O]2O2?8!HE$>>:YG;[IHU'&.7DPQJ[$.RJK:
MHFXESNJ7OWLDE6N&X-0;;DL7MVI2[ !.T'="819V _DNYK .>%.YA,&Z$-'J
MY 7LYO0]#(<Z>2+L;!-.XRCLRO[K9#<6QBY(KSX6[=#J)O4]L8[LR=[K@][A
MVKX1SVZ7JZ'M^S \L3YT)A5^VIZM\7-<B",<U-E(,V"&A?'M5)OCHGU69 JV
M7SI$-FYI=64 -C .6L2'RL$<_R[&Y5@RP73PKIWO4Q0FO1%H:O&)UY[N'P(5
M+,YBI,:JZW"@X@2L>Z;Q>=T=]Q(_WS/K0--<V&U<V_\%BFO<[G&!')4K3M<.
M\N#^,\:^G 6 [LWN\@4P,<+W+L.C#$-WU#P.1$1>Q>0U;Z/^]%/"VO38XU(\
M15FGRZNA\D,D[DG.-N3"]5W?&@PG&J+QV3]A]E@?]FK/Q,-DI_F@ICT=IXNF
MTSQM&F \QBF3\ [#'&UEQ50/MN9$+K(A4KK$JD8"#LN(.C[*7?H3%G(']H7A
M]0[SC)"O18.'EYS>F',!#J$.]9X/ % @ 03_VG^U]J9_^A&/^JJ_5M!AU%6_
M^I;/Q7^/M14 ^VD_^^9Y'63+]'ZOCD4N^TQ<'IW,7:@2;MQ5575I^XWG^DIT
M)'./?@7@])_O^5)OZGBH_-C_G_W:#_LVSD1F6VEWO_W$RORM ?<08QQ)O[6(
MY^/G/T6#%OY<!/]'8N]$A"AZW^:]*_Y5.^1^"$WIN!D L>$! ((%#1Y$F%#A
M0H8-'3Z$"$"*A%T"+%[$F ^C18T;/6+<]U'D2)(E07*\R,)DRI4M7;Z$&5/F
M3)HO5:JL*:#C1YPY2][\*:"GS)TG7Q8MZE/ITHH8FUY\:C&J@*DE0XZ\ZC(I
MRHO[#%2H"K6KSI%;-X8T"S)MQJ5&:ZY5VS9GUKDNAWJ\*U>O2;HK\^[%"_.O
MQ<$8"P,N.;6OV(UA8\)=27>=DH$1+5_&G%GS5\0;(7<F66! @<,"/HPN %KN
M8HNL_V=^5BVS@&C2*V$;QC8 6^F<!7+7%OD[M<^IMQ%/1=Y8N=/EC)W'=FW<
MI>-=5S#,=!V;I/&^6Q=GUQZ^]46-=,&7G#TXO4@6Z[4#5]I^, %S,-WCO6]X
M]LO\&&</_ZB =G@33Z_S9.HKNP($TJQ!!Q_43(H* /#I0(QDD$<>?QZ0!X<$
M.,1AM \Z'  G%@;@D!_"%@#A0Q!L 4$>6^3AQYS%9F#Q@2 >>& !  D;P 0<
M>.301YQFR"%&6V18QZ(%Y.$P 1F$8E'&#A.0QT?#GI0G@1EZ.A&'+&< DL,!
MA#*ARQQZDB%)+\$<T9\</@ 2RC,WDN%#>>ZT:)T!0-CP3?\!"L#2PP1(&P!*
M$%I\(,8>R1Q/@'6J9*>]#G.XTU)_%C ,25MT?""!!0ALR=,='[!E 1M7;)'/
MC_(9H5#XA"K A 2"" '54?T; <H'U'A@3IXPG+%1->F$R4*:'"M0/&9M.\LC
M93'BK-EH:9I6 +K@2DJZ?6#[%J9GW2KKVI*Z;:F !4)UM;TD>5P23$)Y!&$!
M5T<Z$<L2+RH 0RS_S311'D4E"<E_NU1SU7R)3&!?H1*UQ4,92C,GST8;ODO=
M!TQH5^.!=R4IWWK!P:CB#SG\!U*+^E448[P62" '^ QNL<M#2;K*.Y&D\\Q:
MLDIF$$*AAR:ZH&JEC4RF!>(QH&G_I]^YPH(%9GBFZ9L'-:'I'%9.H.EW+'A:
M@:M3FA=L \ .0<N+/DA  07.-N *L;$9<  UG&Y8J*Z;5L"$01]P.O!@ZUOY
M@2N:5GO0!?A.8.7%#>!4@+;=WI>%R16XMVH#Q%Z9'ZTWLAP%K0'$YG$+%-!R
MAK>C5N"#=@90 .JF+9 =A"DW8KOI$5Y_6^SA!F!:'HP&2""$KYT.832?6)BA
M^-D-0$$?&88CM&D9"/^( 'G>-F#L07/@_FT44 =0!L";1N'TO$$R!YJG#S<@
MA$-)9<NEK,;U.?]7(U6*9P.N:XY)UI*MM#PE'P0$35:RQ9>QO*0J'5&@  UD
MC@4$(7Z1_UM9$D+@MO3U""=E>YL^3/ CD7!C>U=('/%H=P6HH2!R*(H']X+@
M,(^@R&Q,:UH0?M>VTRD !>O[TSL,$ \+/*!&))&!/TYWN@<X;!\4M& 0,*@X
M!2RQB" 3"?'<)H\?H2A]1!2;RLRW.2(VL2?[$,T#+! $9?1D!&I<8?IFD!:>
MR<4LRG+,3M:R#@Y4IFA_!.1E)%2<C[!&CRX9 :X>(+JSY2H((U!7TVPQG.8U
M+0E<.YL"=*0&16)Q92:(G29U)+JT7:223'P !WTG@ HZ[9%_<QKJ8+FY!VP0
M;&9\F ^;!@)N\,MT#TA-)"%GD6[8XG0+P(9HJBC%H0BSB,%\W/\E,?*!NS6M
MB:;<V^8.U2^GH0"8HLFD(CD9A!'6$ 1-.],(WG:Z&9!&&6]KG$5F  +6\6B#
M!ICA4.@XDE.*TFU%O%T!SFF $1" />RHI@% P"<6O+.'DSO=F=IS/G]N;FL;
M*4 .^)8KM[G->R)98/WT-]+5;&<I7\$?3-!%KIS4L7_DX8M+]2)3F42E/>:#
MQ!6GV;M4NBT$OZNB/E)YQ<*PP!QM@Y[,+C+&'BH@!%-B@1HUN4%-DO BB5*#
M4ZM81FCFL);:'%37+*"&>\J#'23!@07B44N/4F^,%]S)!ZJH27I4$9CL2=3A
M5KDR>5C3EK(,Z]F^VCUL8&0&:GQ'V@S_:I$<A&!S'=6'57'V,VB]E"O:8NEE
M7;(@/P;2LY]-R-&@I:P#BJ0=!% 7V&PQ@'4$<P1-XZ(\]W;1ZD&.3J1I1Y,\
M4H JIJT YN#&XV++@L?UR!P#4F?\MK8 Q_)-50-H[OC\5@"I3J\ [)#JS=2U
MNM/=[HD:99PY4@L)##)W<SX"@=L>0+*NF..U8(L'%]W[N=90D'NG\QO7+$"[
M-7Y 7>E[[&@&<,L!H+8]NJWAWJ8'.[XM5  ,%IY0^$&[!XQ@'>8@7M/*B95"
M#N^61JJ5U8(IU@4@>"/V=9K4^ 7>FQ%/=!86@ P<^]/9+ !L"< >)BUP*/&:
M%P7WVME(4DJ2_R&/-#G,0?)S)+@_!B*MPU*Q3DMV$E*29@4R5&[@6V J%9$4
M67]1K6+32NFXMX&@'1\ '.8&A:(>$<J'']W( /0!MC!>)+D;RX&HSL3@]5HL
MMB(A0&X?;,$>R?;&VUVC -ZXN0$,( =RNRA>;*B -$94 .98I"LQN%T#^ /#
M::8A1A;@MJ\IP!:Z/='YL-&-Q^6@/NSPE;H<^X#;*4ZMQT3PY!)@@@7PFH0(
MG(F7RZ47</01M,=&-@"^0J%A5^@CB_OA!\CA.*NA)D\:YBOBDOD?JV94K7]^
M< (:9E!N[&V$5RFW6G$L WW,;L?K0"J=.778S2&+NAY5"70W9T'(4?]O<6 ;
M7S=*ISM^B57<=@7RI%*,.7;\>XK4'9]C+:!4 9SRUMQ 48H?T,X!G*UAW"X
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MV,*D[H&4_U* ZPD-$Q#/1L$\8;(%2'&O\=&2V@*9G2 NT0&;_Z.S$:H5=A$
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M/0U.^SQ,?6$B"V((LJC@"J8DN&WJ!W"#KZ&7:;0K=,[2AR6 0+*(>'I$5.7
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M V7 BF0-P;&^XBU1B&4L(LCPY#M=[I*7N4O4&&_Y*@&H4BGKB"516'!"A@B
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M!4Q#!BB"[WC" ,)&8S2O"PT#,:(J]@+$+5A#&7"C2'30#RU% -RO($  :PK
M'RA"(D[B\@)/(G2C:U B""AB\^PD#PW %LQG;"!A2&@%+(#D2W90CO2N(![
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M0C 4@B[=[D#=J\Y P $Y%*B!:$!+2?R\M) 1."0>;42!2 J@*0-@<"7ZT=U
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MYIDY!SEU>A7D@R&UP3(+UR% HQN_0BK2F&MI&$3+Y*@H!U<_**FG8QA[%QB
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M'@+ #DEY!1I!-A%$'6 ['&#:%S-0(.TY' _P$RR@6E^Z1@MD%_]A ?J ;S)
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M$+S$QUTZV8X!/H -T5 OAC),SW)Z,Y.]:&D!&-L7>EBV0)KDP 024]%(0F"
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M&/X;K;Y6W>S=Y6YO]WYO^(YO^;YK!?!+Q'9<NIF!' "!1\&E!3"'?=@K>4B
M 5<=$(Q5UDU"&6BS&HFL_7X4U(B\ L!H=UH@9@M)VG;/QLB!'&"\ W?&LM:*
M]%[AV5PN8QWQ0WYN>YWDO[%.JP@YS9YO&9]Q&J]Q&[]QLVANU<J;,9$!'_=Q
M/]D*%I"!H!!RS(@X7.)O$&@RSC$/'# !\4-;/8WD46PY92"8!K-NT%@WU$B
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M_K[GJ@2;5#\&&)!" OKS<1)@  H&2((-/% !]<=  9I&2 &ZGOH!8" 1L1%
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MU-F N]6>*]JCR0&=TAG&W8G;V_V)&E4 ZFV 7-@B>KQ= LB +2Q)V 70"F
M@-BB?]B %L@#>O##U!B Z!W9!S1?3@BA^ST= #R#!PP>DGV &FQ (FR;V_6C
M+=@CP<WAQ]6%<&3. R"@U34?&.*<1?Y'@("#F"4 "?B'"6! )1P%":C!"-C$
MYFF:#'S> HS  R0"M>EA3V+9"#A4S^5#J_"D3J"> LQ<M1G "FBA0<A%!9"
M43ZD/P80TPB@&ARDMV$#JQ6 %H#!!O#A##R -J@!>L1 %9:B28)D@/2*%@S#
M=MBB!0! 31;C:.:>0.0#_N&AVU4?-PY$#NQA(F  _UI"C1J\$79TB=%$Q[[X
MCP*-1P(83_ 5'S429W$:9_Z\8SX P "@@ [\3_1XFYC-G0U@PSXX8@6LH $(
MA E(P0:07 CH0/<-P#!@P BP *S18ST&@0?T8_NM0&R80"6X7^H1P&$.8B+D
MHP'80EU:X4J>H U 0OV9'-L!0 *4(^2]'0&:()Z!0.5]GPW@(0#LG3*P!;_4
M7>(9@$J0H'\< 08\0TP  !1L !"6I'9*Z.<! 7BLA DL7;(%7 70T!-JI0P\
M@"(61#X$' ;D SA4G@&T"@=(7,M1GT#D@/69@-&%QY$4!+2! 3_H4")D) E$
M20&@G %<)4&,W48&T 9R@_\MF-7%K><*5, 5R-BU:0YVF( \2$%X-I\\E":6
M&@ 8:$X!K"<)',$'!)\!K*?3\.1BUF/B95L,%(4!D,"<R,7SB-D(;$ ,D(D]
M"IY &&@E , MFD!!-%\.H!D /<"C H#+>4 &J-VC"<!^;JJ@"H ,)$ .*.=?
M#N>]/(#%:<U:?(T,R-%QVNJMXBKCC,#'O=$ -!^X!=#FZ5D))D"^54*$8$ (
MT-#,S6D0D$#WT:3[2<'EI&=!V",0:!X85%_>/< .;BI=66 %R(.Z0>D#<$"V
M#<-PCIT'0((/CJC=0>1 J)L!L!E!H5\8(A2:C9T.>.-M"J#[1<[\E:0_&IVX
M#8#_#7! &%X. ,2D/" 4=.8= +A="6PK"/2</^@ ""0;5\(H ,C $V;;@$#"
M#"DDP:[ NUK@"Z915$IH#$QE(%ZF?V @&)XD ,6@MY&  ?A$(FR &L@B09AE
M'=JB$J!;6P[=0$!;1D("!["#/%A?78W#&&X@/53KQY( &MHC1N'= Z" ]&F>
M]54G_1'@DI  /Q3 /S@4WLV)GN%?#L;L XA?]RW 0IIF]PT$:0J$.=BBC?!#
M!>B !*+  VA! N@#&-Q=$XX)0CFJW0X-",1#GT!NY/Y$-^1JY5KNY=)+EK[1
MV/4= "4>%!@$ZN68!"X )%2 [TBH!'B YA#4T@& *QQL_[Q9W[>M&D-0J0?D
M(@:@@--TFRLJ'9/<X\DF:_G1E!8HP\\21'S6X<=Q@!K0J<F9PY!DI$!P@P7H
MP+9"'6#JXZ=Q P@08/6EF)[)@\997\V!P-S-9T:.0 ^^*Y81(,(!IO7%@!2X
M'Z$N8@-67XRF@.EZV_I9X;J5;R*H 0LH &P<60YTJ$ D@9$2ZAJJ*)9*X- )
M0.+AG0[4G!;$7K*M*P<"01 4@#\8;ET%$! 8X.?-10TFVMCUH^!5JS(0ZISV
MWQ$8'5P)(!@ 02(, /(2!/( P3 P#0^\H%Q< 0<^@)^^Y0;T\.PR'\[QFW]B
MP!%@ZBQB@$ )! '(X8DN+PWZ8_\%9 !Z/(#UR? "L)D ?, "7"G1- NOQ-,
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M-HP!\"O_!@-A/;^P6PD@7N"N".;C"N!@*+-: J3 !6^#VA%%=Z@!]6DBE@V
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M#'( %*RBM\T=!YR[Q[^# ,R<F"8\)(AI\Z5>#BQDBAE=!9PQ'#%AV@W JI.
M>"3 ]<HYI&* $AC *FHRIT-INJ>@NMTB]>$*H1Y#]*F?*.M=S96O&LR%E+J5
M!;ABV&TP%!R#%E";/_  *$I!#?IR@@ 0BTI(.7(@7GR>>(S="MB"86-9 DB
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MF_ $D)0S ,AAP:,$3+!A PYV$FI2  HXRRX.[MR@5$,3&L'2:4.@] %:\5R
MA23 97> !3;UX B63$C4SF$X&]B#%2H(8@0X%9B6I7'45+,E4">^&..,_S7>
MF.../?X8Y"T+"(*#!\8IH#&Y@,C3@!@, &D#('32R8('5(7" !LJ>("FRRK
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M[" C\0 !-*(,2QGF7(Q"B!FO1P(;<$,>!MA;AF:X E.5J$T50(@N'84!TQC
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M)LGC<,MK-F!>/N!G+*=D&@7,_$KH9F(Q7"B7_@F;+(?QSO^G_CQEYGPGNTQ
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MHL6D:^@!/MF%%NJIYNY<=*"X;*+"'J" BH)%:D*4$J4 7.$#@D '_$%;(LT
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M2ZXOK13G+4QEXS!*'PQ.4II9G#9EKYY8'HY !:=I&$8Z(7( 7*;CG8B*H#
MWP8ES7& *!UEOA,E!+1 G!_@)E)(BG9R 6) "?Q9 )Z/Q4\=U5-=HN@\M"I
M"T9@9;Q&@.C" %( -:Y =*ZGQ/&&* > KG2&KC8@-93H<\!E *SZ;V(@"#Y'
MYP[")4H@6&H,8"!!CFK/!,19Q(@"UZ#*7+#[3<C_P0)TXJA1[VL@Z'H4Q@90
M ()4@]6QP;Y^AID%PGK0SC2@X,*D(!#EZE< Y9<W +L\K7NN1F<J0>CF8@'
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M>H"> "A(% 08#SQS3 8/#)#B PML8!X]5=6YX@Q0;+" .2,80 ))[8  !)$
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M.R'D<LSJOJQ 9-!@4(()D9$&AJ-%?:7% [N@5!<&2"M]VU?OOLP9-@O.Y2:
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M4A$KT&FOLE:\XQP)T&T"D!DJQ4\CL $OA((H01BB,U 1]"33)@ 8D '1\S&
M94\E,'3J\C$QP VN4 ")L&Y.$4!@H$X%\U#YL  DZ!25@EH& (4-(R8?8  A
M12D>Y":2Y";M( "G,F&M>"JM>!V\02,+L@]OPHIJ6(=%(0!IM NJ*"K_P0@
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M^Z!H>I02"L O;-$90BD7 E 9T5(8&_ !3J$6_WU!4CPI #G %IA2%>OB 9"
M#5WC,B$ )X5BDZ%A#A8SDGOD(PD0%%NCAZY1:]!3/*Y  /)$ F8$<1YP!2^R
M0YQ&&;W#$Y#U$#I2 EL6EDD@#T>@ Q@ !IW12K/G-OYD'E?%3QX'!L>0!!RA
M=@2E# UD5".P#\+A+Y8C*>[V/BY#$ +",8,$ ,_03HQH'0M@ SKP.)\S %!
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M4.%I.6 :0944'T .?+0!27 1=V9MI-./L&HHD)!&_\UU@[.9"!Z0! VT(V"
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MM@#_#,$9:T%*D  %G)9JZW#)NP$YP[  )E )M489N+N_*R-ENU28R(<00;
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MIS><"*AEV%PW,15A,<*39U^Q-7>Q 4>0 VXM%Y;'$TOA,CV$P:,VP8-7 3K
M 38 7(9M2+I+H?^6AWTQ0B*!?3UUIBXL5!G6W,X-!?1P%!F82<Q#.GW,/S;
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MZ:(F0T,71R(F'A$7!: ,)L#,"Y#+F7% *G3NJ'<<%5\2&\,;!6!9PU8429$
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M0%27R=2["&  "<#&3A:0@&?D8QP#6.8#$E" $.%* 0^8@446<$BJ%F0 %1C
M5P9@"Q20]2D"X$94$[#,N9"C %P=T0 >D ,!A" '=MU+ 6SQ ,8R=@&(U8L
M%O#8H2P@L)2U"%@A.Q)<,18:FP5 .ZX*6KR(MBKD8,<(V&$7<H!U -A\9%[N
ME!C)MA4N[5B &A3P#]M"YIQ%(6IPA3O<!A7  /\/8)$,>KL9RL75J<\]C@ 2
M8(,*'#,!RY6+="LP5@$HP 8*\$@"#& " R@@K@M01HDV8(,%)(0%">"  4AK
MD03PX+H)6>L&7GO7!%0@!A50@ ET^I0"/* "%G@M.7( 8 %@0 '*Z L[4&
M&V @F?M-+&,Q+%D%D%6Z:F@O?4,08J@HU@ HL.Q""HR!9_2%PU5Q10[4D("[
M)$"9%F%'"#!<E[_: C%650 W\C(.&1A  @$>,&74\%/B-MG)3_Y/!9#+HOEZ
MIB5W@B9VH;OEV@A #23 @ T,D -7I*0=3AF+30F<  \8@$4< +/E*H"!!<AC
M 3,H@!8@<><-5,"R FG_ASR4$ ^EH$4 9RY( DAPW91(-@;ZU4IWP7Q@&60$
MT0:DRC474 $2;*"] C !%![0#@?O6+91Q4";'S""CQRZ !X9)S:7(@"/ 'H
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M!X#$ZKJN!8B!XZ*P!+ 5?;#_@!P@B+_" #4( AN0-JT0K.W2.<5CJP20.@#
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M^#G$<RX"4P E, 'O48!A2$8E$$EPZ+/;/,&;* !YD++B\_\NQ%RP"E!$X!R
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MNW1,!ZNTNFBM"@ #PH,\R7.S?(#2!<"&/C,!*45; *BN(  !(%  <UB'/GL
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M!%%!<P:0, "#1SQ@T0KN : /"M <-X "'AB@0 PHK6/+4R&,- )7%6S 005
M/$"  $E (L6#,.44 Y<5@"#6 V(B61$&>8ZH$$SXN0>.+4"$$$*&E(VC@ 4Y
M6%?F00!B: "&%:PUG@>0_SSY0#X)6%#! UOV9QPX3"[P' #8*'F5 0_\%42?
M"D!AP#H"V/+5D^M!%-=X-JB67T0#@-J-1,(&UYE'Y_&&VCZDY;0LM-'>9L 1
MRTE[+;;9RL:"!,$)!]U[X)'S@7/@AGLNNNFJNRZ[[;K[KKKCL !%(@9XL.8N
M"T@QV5.CIIO/539(5@!A6EB )0I%=3>" 4J8P&0!\K0J4A 'AFII3%?%\, "
M2=A@0 PFW5D!"2"9BUU;./3T@)K<R+.!31XIF,"]$;7E*@#[<(,!41(0%9$)
MK2J$TXX")+ !!B%4@ V6)"B8Q#$A6.1T1 TED(]Q!800X  />) $EC8PZ37'
M4/^@P,$&*)"@ * @4+HR!P^XK,10'JBA@,!;V8LH@#*$-@ 'DRU$P,LM*O!C
MU:T^"HD"&6  Q=H*[*A 8A#=2H\YS0' H4XFG(P<3F!8NN4X01M@#F#*[).
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MA6$L !P)( ''-J:%]0V,(6\+2SR5\!2QZ6@&(_ (DQ)0 ;L(0!GXH0R#0C"
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MZW+0S\XH<BQ% 1@&^@@ 8['CDM!#UA%*P\IK/6NORIMR: S_4(FZ6KG+QRO
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MC(.PZ!A5@*;L881:>  *% #J8&(ID1JOGL5"_Y #3V& IB9"!5@B\@U)JEF
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M<9()(+@ #E2E $LRW 5=(Y&T./$('TR(R>@%B4L" !LUFU<"\#:0 @3A/AX
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M!( Y,$T&V+A[)"@$=@<M#XDF#BD*K<)DQKMF&*9F],%  2"'0$>V!7S ";S
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M@0V 9JCIIK CO&)Z8<J1Q\.W> OH+^%#0N1B +@E-BH@-D7]]IX\!I/%:([
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MS40B]D7\>8QAJA]ULA/]9_B+O3_^O<3+/[\D=L%)\$3YL3ZM%26(41$Y 4*
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MW\<#&_JKA5H27&("<\DE(T$?%#6@)+ M*&-?(Z$B(Y4 .I!N, $ #V  ;O4
M4 !47,*O%"4BW" H"[ !DYJ.6O 1"P $]C4C'<MN'_&ENLJS/1L4D9*+'H8E
M")%?,6BT,_@ MB /_C"#MH #2NL/_J"T3GNT1DNU4RNU\G"U.)  6#NU7'NU
M6INU5]NT2&NU3QN#4)NTR:1&1&B;!REH3Z@J>/<FX\ ")E(BH6AGO>:5J+@
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MG#G_=>[DV=/G3Z!!A0XE6M3H4:1)E2YEVM3I4ZA1I4ZE6M7J5:Q9M?;,5V#
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MLIV B /_-@GF8X8":+1,!Q[PP 868$8/U.D(]JFG8-);Q@0DPCG2#<)0]6*
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MF5( ?7@:2=J;,=$\F'D:/_DCS'.\>.N-3^*8@;*- <"!CGF@TU@B)_.)_P+
M/Z]0@ VH#4O+LIS O>92MRG$@*]X .]0 #48.C78 *P+'XN8NSRIB0%HA:&;
M"<!0%@$8@41 / Z !#6HCWTAE0JP .DJ@!&0@MWCH[3)JD#S #4XIN9PCA&8
MJ66$BU:,#?12K_1R" $ AP2X#FA"@:?!LC\: !MP,XLXE^Y0 !- .$L;AOG
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M\:O'$B4A 'B&PE@CFO@RC3!<Q$4NVX,> ?C07=51,$$!#CB+]FAB!9ABME.
M8? ,$\!@2WM1_H 3EBG19&SB9\S2M1* -7NY?5@ %(""8U""%% "U^WBCM$"
M$, &T"6B#6".;"3+)7.("@C7%C[9=;T\^B@4$O V+7BI!2A8 5"&')W:P#B3
M?#BV(I&=K_@'A4&!*P!."["E?="L=?*ZN/@*LWL@ 2!2O$VQ#H4),(P:KK2%
M$> 0_T?3"%_L.N-E.;)]VC@AT_&),QMU,__5.U]\5=KC@-P# 1GPU)-8N7UI
M!_G8"P]09L]X"()LDJX #'!8K[6#F1B0)%05*2^E/=KCKDXURW$55[UEFNL
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MK_@V=X.:4?R+;SL"[.( :IML 4A-#89/F" ':.R;=P"/\L,+;]6*?;#']5*
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M'0,4K!@@%6/9!RP$#$@4 F\B>N:L*GA@(X0,D(8/(TZ,.%^! 8Y?*HXLV;"
M&8[E3N:(-V>"<1<%8+#% C'>%1Y.#QT19 ,&A4L3K( ,X(&$ KLNNB*88.[&
M 1N H%;PX: !-9 %0O%W4 &&"AX,W 3030V&#1:^)GR 4< ( XEZ/G#<$$,0
MJ0LP8,ZL?CW[_XOK!$,9,!WUZ03F0G;C\&#=P9H)/EQ!SW(*&/36!ALD4( ,
M&&@E@ VBM1-$(A@H8,XZMF!@W@HCB 1&$+)I%!8&'E0@3SO]F>0*1U45D(\
M335FP7,EF?"6 1GE4,$&!F   @#YV'*,%@_<-\Y S9D@E4!'M=?D9'CQ2. N
MW 2!@0U!?'5894H!(  4D"0P W/6%3"7 0J<>)  (*RP@0( G+F.*V%5H&)&
MY!10@1*HF03 .P1V9,X#IVT0@U8%8,C;BWK:D& !/2X0V ?D#, @7C:8@! *
M\6!$SD+W 2!B(E#DX*2IZH&#X3 )C.9>:*""A!(&!CV#P0@%+!"#$O]*2?4
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M$ \D2)]H/%8%.%2 WW@ ##Q@T&$&L@*!,$>:ZWE7B\+B@73*;P!*(($'=C0
M+@;2%AN@9#T35@$M0$(N&>. H4QJNXH*)"B/V]*;(O,!-1SH.N102 &NIM*S
MHC6M:ETK6[?:&,?HE)!.&\ 'F.HD?JBD)-T:@%'>U57#H"0&MC!!24:@'J<I
M( 435=,'M/#7[8" !&?"  EHB1'GS*I=&UA: 3P0 J"VU4E0Z:M63C>#!) @
M!-VHJ0*4@%,EO/)QS!D G@:U6-LMP$U?=5,&!2G_#R L<Y$#&(8"0H 6E"QD
M)Q6 'DP&X-AU3&0W6ZW4C?(% @2!@$<"X-%10^O=[X(WO.*M)V,<.8 Q0M*,
M< WH=1=@ ID(  <*^,\#?'28AQ5K'6<9@)&>$IZ;C6 M#WB 2Q=@@?F^)"PD
MR%+"5J( (%@4(PINDP=(P(]0@2 >(=!*6SA $!*L8$[_@$J8V$&"O"H E2A!
M,%[F"Y4'!'>\ $":55H&IHL4H$H+,&NL&B(0'^/JQ<,9 #6?LA24K&6^"3 !
M)=>I1_9QES$*  -H/[, _0#@ VXJTUE2W. $7"$PL3S+6<+3I5Q*(:4O*J8"
M;#& !B+F 3]IS /*#$U$_R8,I;GT %\QD(.$I S.MAO!!J#0%)<P9B=>'EB2
M3? YOL8#!-@8ASS44)/YWE9-E;I"9-I!#P]\8,7;Y8!>OX(7-1QE . P4J34
MPHU\D$,&J/ZOC&MMZUOC.M=(>VLG_2G)AZI' &KXZ0""H(5UJ,$&\[7%37CL
M$4(' 1MZ"UD!_!$#*YF$'?*H0 RL@CAV@70A!Q$4#TS]EIPXY[$X1JT'@*"#
M%(0,*#FYP@<P4 (@_ 8,FU7N$4+S 0\T1UA@>I%"*O#9!) (W7/,=00?98!+
MJ0%^25!)E26L  _8HBH> ,=&A;60=:(@)Q+8,"D54ERHL" L!>$(099= ;=0
M9O\$'*#'.,RAVX<=P08.;2TD%,XN4G=;C[D<1G-<LMVT6&7'V#.,/SSP9Y*5
M! KE2>2+*BN2RE8E,%"H0%DIDY=".:Q+A VW,DH#"2B<R3(/R+E*<*(%=!M\
M:;N@KB5MH1]P[KA=&,CY7D. [A3O0KF<D4O(<^(2AB,^\8I?O#89<YD.]E*+
MEE$&L#/S%@_@=.-2("J)+'*8!9CE:P"VSEDJ.P U\$ ?>-?7 $"0DX.\IQ78
MZ?E28C"4C2A8"=\A@3)D8( 8,$4I!QH&&(91,3@9:D$56( .)";L+7L !6NA
MW0-T /P"S,ZRMUZGFURQ ,<>I!T$48:@/?*!>*1 !SK_(,%FWY6$2CFT4AA@
M,CH]8 ,0()D@3/G]"PV0@M/HP&E47)?DE@)@0U>XA$+4F6<12V.@ ,9! H)0
MS%?M"[=QV I\5@YDFF$,"H<\0 D80 Z,0(P%TD#H@$& GBWL! F 0;B0!J&Q
M7Y*$2F"8 &HE2%DH!5.@!.'P!#94QUZP"P8LW9FUAF0L","I06'$P)!\RQ'X
MWL>YGAXUU$W\7G@H@1KD$@IL(.-Q81=ZX1<:3=+(P ?$U2 E35V5X4=@WT\-
MQ$_QQ ,\ [<-X+H<3J1X@!;(0P+HP$U FPD\P((Y3L(\0 QL@ T@Q!^2!1@H
M@%P4X$:8 VH9G/_Q@\O\@^@-_TM5^,IFX0I#-!1J&:  *)]0[ 8V>,!3H-1)
M()SGY1I>4 @K=I7O#0/Y -;%39(!<$ [@(-J\(0-.%(%/(06W<P&7(&I"8 _
M@$%-?!S+:8$)L,, H #,P41NM9N;.,8*8,D,E$1U),' \( \0($6O U8^9X%
M:$5-:,<1.%0V*0;"W40J\E :HI&"?<4(D$ 0\,B <9M.@>(*L!_73=.[M()+
M%  )*,"KW4P(;, ,O$B/3&&6\<32X%(11L8^-(L"$%U"V,IV,8A1S1B/7%FW
M; ;7?8>R51X8FN1)HF1*:L:O05YZ\5-)2D8!#%L[?%4B'!TE&< 1%( 1@<0"
M@,%2&/^8$@3&B>6DNT0*"1P'NT#%!AS!(2H6 )1%@G#'!D2<1KQ'"BR% BR8
M&F0 APC$#*Q 2]7BOIV) G! !9B #A@=_*'6H>C 2M#.S>BA*N*:0"2"'BV
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MH6!<:L9'2A@D*( )+, 1Z ,&Q(4)>::OC.EJ3(L%N$1$9$IK#(?%C>GY$,2
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MP#%(%^MFA$W94)^%972@3-18V<H44L+$0"(8@$LI0+]!!X]VA--@@#[47$Z
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M>7P@9GR7C/PAHI3-@__-YW!\S8>-#6U\($)0T(?.^P3]T6N\Q'=\QN?("@!
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M>V !P02HLU !3C*! QLH!L* &>2BT -5*]/.3PM(B@HT&RP8!P/P0C+@ 5M
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M(1@ ":TF<I('D*UMZ"M-^PRRI!00)P1N"@EQ2J24L(4E/N;(G )"8 -(6,D
M.G!1ZQ[P "#DI$2M2H1MY$&7IH2 &V=+P 9*5B%3P;,D'Q",...3M9)8Z9WX
M*4#)Q)2('.3C)"#@P*IR-\U?>0 ,CBI8^>*"Q&W)ZR2<*XQ2A1,VC=1I!-,I
MWP*&%Q6T 0 T495.3#!P*4L11 &T7* %-L(]$JAA!.(+0:L>  ['9.@!.DB
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M4L-#(P9#92!B   2IY1:L$$ZSDX+'! F+C,1P.+I8$0K,D+@ZD@S7/)1_T;
M)[!2)##@V"3"(" NGF+E'%.#.'AN0=2 I/K"/03 \LS0(H["J\A$85X+[21$
M-C  "!Z*''P# Q)&V-:F-DI' 6P@1GU#)FS@OP# (DOE.;V"O$II4UFH1WU.
M"\XT(U1#5ENR0VNC'<AAAD8'P/J/-L:$+' C)P+( FXGO!YQD()*J+!CT:1P
M.K B.9#B!F.&,D(H.<0+ Z"C29O"X CK/>:E]V!B)*I37,>57,N5I7!T )8&
MR;YC1+MSD';S/B9")3=#.VAI)<!@&+)B!&K59<)G51:@MTH" RP RW3@PUP"
M!XY@+,#3/18@!K3 %4TC)U0#"/CB3$A*"42I,/]VPR0TCFLL P1.%"R^4/CD
M ]]>:@!80.[4T4I4]DN@]25B P# 04$$H&D6HG06@D_,00"6AAS H0#68?UV
MKQW 81U"36;YI2QL%AQ<(1W+8C V@F;?"6J3MB,*P&D! -_816=IEE_,(2PJ
MM2,(@&<[ FP5)&;%5B,(@P7"HG1< 3VD1&?#(FNA%FUUMF:;)B[<-BS:@06>
M(M3*(B]> J$$X&BS9FG+ FL$H&T)X!F1]$Q03VT%X&R=UJ42MU 12FG==G/O
MED^:9R'4MB,H5W/;H6=C]FK:+PF6=FG*0G0!X.G6(?=$ N_ (6*Z-C%<BF?W
M8?U(=VD[PFOYI0!X-FO_IX-//G?JH$%LFH<PSE9KI>/IPJ( I"MJ":!FR?9W
MWZ-$9R1NS=5[OQ=\P[= R($%E&%&G@*5!((<D"Q"ZX,0%Y=Y#D@&; $#5N #
M8.E="L!ZT8-%$.IX"T(9CO8E9$< \$I[2^(92^)X5<I$7B)]L6,B1*,D_()/
M\F$ 3/=S[=9! ^U*XBYKJF0 S%=\1UA<.^,(E,9<S8($>I0^2I"%O2E"7):$
M9YB&:]B&9>QJ'&-&V-'V6K. _\$X/4,C\.TEZ&<C=F$<=F$A#%@CLD8^E)AK
M0^TE=AAM 8 P$J.*BQAV.6)+;2^E*!2'9V  5(J';]B,Q4FA:.:%JQ,<8J)]
M_Z6CHD@QG$8@(\_8CN\8C_.X%*,H5>KX>R=4"&EL>$ 8C/78D \9D1-9D1>9
MD1LY;T+42=[87">TC+_)':V$>1Q9DS>9DSO9DS\9E&=8AQ]WAA^T>"19G"@Y
ME%>9E5O9E5\9EF-9EB52E>/NDI>GDF=9EW>9EWO9EW\9F+?I]JP$E<')I;HD
MEX-9F9>9F9O9F9]9EHGG?N7NDN$1FJ\9F[-9F[>9FVT8D%<699.YF\>9G,O9
MG,\9G;6DEN%. ,0XA&4XG>-9GN>9GNO9GE_"' 2MF+_I@Y'YGO\9H -:H <:
MEM?YS]IY (I'G F:H1O:H1\:HD]Q0O?9FW;/GR,:H_\S6J,WFJ-;3!W)F)I5
M"I<[FJ1+VJ1/&J7YXT&M))!IS*!3&J9C6J9G&J)/MDO@F<:JN9!IFJ=[VJ=_
M6IM7^H+CSJ(3>J&!&JF36JGM>32 9#4=1LH(P&XFPGI6,Y!HAEGGICJ<^B<<
MIF T-QY+0J%#^J+_8R(612#$>32<A*TI6CX>-#FMF2!*:)]+ HM-Y*@#!*9
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M+CPCRZD)OU"[*RQ8);$!!'PBBSFBHA#]/?)A!D"#P2NCNJ5#.T055?R.FZ#
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MM,UXA2LL5!+:1<FE98**E6!#CE)W15F 32U6$,("$:GA@48HA/_ 5X90!+&
M%!YX(,4#,]BG750,)6) =2$4H( 'E?2G0$$_)M>65SEY%6=,-A8PG@']Q1 4
M!B8458 K P01)5CL@%#!$14$89L-H$&2'TQ=#C0 IW?F5U6&(1RH$Z.^ 3!
M<A01 *(_^7#CP0,\5C0#HB,64%!R.B;A*D48CGC2 *;EP^Q'PXWHI6@Z#: &
M!F-.5%Z&,>0%I0T>+#E ? 3^98('J/+*P@(CZ3B#GN EURH_,4'! 08#.$NN
MA@68-U(%?[';9GB&!56!!,Y]Y*,-!#[PWET$4FB1 2MXP(U*P/ICPE8ES/41
M 2:TJX"PTQD A0'R4 9C!0F-FR$8$KG_Q=)J4EBPP+@;4 81 -L**MI*8("E
M;\61 D!. JLU-U#![T#A)V4)5$#@R("R*F!R:@P@0] ";(T4#F XEYQ'1Y!
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MZ70")A T!($&*8&00H " M"F/PD@QSMB\"4.0$N+#*&0"?BQP<L-8/\%: ,
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MD=@2*;( ,/2G/#%XQ@(,SZ/%HR0^,MBZ6H4L@_6<UD[=<$42$'7,!Q1P-1Y
MP4CJS9,ZG^?!$ER!%,Q)G!%(FV< XH]S_E> $M"#1TK7'"1T&)(D=A8D=C-C
M"SD@+,5E 1I1 4'# @6P/04R74Z5 YU'79BW9V#2*AA$=JTG UH$55S'808
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M::>*.<01($ =#QKQ3Y5?_N9__NB?_NJ__HHCSJ^W2[N40>&5<MA!(Z_W0HG
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M!39888<EMEAC0QJP &4^>.M8A_)AMD!A=V&L @QJ:DD+%!ZP8 ,Y'_#  EM
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M#3Z3.Q%C;& "&C;3F<^$9C2E.4UJ$LN&#PQ</FRXPUV1(WJ#40,)_&;,-^F
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MPV"Y"0H&2$@!O.,>2BW0;Q=90'AB  USI%%F'L:19Z!0 9(=R6CT5$80?G9
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M "YS( !HT)&NQ1$;L)!(08&BR0R_2-3)8Y45B%B)C93L@ B@"#F&, <4_\
M&1'A&CE4JAB !BG5Y("(:.G(L>/4YI/A9VA=HAP);* <I\  "_".:W&(CR04
M@".2 GA'(M*"*,F!"O"'#9D4>2 4!3@&K:D/:FLJ,&*,=_@7"EZBFU  "Y *
M#WV/5]4:#TC)AM#A-X($#("0+ZR2(]BQ5)(7^?D #EB=!-@ /6N9!P"!@N6I
M_2F3,)H:&\@!G>SC##N"/447.AR'LK@DK_ FZ,H!^J#%A0@TX/@9A#TY57&8
MV/V,BFD(6[B<M<@; W4/W.E7!/G>!( :%D!@#WB&MPV9;<&&0+X"QCB".*&;
MR.(8!= "<ND+:/#%P&((^XFY$ *C!#@""V!,;?]<&+KDXZ,J&6I1G9-#1$[2
M$P$ !Z/15-S1,_GA"S4@%Y(B "?5Q@)HA]$(YD0 7H6@!QM @3<Q !SHL'A5
MBQU2RQD) AT@8_,1BKX 4Q ( BD0+WT(HSTQ "T 9$D4$2>.DC22 GF D"(9
M "!Y !/ SF'C"0O94]*HS,H(IRV*C3!;  E(F=:J:%M0@@=8!XUPJ"!('NDI
M "F0@A%X@)3IM4A) !]Y 'UH*57Q !-PJ K @? H#%?4,U .@GB0%Q@6F!>C
MDA"P9]P9HG'<%,R4@!A 6"V 9OMY !/*,.=EB%[\E^ (I 1H$')) '+X:37X
M $R&$."BC5QL!VM9 "S_7(@%D%:M.9X9,.4GLY2;H ]H-H",K0P%* &'&8<N
M*QJH699X>0!P*>,&>0 J%@ 3J #;J1[3XA]U @?2B!S5J6C:(&.V=IEND0@%
M\"+6QA$/J&A"^<B_V)0'V-S% R8,> 8_[4EM%.&?@((8=K@FT@X!4"D5ABQE
M=0YJ+#_]>T&K>C!*00YO^F&'VQQVL)P/!HX$D!T?TL:06X#Q^"0%<&#Y.8HV
M(AY??+>14@-(T((WB0&"Q!W=046N0"7Z,",30,F(\ #?4@IB3AH3J(1$  $P
MV!>_JH\!P 9\8>O/ !\%\(<CPT?7'J)H!0%@%<544H,GOA9A^J!F6Q^JPF.$
M_P@.D6)K6&&(\$B 76"'&E&=&&@*FO0;&SB"9YL!H0,LFE05(I(')=AK*DF
M,4-P=W,8&N$ ?O,=^OC"/:')A!B 2B@2VNB+2?E-3)79H54(<O",!%B'?7F
M3SH=T%FG$$AFHW6*%*!N*,_J##8 ;F",!>@P5!JJ=QD'#IHQVK#J3>%&$!4/
M.+\7&Z$1#^ F5Y@<KJ*1S<E.$O"7GJ@K@=2B7>"&^E@+:R&>+STL!VK)A$J
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M &!0P(@-:@QB@*2&Q   "#<H&$#B00&#$D<H,+!BPP@!(38L$* 10($$)!8
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MVKT&;* L!^#4%U,%UJ+T+0#0]"@@9 LDP($!V+@B !08#"##C4P!$81$6E0
M;$3K;9!4*PF4FL"L#]BP@3+[/,!!2">9@P,)SY3[TGJ)C,<2.W:M3.-.:E2
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M26B4 2$%[(5Y X"0R3K3#N?E2H\"L)G/EE4!5Q1 "A@H0&ID<*H$W$\!%C
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MCRVH-( 0:$$Z4("E 0K0CK  V1;[L-*LB", "WRE(QLXIW?$4I$"@$"^8!D
M#E", 0Y L5P^#**.9&H *,3 'R$2DX.8?+-2?:54%O'9O@QV&3&/2W@5&M?.
M!A.DKUB@ ,:RLC)>JP  5R $ ]A% :ZC,0Q%5 D[@TP(6%>;),A 'O\5@(($
M0L".$00!Q1:PR0##-3GR\I8;YNC(N&B"RAZI!I!?L0&CK'192/BHH0D 0\X6
MH( 8 #@!_& /2CR@KP\<(;>T_(I6H+  YWV%EQSJWPR0'0-AZT-8$Q98""10
MH8H,I*Q%^L!? ?Q$[\03FN"&)9UJ[8JM=/D@_GA6RQ#99AL/0-<=JP 0%K*:
MQ$K E"O),?1B+&4+A,UV\ZI0 ?)AB\LJNW"_ C(D*FNE###Q-K]Z]8(,<MMT
M.N<*&;Z9'FN9X;50F:_7,L#'&2SKCM4ZQHD8D#GH 05(D"X!RJ#,,]:#:YQ6
M" .DG=+F#I*HLQBWZ$8_NH>H=5:>[.-^'M/_[0C(2U^-M ,$5S5N1 FXE (8
MT'U *H")08AT"3D0@NU;CP&NX*/4(6@<YD@ #GKR@$$E7'66?@ ]0B" IGHE
M*0A)Q)\L,"#</=L5[9!'VD%0@'$ P!S$:=8"M%81M@]QQ[;<"PC880$=+=E\
M.TE)!8+P@"M0&2,*2(*N2W:%HZ). 8\121(>*^:.)*&& ["%Z6LO8^?NX^US
M;4I&4A+/EF^]EC]]4#PQ0HZE^.M8\?B'20H@#ZL8@%0 2(#BZS-1; @@'YK/
M08BLXMS4@6,!JX<S2K)"K@'4DI*#$H KNO$ *%0D_<-/3@'\0?^.=/D\O!V0
ME6@-/72+<_'$PX7 _XA(2:%0G0$$' "L UA<AI5TA,_DPP#0PZ"$ #3H!/NM
M&8K4TA4\!H;\BA0XETE,X(IA"#?<V998R9:TR$_]F3XHA3(<BPD"0'E<"#^E
MR=P-7@*L7O9%5,"9@U2%@&>%!!$.GP0"$7T8A*Y)P<$,P!7H601*Q%?4A_"I
M 3W(PP", Y79DN?QA*X1!UA(51E.&?N!H0 0@#S,51)@Q#@L0!!T!&FAA"T,
M7T:0PT_$ QM=ABV%TTG,@#_PENA91ZT]@"VLPSC(P* %@0'DP-8E 0K\$IT(
M5*!05U8H .[EQ -4'/8%G_J%H48(E_'5FK( HD;L0P=2X$%(E9NU7VH(E_\M
M6$5V"( R!)G2C&%28(89MIRN%8"MC ,+_* !X !, -$,Q,1:E)\!&.$6G<<>
M'02N$-_85:,UQD]KB9U!P)9QQ806Q(#Q],\D%=UN]=;G*<%[G=UPZ=$UF@AR
M:6,[YL\*X.(.FF,\WB,^YJ,^[B,_(E"!V6,^[H,M]>/[*  ()&!J+< P7$$W
M/$.9H")!1J2$!(Q65(E$7F0\<HS+4)Y&C,/]Q!9J3031\00X-(:QH58!#%#%
MK<;#F(;[O*-R2639N=57822)# ,] H #_8E-]J1/_B10!N7&G%<_DM(6"25_
M4))Q$< ,-545(B54.LA J$E,1J55[D> N!9/Z"'__JS6;"U(.#K(.'9CA8
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M@!JP*9YXA0Z<IE<^0]C84@BPJ9M^!#66R#M**5#.)#S^Y#-X0/;%WY(@2'D
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MA 6&QH7'A+"9PPQL!11\!I.!0)4\ !"DQO5LT;=$.8UY,BHI1 $D-KD8X#
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M)<"*I'>]UW\]V)_ORPR ^1[J:ZKO-4X,;V6%!U@ \%057_VN>,X ::"$Q<S
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ML5D7H .B++D 5R#U7N:%@28+(%;]5F5OG"( (,3#UN"T3Z6SN3Z+A^5#*%@
M 5+_*;X95  *D_8 @-62 $B\1'W2=I;M DZ6J/C&52]/<084T$R=A$<?(CKX
M7#!PA6HK .;F?0 D%) $2!Q!-Z9IBA#15A4.STS.(ET !VQNM1I=V%5OHLL(
M2?#PBYCC)5[U;;D9H@"YAT !PW&>VOGB-Q#)?>[V:D^U^;++"L2,[PJ@NP$2
MD0@GVH6KF@5G)NT[\D1B&@.:=HMGC+9&VS"=T 7(@=PY X 'C-X P*R=X4/T
M9'G00PV:<I7<7?F;J:PC 6J@X7N:0_8$N"<X1MF]>W(. !8\0P':X<8N=_\
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MZ [ !& $<(\K;&,!_,)#T$,\KO^CB59"#:)FRIC'^FX(]  / &; !AR.!9(
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M3"C';PR@!/HE!1"/V#9 "^2A5!-E(W.F.-!0 60@ 5*@.5#V-]Y#:S D/0;
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M+0+0Y-M_I &A0%C8&.#! P] XIY2(#RPEV,80"'# S;H,^!I))F080(2056
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M[%AC96A'C9#G9&"!'$5[VV0)G+S\P6WX&H".X2;+M,N-;ED/P$RW'98M8F
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MU/  \\H 2ELVASL!/L@!%&Y:22#!/ MXKP+H!%79DLQ":H2!BB.E15J8<TH
M&3:P P$2./V(/)SU@!R8(R.2@9%S%A*<&<&V(JQI_[%WLL/@0&72-&H0#0=+
M1)E]P,X"['A>@3SN&CX[Q0(5X)V+25 KY_D1@-DJ0"*F="Y(C'H=MB -55X_
MV\T$5P;2&\FJ]</@_W[@"#%( @H\+M:29#,EF20!"=1@O%E5@/-$_ !PLIV(
M\P8-55:$XT68 @8T2AP%<#<!Z_GI22<MX,AM9G17Y:$#H<1@CK1-ES8D@P(/
M4 +.:30"+$ #/$ $W(MQ")QV2T"4(*D!4 86:(S4(  0<*%TT8]TFI9-:XV:
MRA>%D(=V.HCKT(M\X 8?(1J2(!-;V0N?PX!GD8SG&* "&2L+*(LF29+@::H5
MP"FM."B%T+JI @+SP( K>/^ ]5,&;H $/@*0#U"#L!()J<$SBM$N S +S@ 0
M<G"%;J@ "?BZ>Q&-+TL7N#J/H="+=]$/?;" ;9$?&'F 87B6TG@6[_*0#= S
ML$NLO/@(!9"'5SF0!SB7*\@':(@((>$Z 2" E,N+9Z"'BE,()WF2?_D4V!B/
M 9""AXF!*WP (KH26Y"M)'H !>"5&5 #&%2 T"B:@8"29I'"MK+ US,N$ @X
M\/B(^!,(=4F*W<, '@HEM#"''F-#"ND?/EJ_42N::5F<$N$*A0L!TV P&V@S
M'TP"'8 1FBB0E)M U+A&%."C$0 .K^ CIO 3G5  47DF[T <E'"%#TB$?]D+
MG7'_I!AHL>I:O:%("*N3@2GYCDAI$K#!GG"D$9VQ@ 2(!PL0E>0IK=<P "A
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M0BV):"2VK0D*6(JA#&0UL(.O(*"5&6A3BSD)(&NS!5J)#0""-_H(UZB2Q%H
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M^=DD5CN;COZND&B'1\&&=;B"%8WA):=PI1G;$*B^!BX:5/$ %" *B- 2WUX
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MP( 04BPD$,!B@8)\$C\"*."A@L,'!00 :"=/@8(9$P<H,*#@)(!Q,A14>"#
MP 8%$@KN Z",7H6" @04)+!+01*4!4 8,)!@P/\" P,2J"F@8.J#H@OVF4OP
M0.$"DR%-&("4D2R] N1 PHTK=R[=NG;OXLVK=R_?OG[_ @XL>##APH8/(TZL
M>#'CQHX?0XXL>3+EC_EF#,A<H+)@ 04RRT IF9R !QX6B.8L^8,'LX*AV!B@
M>C;MVK9OX\ZM>S?OWKY_ P\N?#A>TI]E?$A-7"&Y#YDA2E:  </,Y8$+*'E@
M;C!.E]:_@P\O?CSY\N;/HT^O'GB^ LX';/^>S_-SY8Y=+4B09,;;]7(%)%!
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MT2+:\VSK_"A)P<A/WV2JHR5=:0JO2#.* N=F;&0I37=XTMZ(+IPUW:D,D2C
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M[."U;)QG>*&+_\7D6[+?,NW&$LK% /&D7OZ?2NI&R8T+7KJE8*[>2_+& R2
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M^NA'#  )^ / 0@84/ 2*#0 D$)H";(#&\@7HJ8&6_FMNN,(,% 7I94!61,@
M>$"_3896;("4[,, Q "URH7PK6M$#-D& &N>.D2V9@>3V&P9$8!#0 -T@-Y8
M?(1T=!3AD2S8\&56/AZA/4=96&9\(!\[*  07%$0@ %J (@' *O;%<1F>(9]
MKFV="II)'%0;"HWC_UU!$!1:6<C99LQ'66P%H6F%?:I!Q98=X;&EY:'&A%:J
MAH5 / 1(WPK: E#: L2 $O2$":RJ%#P$ %"%#)"&Y154 9B &JSMCMB" CP<
M7%"%V5;$23@>Z@J$ACVF[(9$?H" 8WK'1P1NW$JNVD*:AK$$A::-VCXNYQIB
MJ"X8[(I& O"FQ :8Y2EO61AN[-JG\/V)A$8NVWZ X;)N?@C? FP'4J! $B@$
M\+XM *C8HA;4 O" 3*#N K! AE5OW0U #MC" \B##!)O >0#.5S%%<@#]3K<
M^=9%!51 [];A ^2  H"!H"7 !ZB= PN$\/%N0?FNZQ*>#2B H<E#/#CF3/]0
MZ-KN@]YB -L^K:"-@.0]Q0.0KK/X[N(27@B8;9?ZK=8F@!1XP HH@ EHF $H
MJ@'8 DI<Q?L>U "8@%A,A>,-L.0FF=]*KH9);GM &LM0!,-5)^(.V524K]^F
M<!._[TG A*7!!%540 H<@534:=;"QSBL'33<KA;;Q8X07H<=Q0><+@;<K D(
M7Q+@[P",@^5)@8(E&06_+U4H@ U WD3X[52T1P+8@*(^W&?8KV.&AOE69U4H
M@1)LQ4D,6?:V;0+<+A/?!44\WO1E<1M"\).R #2$ #TD0:4M@!3\<+]^@ &T
MAO3)1B>7KNP*7P[L4@][P 9@1 %(*O'I@Z&)Q0K_*)CH_D-(L"C<;G(!C  ]
M(#)-M"T1?W(H)T%U-O%:, UAWL8'A)X"P!W#105T**-@V.M)F 9J;$1KE*]T
MK, !'\7C30<](X6<58(\5%H"R)D&KRN R!EUC   Y  4;$ )R(;_2L<10 (0
MJ$$W@,$1'(.^N7 =ZAM&\*'\ 2OA'<,*V(!.U)B^F<!58  8<$ %M$5$2$%L
MI*@"H(!G!,$*_.P"O,-T2("./8 $P-G\?01'O,,:6N*2V'-19(8!V$!((#4
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M"-QS=<:$##:K-]>%Y=VS]%''XT$"M2Z !00V:@R 0V# SEZ%#@S .B2 #BP
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M=5J $N!  D!!(@CT 4O!,#P &&" / #(,?A]@+6J+<Q Z,F 0NBWC0$ -!@
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M3. > 6Q@01;P# C(P1"M@.$=O4I 7X8$(Q)(P2<?2XQ5%N.3_G"D(P_0!CL
M,(*XF.-6(1@ #T#@J%:T[BP/4$(%KB"%!<G#8Q5P4$:R8P&))( $H0$ . K
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MX]+" $9 5Q) 4!KIYPCKG$9/ EYE0=@+"0?P&=(""%+B W!I ;K!4:8J7SB
M!I>"&X!O 0AC9);C#9ON#9,@I%CL-- ()11 B@" <13@$GNQ)-9I /8!+3H$
MAUZ#/:;GW$Z,!"P%*33"ZBR/*9O2*=N'.63 .Q@/__*"Q!R>(0@4@,*<*C$$
M8 ;V1_1<HOYLI4"^1P4](V-ZHE)X!&<>0"]L  1<QRT](S_.8A<$HC 6;%"
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M:(M./J!$K@J)P&I#:P(;A )ZL/1E*D4JAJIQB 0CFL;&#+0_0, &;*$;[*7
M<@!E,  *Y./$*L7ZF$-),*,$4B*0'") ;6-)\//$J+$F+L.+RL0"M*#E[ (:
M/L 61"<15B!)O/-4/$Q0V(,#H&$\%L(<Q$\*',,GP"V0S/,!VB'#!. O5\
MVF'_'7*O278A"8Y$22I 3!;@2,0M7VS 5.5#&7.JD4!P.DA3*@Y$*$;05F2
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M& 6";[#GZM?FVI=D6N(P$.5E':1^IZP < #JVB$]?*-G'R!T[VI0R<EM_Y<
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M!,9RFR-/)*HI!&: >HO#J\3BW8;YF0$$E^385MYA?O]9KOXYMUIEG2F:D$<
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M)R3$C\6D0![ (>%T0"E0(+5?!BV-" ?ZS?]!2-:0I (:*J OZ ,@!  82!!
M@0<5$B8H $#  @-:0@PP^$!?" P*!A P8< &I 4"!!0(<J3"@P+YH%50@,'
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M:8@@"^S[QTU>KR^5%Q0YV-E0 1_(, #\"_J0FLHU$;/%"492R$W@%C".1YE
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M@6' !D2L * :98#]K*8U!$$EZBPSHF.M+2F[6  0<J,,*W$2F5X9"1 R@B
MX"Y.R@%J_IX4@@+,\C$C*  !>"D3.!8 #/30GU4^YXI=)"0'7/T WZA2QZXF
M10:!.YY79)"$K@S@ XN+GVA'2]K2FO:TJ<F'7Q$T/O_4UD< ( #)64;T1 $<
M"$$\_,^'E,"0!( A!^!8!S10),V,"" (UY)J8Z:&(:%Z@)8VR\D \O&,1 !1
M/:S!AI%B< 2CD7 M&( "#MB5H+7:# 45W<H 9#@0&] + "6908ER\L2D+0"
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M!3_?@Z2VF](JO=(%_Z*+Q&M:+*  ,:PAEXH<.G>D^#4@ I0@(9$E[]D0X%
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MY"904TD0! EB*=;T\NVK'(MN"SC@_@"1I   @@4!")"A8(,' R &# A10,
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M(( BT@#X'!N!2!N.@:(M&\#P8!@U@!H $B"O^,!&C1ZH4HUNS('+42@<HVH
M)^%+HIW+'MV1FP^H+/*!'!0B80,#$@"@@C.AW!. <(&$)(F0B#QQ)0..@%2
M/X$\ H70X K/(\9.K$"?&:8RR+4=AZF@)!,<!?GA!SQ(!$H,0$O !BU@2]5
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M#. !$56E !B0@LC"0KL0>& @H:I9$C!0 APL0"Y)  ^_:#6"_P%@%UK80 @
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MH#8%T()$8XWO^X ":"G]* $#>(!WX($'> N^(X@+U)CZ81$Q^2$.:#G_#]B
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M%@7,\0:^\.L KD^7,V_>%-L#2 J"A% 0PH"! 0*.?K#Z0=DZPR8#+S;[.:*
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M((H&D!4+R$!%*+B"K#SY@11!L&,).%%WFN7(-/)J*-JY(3 !D$,#C$,II_P
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MPQPA*YEUBM5 %#4N'O^:#K)TZ<R$ .]$P;QA5+12%:M0\ $U(T=O!Q##FU1
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MF+>=,(9;<AZJKLA"JB$+:%34(@]AM$4K<K&)>%.AVYY5D"]E1T@D?(V_N'C
MJ<G1?1]JV5L^F$<)=:IFJ7M-_ZEF&$ D L=<UW'C(-_W')T=;T6BF>*TMM>-
M'9J1A[0YC74""1Q'+I*2=/2B%)N3F$U61!Z;L9^L4%E#&NHKE:Q4I0Y5V<I5
MSE*6M5P?M>AGO37ABI/]LX&*)AF^&P;! PWT) J/6:5U8&-V#]+C,]/BBIH-
M8'<V/%YQ3/@S1M:/D$!<X0WQ%DPZSE"<P\L>K&RC#*1=#U^SP5K08"B8PP0S
MC.>\)C>GIY$H&A",8M1F,@$ZI106Y%CEQ*=&UN@^WDWF 4K &2)9Q((9 *6
M033'1)4"SBM9Y#Z8PV%OM-*.&;BE=M T*5GX.( +"3)[#ZF %&P4&+\\,6O%
M6YO^,O])QH *$C.'[(V,KH,N)67D-,A<B/3*""QY\B]GH&%.LZPD4V]6,3,Z
MT,DG>:B^G6X58 ;5I#>'(R\ 5G(WT F-4PO24#^&:2GO 0$($I  ^XB.!3*H
MG ER4+D$+4BBZ9%'@7( .0&P@'(+*&!03/"23ID@/=^A'&,'L* "?$<&:)IL
M8%G6C20D  3^D.M5.^78NU(NL@D90 Y&(+O/512B@\6&6SIX4MF&)82>2@KX
M<)N0; JMD2"-DD8%0\ZIOHBWVV0J/_U9'.2,PP0D>)HUS_C(=1$41\C)*;30
M]EN6'C2?6J728;+U-!+RY4-)Y>IYU32X?"%N,3XEZ!7J9D__K-HPGJK\)T(>
MP $TN5<QVS$ PD 2 OOL!"0 M@!4%""G3C7L35$9\%)"\+&,$BS"#^ /?$#"
MDC=912G*4, [K,+7 0QEL .P14\TS.'!?N1- (Z/+4 [$!:80 $0NPD.,H><
MQ'3E0@68[6Q3ZA5CIDDV?'FG*(WC1.".\W!V\Y6]O-O-VNA DMW2,6^2AX$K
MY#2.W1WN-X69+K]XM;5EQ9MM8MQ3,ML7O6V&'EFG!+<F?QF4_:N$+H4W1-H$
M00FL==7AU MH01=D*0;3DSZF\@X4*$,@!0"!GDY2E:H\P+ #>+2>)/VF 0]
M'T=A'9OR%(0+@R32D@Y!I-HA PM0_R4$%"G ,SA6DP$=I2KZL<JH+7"20"G@
MU/_JCU7,\8!XT&0P*JG02'XL6VG6[*&\V6UN/RIFL4%W33P*4Q:A*S#B&5=$
M<$8DG@F23C#7-VCO)*AVNTQ<C$B4HK/T[?DF$]X0D9=L2O8B.[M8Y^@Z^5<M
MQ%\]$Y)0?T+;D-$RDZ36G!$6C,!B27D/2PR+ZR0D!1L=-4<[_G02^T@N/RW!
MV S4(&&*$#;"(1BU 4PP *!@U-4#R--_$X YE^\G,R<!065GL  UH !D!6"Q
M2!;X <85D'-3"<*?"!3C7BZD<=1,]DF#?%O?5" &Q!KX?.FL+%X*TC'>->_Q
MAK8\+H^;S?]CIU^9LPLOQGBMDT#M-L'9>UR"%/4BUUT-NIC35]06< 8R,(&!
MY"'7C,I88WG%*UY1N]:,Y< ^,I!!Q,.'9+FSN2"VP8V^:<-?H^4[W=3V_%.W
MZ^VL@\_L239?0?PW5N1>/41P')?+IB)@AW-V !F< 7<VCKD"9,AC%ABP>XSB
M>PH;0!\9Q;C%!# #>8 D]PR4\0(:C)2@L,0$G3(84@CB<\\R#L-R8B !VH&0
M'*@APB NOQIDX&>LKT.$L7WZ,Z5I(2%S^^P$>;9VRYNK.4]-\W7_=U.Y:VW\
M(@><"][2CKJ.2(ZT:@&"P *"8.2"8M9 HBI,('0(8@1:3,,^IK+_&N)/6HW&
M6DW]I"LN9,5:]LF>R"TCWH4O DUQ6I"]8,F59)"68JD&9]"6]"4&E\[-I,WS
M!$#@1F]<]$;QI@3"$(8>Y&$!1@!U".P*DA ]'D^=!.3 FF3Z0J( V,%@0":#
M4JWD3@X$&&\^^(%1VF'$CH)C+N10UH$^U*"B7,;5A*(EY@,*)>5/ID+2J ($
MVB/:P.&UO,+'WN^9HJ[94@7@2.1WK"X(3V]%H@SN.LD'@R3A"DYX%@K,T XA
M(BEYYF>4*E$ M*ST1"_N.$\O"&O2X% _*B;1$HPI@D)/=HUB0D"Q$F)!Y*'&
M!$ >XD'4=(J*^F_)$D(SE,X7[PF%))$'_]%H]68EC1KB_J9-0S;QS1:"@/8-
M.\"!)RS@"D@-8ICB VS!81PF" ; *>*AU0CM&4!")#X@Y!2 *4JQ)4Y.3S+L
M*&9@@IZ!)6I,3Q) U4*B&GO"PI@.P[SQ*$H+)A;@0!X !(SB8M8*-.X#M@(1
M_D2(FNZ+D=2&&4.Q.O1'S]Z-JE8/%!5Q(XMQARJ#[2XR,SQ G;ZJ$[_&W(X*
MW=1$Y]Z!'%VN*A*@XH)B*M0@!V " UM"Y5SFTO80(7*N(#6.'A1%!!?1GR11
MWN;(,GK1&*'2*9F'C@0""*<Q\U*EIPC"]1X1.&0G ?2!):Z *B*N )8OUW@M
M+1\@ JGB\B[(#/]!("DJK+1@[V-PK2JD0BK6DC]F#@1&(%!L@6."0B_]:+(P
MC>?4LO98QK_B:D!$ BDK@L>2XB'U*'?<@@@OT7<VP#Q.HC,Y\S,],S2O(#1!
MLS0]$\1(\R10TS19,S5;\S5=TS7/\#-G,S99<S5M,S=A<S=1 &%X\S=[DRIT
MDS1K$SA_4](4H )(@-;,HSDC[3EK+3J=4SJA<SJMLSJQLRJ84P&4( 'S!^PF
MC]"<@D 8)P=F8D8^@">Z@R#QD5!,+#[V4"MD( 2, DXL8!Q_CP;'!7L&(EMH
M+3NODSIK[0K,PS<#]$ !-$$%%$$75$$9]$$=-$(;=$(AE$(!=#8KU#G_"51"
M,Y1#'532-F S.]1"2?1!,11 ,4"_ *:M5 H]# 0J^*0 _.$</\?Q+H2PKF_D
M(JL5K[ \)"S\_*0?^6/Y0@(]5*K'^.,O#0 :?HUB]B,'IF(O"2(<TR\F0$(/
M;11)"4) <-+0"J17;(0%N.'8W(\R;V?9'*1>AN8@#" %2( '2,!-X71.X[1.
M4\!-Y;1.X90$[-1.YQ1/^Q1/[_1. Y50 ?5/$?5-4R!1Z11.!?5-%;5/><!0
MXS1/)U52 S52 753]51.%[52[W12_S13/352+_542954\?12^51/(5544_50
M%955^110,=548]52-557'Q55+]508=56.556_QVU5@LU4X,U5SLU3SG5.T6Q
M)?6B$85Q( K2 3EN+*NO(#X@U$:.)X_.12M,%OEB!(RR.5GBZ##SRQ*N.+)%
M&^C44Q/U4#]U55MU4MW46#FU6.^57F&U41?U7T458 4V8 EV8 %V5A&V7S]5
M81GU51?V51VV42&V7R<V82=V83&V8?<57R7U475U5/.U53>V3DE66#G69%.5
M43'V6"G54CVV3S%57_UT7D^V4FWV5^,T62G5 V)N_Z8+!@<-:/^&31(@Y0C2
M8MK#T4""'ZJI4X"2^Q;@&8AT 0@@V!1E=*I5 4XN/QO#' 8 86A"!M3@PV9B
M@_QC( L !^BSXEB,:_^)0R;>8317#2H$##(!0RO,P0^=SDP]**6TM#>4LU4%
M=W )MW -]W 1-W$5=W$9MW$=]W$A-W(E=W(IMW(M]W(QUW(-@,MRRB//;BY*
ML<9<YFPC)^1 9BF@#R0@00,-8 &&C#]DX,34X*]JS&U5$NNLR84P<4\SMW=]
M]W>!-WB%=WB)MWB-5W*)#?-\8P9NXM;<XR0NAC^ZT0)D@%$B!S[V9 DS+$].
MQB'\@P,+!?FLM'6;5@#6D"5T,C-6#1MI(MB.@D_, 4H];7) P@3"CR'H P4>
M0 W>H0,> !H4,UJ0@P":#BSX]DR[PE+L5C#(X0/X01D6X(&?(8*588(E6(+_
MG^&"*YB",[B"._B#.1B#-?B#1WB$*?B$'QB%(3B%6;B"3;B$73B&+5B&)3B$
M-UB$99B$-W@ 9EB%.5B'9SB($R2(<?B#@=B&>[B%@5B'.1B)C[B&H=B#7_B&
M91B)>3B"1^ 99$"+=UB(HQB$OQB)Q5B"98"*B=B,AQB++3B+%X ;VB:F$ (F
M6VT Y($L(R<LD0(<"H G P4%- P<!V9D]/<?!D0;K\W;7$.UPK&&>;B,FYB1
MO1B-B_B+(3F+MWB+L]B2M7B3+YF3/;F307F3(]B1^4&32=F45QB5U;B3,]F3
M6[F56?D97MF59;F63=F6:QF4*UB7'SF'39B'G^&*_R6XE<?8C)=XA(_9EZN8
MC%.9BWLYDM=X@H79C,,XC*]XFL\8FM.XFB$X74,$]G*M0.1!*BP@+H<4)(+
M%G @K@)O <#!O\8Q/.YS)IB")ZH"KM3SULP2G1_ '^3!GP6O#$G,Q*""YJ:P
M*H(@/*I"'O08P_3!%@(O 0(O4J8T/VQ!HBW %@1++V)G=M;A@&\GZKQ9>=MI
M:$WZ6=$EI4O29RG%6I#J9TOZW$Y:I7N'2&A::!?IIO=O[*1'IUUPIX$: ,\J
M5'#)5@9GBS:DJ.^'(W106E^C])($(99BHA8D!T* / =@1E$@*/FR'^'P8>0*
M/09$Q1#"TB3M0*X@".1!ZO^H2B/YT]V"J7F"-B\&AZEC&E4.(J\M0Z_Y>J_]
MNJ\!&SRC1J_3)7W^^K /@C0".[$1VS(4N[$?6Z]QB=YF.J;/Q:]_]J@K&Z9/
M.JFAQ*Z'FKV*6O*.IZYI1:D5Q[ =(DNR1$R*,8+ <C05(!Y @M( Q&-(#3DY
M;(\;,#[@L;8IFH[OL"JH(D8!<M=H$G-D@+:SM10/S 0:C4LU, 2,FR6HPD"M
MPBU'QO=R@&3*%R,VR"W  :1M!TWG3UU41+FB<KW9N[W=^UD5PG-Q-X+^(0FQ
M00#:Y ''MV>/]@H>0+)XDK\[13_6.B'LT(\!Q0#H0<&B;3_?^\$A/,(E?''
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M01A001#%80""TO)H 81"#?[T9048<K1 /B9M0'27Y@HPPP-&DE< "+P/L^P
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M,!@#R(0F+<0 8?032H=8KSM)D8(%:%>^(TC  I"H@ +H!KSNG @%)!")]8#
M$AU 8GDFT8%,V)* !0JJ BU$F DV,+005&D "?" %MZ"@BH!I1M0\$ BX@$"
MGU@2#/3@$$^NX+\"<$,>6$K20@9%DGW8@GIP%!WR:F- X$F0>0](@4P,,(R7
MC22"&[@<1SPP#'6=:C,6U<):M&"#!T B$; 1@ F*4X!V6-0#+,'EK["XM;(
M98"&K9\-"(,!/'8J*6^AB1PA0;O.!05O^=B7/_$)'<;]!*"B]98Y=(85%NC,
M'$!#DP"H^$FN@#;_KMX\(WI, @;D0?0?;N%L;1!X50L4IP(Y@()#W80!>C *
M VV)0>46  (;I, &"L@=!3'PD=Z(U(B"L4 !  L%%#"5?9N\@@W*ZK+.->HM
M4," 'M67PY;U*@,5<%,T'U,!HQH -$#!C1:T!H(5:,$UB;"!F@2CA&$8( :A
M$PA,<F-3#&GNM&X"00*4\!8+>$ -RB!?3$ KG]O>DY_4&58^QO:,DH!@: J
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M^SB4\E=L#<8R3 J7$'2BUD,";CD B!2*P62DZB<H[K,A"Y (*] H3&4 8JH
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ME6\MH-?O>_COB^858)%Q\0$R$NNGR?^I?P#W$[ F_@J<R3_@[J-MP/P89##
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(8QWKT(   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g29172bii002.gif
<DESCRIPTION>G29172BII002.GIF
<TEXT>
begin 644 g29172bii002.gif
M1TE&.#=AWP1+!G<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M1-U82#7))+G_*9(RRQV1T*1-HIWP>=Q,"C?QA,-0BDZ<+?$F@L"Y1]V@DYP
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MFJG+(CQM-8NZM>OK4L [8#!#C4%D1BU/9X,JI!S/TJ8LB%?[/&UJ5]O:C;G
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M%M<EX"FF8BO*MMTT$DI[LL]-HA12Q'%AHX@]-+85H1U&R?]RY6&9,2" .L.
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M"EKO\86]",QN)9A;C1H$7A0'SM6D7,6?G2 .\AK>M)I^E=J7A0]+X<\>;9+
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M/[W[:V\*8J[1<2E <) 7( "\  ()!FB0T"!#@AP:$A3A\*&(B!PF$JQ  P,
MCQ]!AA0YDF1)DR=1IE2YDF5+ER]AQI0YDV9-FS=QYM2YDV=/GS^!!A4ZE&A1
MHT>1)E6ZE.<%"PT7BN @<?\JU8()K4HM6#4AUXI8$VH%&T"K5X(-S5:M(& (
M4[=OX<:5.Y=N7;MW\>;5NY=O7[]_ 9L,8>'!V(@$28V=R/4PV; ',Y[].M7@
MXL58+T:6V+"A/P$= X<6/9IT:=.G4:=6O9IU:]<^+SR+V%@B5K%C,9L=6[4Q
M98IA=3\<N[;M:^/'D2=7OIQY<^?/H4?W.+CP0LC7X?'6+KFKYNS<2476C!OS
MP?(8,R<D+IU]>_?OX<>7/Y]^?;<7%%C'[76\6/WFQP,K,?,(*@PLC*RZ:C?R
M-BK.O@<AC%#""2FLT,(+CT*!L*]^$XX\L SB"D$$R]LMHQ#!LBQ%SC3Z#,,7
M88S_4<89::S1QM$NV&? K6R#R"'K*JM*'K,L<FBJ +G[CCP?#[JH*XUH</#&
M*:FLTLHKL<Q21NHT"X] QTA\4K&KJC)+R0 ,O&Z_@4SL+J%VU@)-RSGIK-/.
M._',\RZG=OQ0-ZT:$BNX#_>SBLTO#<-M/3T9;=311R&-M%'J$(N,1>X"Z/-+
MM"+S,KO%#L6TS=H\55/! !J45-5566W5U5>EP^_4BH[DC[]9.T340XR$] TK
M'P>M2JQ%82W6V&.135;9I"@M,<4FC3Q0,_2<=8PVR(+C]$"L/)-SV6_!#5?<
M<;]URKK;*+*U1UQ3%)8R=9U%E\R"+&U12G+QS5????F=_Y)27TGD[<,=-6L
M+06#O2HR!/L,4TQN7>Q7XHDIKMABZ'+L$]#:J.),7E\)#50WD*L5UB&Q0A!
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M3[$DRIS2ZZ=:;I2\KUHT*$"*[OI>\ <]S<>N"[&T[ 3#RW;@Y?-<2WP."^N
M\ EA#7B22&>NA6$V2ZK +\E\8\K"JB$<@".@, P[S872;)D&*\)JYP2%)($\
MC*D&D /%, XKK/V\IT3HJ:#RR[\@2CS::POK!P[E,!#C:_M^I VMRU>,L/5H
MYJ/$9Z:,:YT$,1)WC%+P+]IB[%08;5NPT(CR:7EXRN-^CR >3Q))D<#P(TT*
MI=?T UX4,1$11[C8K(ZX;()*L18M+ 04 !5SK8Z$J_Y(K=?V[OX"ZV1@B]5L
M\1@'C!#/A5ZLBYG_GH]US.A2<"U1NHK@'A$9L1&^VN]Y-I'>'E!:_L]AD.?
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MWSO?ECG9CS_+4N06D'EFWD2)@S]DX5<_F9WB#(;  'K_#.P ^'W? 'A_^,_
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M;* #'PC!"$IP@E"#P $XT)7-6) #[<#( 43 P9T$0 0%Z*!Q(!  >,!!,!
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M& @ P1))72XV9^"$:JR"QAX!PBB>H('!BF"X"6 L(?.: T8T-LAA@ $4*H$
M;\(C %+^B*;?:ERXIN$)A\8)$F&!!B5D  &\;H</ETR&- 2A!?)0;!Y8@=&1
M1( (2!" %^8@"2]?!(5VE< ,PB"&1OA7(JFPP124@(-T'B"%1SR!#0 QX0 X
M&P FB$<U;BUN]AYA%(%HA KV_4-VY*"XQD6N#I1,$\M:HKBFV ,W(T"&;E^W
MSQ6)@!J0( ?I\O, I&C'7=G@A$! PM/C?BP@='##@/MYT\1&0"K(( 8E2#HD
M>86%%&@ B#V -B<0.,*]__>P8"0. L)>T,'0@0#L+FA YA!IL VJT0B0-GO'
M+9' " /P5S<409@-Z+<EJ,'RC;17'10(Q,-):89%[ #(%1'R(L# U@/ X]DA
MH4(/LK ' ]3 $JO80#I-,%L=>( #\.  DZLA])FTEPRW*$(+1% &-8Q #Y(H
M+)'7+1$JU, 3Y-7)#,;A"0*K),_D6(4'*+)M1B@@"9+8)TWFC(540\3-8V]
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M=F!-WL<'BLH W[ /^Q (V$5U<:%I,! (FZ">.9  C+  A?G_!$P09J@* B]
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MP# !GWB)MB=:WB #S[  .M<.!S //K:A<;@#/\  P+ #,%<*N>#_ XP0!RP
M!'-0 @"J>1/  %J "<<: /#W#1,@RF\@J1+A<5E0"%3Y6>D$ 6H GT-WBWZ@
M!*^@9XSP S^ "?Z  KSIR)A 50U0"C:0?R.H@'S0!R<LGP2H!SOW3>20?R94
M6%]@ #WP8#WI 2+0 V_@R RP $\Y!#T  UOFHTT #*"\ Q>09'.V!'SP!J.@
M!=50J?"X ''PD^FW?KF\ L '"_,\ L"@!68V!&&054DP8@]Z B@ #(3P#0N0
M!'$0 YG0 V)P"_ HSWBWG06H!<  #);@ XZP<_E;"EE0!"@0!5UPB$@T!C!
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M90I@6J+'!5Q 9EBP A<*6Z3P ?%0VJ<=Y<+[DB'N!P(0W2Z&U5QGFW;LN0D
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MDJ&9%J&3H1G"0(-.0BE! P&(@!\PL0=1P<X/71C@!^C0CP7 X"IP,$,N=H0
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M$D0C]'DL>0SA'EO8AP4.)Z?9<0!E+K@#1D)AB<.!\5C><P$C2G""33'A!CG
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MP"P$$+B!16""[OD>'7@!2.LS[*A$&,B#']A+6,0V,#J _LFE(0B#;WB"$+B
M*H@O=B,41B $6-R(8@B-#$HX#X  ]6LXAE /YE$(-A@#]'*RA6"'+X",([B
MG[H?C\N$4@@&+1 $.I%,14(Y%)A!%' "1O^8G1JZ(42*S5?\ 5S8@4U(')""
M #: A<0# "#X@BZX B=XMPGXS-!D@0^ A5M &C.0!4'0 "[RA"_B2!XP@@NH
M@ IP@BP(A&.X@B80!!)+"5ZZ H9#&EOTAD;P@*+@K"P R1"(@DDXBQ>(FPF
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M2]V -G Q2/BGCWN.+<.:CD,,C(HV*OB$M:H$BNDK'YB#A?2!%!S3AZRR)TL
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M5KT"(F4;(P:6Q&Q3@H,*QFUSBI0A(R1-OQ\,)I2(\8 (%U,@"D(X,L9-D09
MD)!DP&"D'DFEG B"%(-'&*4V+5EX\A,B !,G8 $ZE@$"&QO[&/5C($2!*0V9
M3B#)LZ< 5X@B@.Q+0VA/*5 )''F $"'>OB>21/2PE&:!S0EQ/'#@*H((#$%,
M0K@S$L+() 5*-IQPXJ41#@@BK*#_>:*!AY,IGQ%$8.<#RQX$0"9Y0:MEGP!
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M A:"!H%4P.(6&E!4*+Z@A$I$8!PG8FX31O >^,KW(6:0A2"TTP.7K8 4$#G
M&D[$AQ"$8 2.V\,_PE!0!9\M5!DP0Q,P\> FL-(1U\S6$9( !M8^A!TC(,0K
M8+$#U & "@4CF,#B1(0O,(2-/UAN.UT@!Q;_9&(1M:U"A"L#@GM8V*LCJT$O
M3OK54M@@"3KH@!FB\(4=A*"M(]"4&LB1A] .=@<Y$T$-0,O6$8Q !QM0JD\T
M9*LGZ""N5YLSG>MLY^< P09/@$89A(D%:+S@+J/H$0+0"@,H>( 32\UN'V0
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MD0C![F"> HA!&99#?$0!=*G(C##!O00%84%:!)0"'"Z!Y''B!PP"$\R70:!
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M*]3Q&I-R*9OR*:.R^D+@&6B&.T"&MU)!,1C /V@&"ZB Z=[%%(#!%WM6*51
M"!2#'1#I!QA !3A "!B ??S!&1QS,:C  _AR%?A#!\ H_)7"[?E8,49;$FA
M!FPJ'=3:<QBR2IC&4^S 'B0*XXE )APSA$VS1&6"$?S#+T/&.H\#A FSZ9ZE
M+T.8*^O,&6! (BN*/-R#"N@,%=R#_V:$P#1S*$!;Y".S@E!2P1! &##?<B51
MB@?$LP&\R 6! AYXWXHD-##'0!0_( ^,= BP -%1Q;X9S!3"0SD %"A#PPD#
M0#F4@P?4-*-* #24@X;$=#E  YO0- DQ*DYCRYKZM%!#0TT[1#L(-5.W0#O$
M=%,/-5W0-*3-)E,[]2;%= L@-43  RI,-55S]52OJ2@D@C'L-%1;]53O)U-:
M]0;8*"@SM20TQ%9[ $XW-5USM4VG<F +]F 3=F&WY- D!-]]6]@LP0^,@@^0
MG2&B(Q!4\J?*"M1N@V5\6_PQ0!YTQBT 0PY@ BY8 @4$ I9![M[,Q<5!6Q14
M@3MX@S5QV_\7Z,(+% 2'S)T@VP 1%YUWJ*?EEO8VA)!Q1<L2,( %W$$)O$ N
MN8 %J,D^$>70& <%Y,%C5-D7I,BYW$ 6@$&@)(84R##?=, ,1$$R;,"/:$%$
MOT__;8-S PHYH<$.7-\\G1@<J!]$P<'[3$(<8@$8J( FA7 3W(T%I '.&$ -
M<,\20,P4EH,H& ,)P0,T/()8/(0M),):>Q\HJ\(RI! HG\):)V&#/T(1 @ \
MB (T?+&&7[@J&$,B'$,*-7B+7_@FD (TB,(C/$(B+ -=1[@JX+6'X_@C=#-$
MV#@T)((HQ):&HWB$?_@C&,,Q>  IH((J.+DQ5 (I-#B+ZSB)@VK_EK/XCB>E
M4%/Y6CLU/*B"CB>"EGN 6AO#DUNV8<-YG,OYG)LQ-\F?''C IO0!\7F4#]P!
M&,1 J3" [M6%S6',I_8);^D6IWK<9%A"'H# %0Q!"I #%C#!'W#""7Z2L7V!
M+/W1B@P! WI#(\Q7+K+4;5.RJ##>"8P"*85&((P1U+Q7+O !,L2 C&F!8;"&
M!6R$"@S!#? Q"SS !T2!%H  'F5+>)%( QB<%CA"!Q#!&R#573Q!,0P!$3R?
M"I",)8B:K6#"89#!*#1" Z153D S5.B "K##/DA0"Q@< ZR"<HR *20CDX'!
M'SS #:C5X@J8+"3!"MRZ=6@%%5#RFD2?_UBK-8S?^#*T0%J+PC$\0DU+@"VT
MN"3,II$;.8<# "K<.,$IN89L]9>W@(F+,98OPR,L@P=D0#F@@HY/M8T;@R3$
MM([O-32P-31L^(3,IBAPN"TLPR8@P,7[N)BG?$QO>$*60R)X2$_S?"7@M"BP
M C1<7%HG@B0(]3(8PP;$>$T+M8Z7 SPD LJOO"A0^3& -<^/+9VK_=JS?=O#
M[P&8@1-@@G$)AI_<#A#HCL-]T0\,$E=0 7=4 R&T!WGH@ %IR3P*!A%@0AQT
M@!4L !2XRT6J1IG$P^-'E#UYPN.I*034HC<P;%!@ L.,#COT0JS@F0TH 3[@
M@@PHP51'C0@4-/_;75<O>$S(21T5*/Y)'0"4"<BT$O2+"-##5 *IW9>,((T&
M-, 'V$'=?H!W0@(G?(%YFX ?I+?$# $U;PB3E< 0 $$6V%4N8L$*A 8>;$"Q
M*($=. 05D,$Y7]PZ8T &=!T/^,$G14DRE,!*]G35%T YG,(CQ(+% T2Y9<>@
MJ3I628(H5<8V 2@'+5&&4\LV $"EZA&K#/!0+9.$ $!("1>-26HGH9PH8QM0
MB7HDJ4"[<A,U@(17\%@+>+82+5.XK%+*1!H*.!1UK(# 1$53&@NJLA(""0F7
M+4/0<5F!A(E@ AC9,T-(L:AZMD  [V$[B)#,2H W4=+;1)NF%ES9#I[_J$20
MBHKU^Q=P8,&#"1<V?!AQ8L6+&3=V_!AR9,F3*5>V?!ES9LV;.7?V_!ET:-&)
M(:1*MD-2R-)C"K$X@:9$"P 03CC!8]:O""!3&"T -@'8CA(O3H#"@P,D #9?
M,'FP\F-56!,GR*WR,)N(EN@(9O184B0L8 @\O#6Z+H'=B.@A#[!+5B*\6-JC
M\BRPQ C*BKZ"1<A[0*4'2[#0@(<PL "A  @B&*2?.$)X,(I13*GIKP,"\"^3
M/JI1HI)4HL#" PZ.L&&5CP#H[X$'2AE#"%9XB (U$\BPA!4. #C OP?N\6,)
M)OXXHI<2*O%JABT\ 2&%$4SYHX<QE+C@012<_TABE0*2$^O"!S(Y81)3@N"
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M](,)%7C%%MR& Q&<P!*K"$$4!$$4*J@!#9A 1@7^X00M-.)%F)"$UD;1B!<
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M$*) "SR!PE(A%Y9 Q$)"IQ0@#03A G"! 93@'Z) C4P@'L[H 5K&!YCO%E
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M(][A01[B)][=,[[D-_[@/Y[D[UWC[=W<96 !ON$-#."DZPD#<"%J$X $\D$
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MFB:6)MA0R=:!7$J5ON=,7WI\>VF"P?9?=^EZ4_ER.28\GSAOEZD&H^ ")"
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M$R*@!EH@")O Q&P<!#N]$R( Q KP#/O NC]A!E:0 'J@ =IJP,"ZHC- JW(
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ML6VE"YO3TK8TC>BH;6^000"R.$E*SH11.<A' BR@R02\IA)P ,(D!+ -3EK
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M0!50P.P7J(M6<E8!S)B@J76)H <CR#,P,,V ;<LF M@: 0-V\.L,R>0 1[C
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M*D$!)#K*DT0JL:NM6< I!+^4<*O(RSFR2C[+P\.PNL-8+#\J- @J0:RW:<(
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M #.(@D1SBDRXA[X@SA )SR68 S#H"UE3)A=( !<IL#WPC@_H@6KHK0V)@'A
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MF^)^AL'VK$A4A$_AZ[J%"-NY6D F?KIWY,\M)#SP@RN6L#I"Y)N4K+PF_MK
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MBU08@VIH!*WH@1SP+M[U@26  A(_ CH J2NP'E/8@TI(#AM87K>[J32 @MB
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M,T4LT\N(TBQ]WF2#41 #7(JE!* !CN6 L,B"+1VIY<@>(K $*46Q#U '%?(
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M(^.G:LL0>N .%L1 W3P8A[>>D@E_>"  IZDW,9VM C";!MR^+CDQ[^$/: ,
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M'YP84J6S_*BL0M'2O.1300LR(2^8)S!!"GCL6@  8F@4%A-3*DP"Z%W8^]9
M#O^<BRO%@PX?BQD<M$)/LTN_] ^UWP"+E3J:58OBXOX9UJ0Q'B^C:%T!(-0H
MFMP(*?*)$08>88&8#67=9.$A)(5^H1\JZT_7)FZZ':QN35)Z\ 2?L(! JT7"
M-&=!@!DL0DE=:QB$$DP,2UX<CA.L5)1R+SD$ AA$\3[,$IT>V;U091T#0;%0
M1K1]0 KD ,N6<@2<P"C<P;-! "<9CKMPB2?X]8W!#T&G"HB!9_O(#WA]V!(P
MPBB(@1R(!6RP@0T8#BF8  \,PB&C!90.B<KJLSPW[ZH9P1A(01KP;*@$-" ,
M]$RI1?FXA**4,E@'=XT>:()BK3KV8$.JY*HF%J*MYJ7__N ('V35= V"=.(6
M!F N!IY_?.;A*;?< MIX#.4!7ZI_'"78..,D;N ATB-^ (@T"W<585DI_  +
M+(^2'.Y0F((D< 00,"<WDT$68,'#P'4@!,$51,.$-80^N.F7R,8ZET1,1, X
M7( &N,O[/(M>Q\:/UL W) $RV-H!L ,,C#&YP((I% %._"N#@0%0S$ 8:,$<
M5 $*C  ,3&?#M4@F_%P*-($/M)/\<!(6$/)18 $8* (2D/A&NR<Q6=#!5,"E
M@%[/ C1)[]2U$L$^C#&V3M!<PC>73ZT$J#*I5E(!SR)_9*'^%2,(8]K?;2T
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M<\8)$ALK.UD,KC"(,?0*QF3K!FP@[[9F=: M'P1" /0A/." !T#A,X=F#!)
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M4, )%(#_$5;A!:S $I)"4[TA$%X11"H5!LR0!6* ![R! O(@#OC6T)!,QI:
M#X06%-" "?PM%IT 20A!9'!A02IS(G)@12X@!$ !!K3D!>3A'NC6%B&S!=@
M!L1 $)@@\1Y2 :I!9YM@(/^R\9KV::L !49@$JAV"'I@+I/DRV*1*8-588
M"?1  \9#""A-!$0R#>;@ D0/.I8W!#17$$"@=_U )I-7"!AD5LVP #F!#*:@
M??DV2\R#!R1.2JI@!;!$ >2@"NA6!6#U7F78@)PH.:-H4 ZLK=C(HM93E@+G
M5K+HU'J88SM%@G+MP2!'C0JVQ4(JGK8'C1;+ZOKHB<6I>E@,_]<\Q1*WB(*T
MZC9,8^V,*B-F467%F!8E 0)280P>XDJ<X!>O@")PD@7^ -YP;B5:PB]!(.'8
M0(V5X IF, WR&$:(0 A0="R9SP)0506-1 84H#X.8@9ZP ?DP .(4'!7 D9H
M5 DVP'#U  SRT#*BHD=SP!3F90@$8VK8( >VL0#@X$:Q,G"?#P*>= ,X@4X=
M(0:FI@;XH !#81+&! $B-1#$<A_%H$;<H0>4\!U/8!32P.8T!H3CSX[9E#_&
M,HV7 &U+P1<K6 W( 0]L,"%2P0;0@!I>($#]P *T# [240'P %?Q+@Y<N G$
MI$&@(A4D+MJ\(!#6[0-J@ L81"4^P/\)SC9*2T\$/H B&,X#4F$1ID )*B$-
M>0 6!*$0*@$ ND_COCENX:]!T#@,EJ 0-" 5<F$*,O-%B) 6A75JC@ D(\ *
M,',#1( (L@!LZS$"+C,/]G9U?4 )_H G<O$ZU@ %WD # AH-8J$#3 06EJ R
M<WD4PC(%R$  TH0E^J"1J\ .8@#>9GBK#RB2'FJ2(LJ2'.NC<@-CU5,2+TG5
M7"US+#:M+4>F#H.3  =YB"6'#-%O'.>C5*RU9*A7-J.TZD=BI2X3%>=RHM-R
MYOJF3);MCB!E\[.Q/<)<S !O,U/&%  8W4PF&#B%.XXER$ ,E.!&8"07RN,/
M:-04 *TJ/Z'_&DI:I862GME!XI(2%D69*'+5%(H (*N2#&K41,9 )H*W"F+O
MDH^@#Q(@'_) #X2;58  #;0,9FX %IX #(8@W222(K&@$E!&2V(8 $R '1YW
M$P[@"+)D$TB!"!'T+KP "SS 2+! $@I B"A23>V8#/;#:6#D_;J EGFL$?[!
M"J3 $5(:9L)Y&Q/.=\&OHN<T"TSA#V9UXF(6,(_ "1*4)+8A <1@&WHS#,1@
M%1RN1Q=A4@NO HQ )^= H:]W%7 D/<@!"R#A($P .N(79JA@M2GM8P:803[
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M#OU0;,WL0-_#>B/_MOH*9:_MQTY@C"7;&\JC$F2L>S^F 3X@!>C ^:#>L\7
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M$+" P)<Y  _\06H>G#JXF7  K:A=% ?802L'H$(*0O"'H)7['T8(@1TV#9(
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M3Q+W&@JEPAL>0897*(/Z&5#P)<A!"=)\ *ADI;:KOC^Y%4,7SED?57-)U]5
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M0MYJGV;@!$G@*'QJ-H301?)A;7[028A$%50P!%*AA6/@",!6?/*0"=DE FJ
M!$'P..]1CQ&  0B:=A'0 UE@4]41"C\ !7TU'_=I$)UDAKP:8O' KL9U?$TY
MDZ^)9(ZI=A 0 /+P  _  T1P*SC0  ^ /#VS W'Z3F:PL) @)O5Q $OG.4#P
M!6V"3BGA#6-!K@)J!C: J&RG56A''C\1!GBP 1PK'HUAM%'Q )F@!DYP"WM
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MS*%5&\MV?1Y-5W&HS75UG<]<4Q6YX )*4 0 AP3F0M>WK"M'TFT04=*JU ;
M,@<KD 'TZ@__4 &._ %2^MFR%MIPP*\FU\?C2<A*S:&PG0EY/2O3EJ2KQ@/L
M9@3_P,,""QX\Z[/F67&7_WTD](S>YPEC]N4/+KJP0E "=I )V5FLY*P"RFT%
MP$"L: QDV$MH)DF7QD<%5NV]/;, A# &F<H=$W=?_-5)<\ "Q3O&;RJS*(8$
M)B8/0+  21 ,9YH&>F"*N8Q9+J"I$\  4V"^K%8*?3 )VT"&K=4."HL$6J
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M!@]$Q&YZ  $<R.HF.)A%LT&<02X6  DGWHL<<4#&#093@ , P5;W0,+@J&
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M00FO(.,67(#&%IQ@!#11*AV@L,HU <$)EH*;T"!BIFJX,8I(T. +Z/:#)&S
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M<]T#&XZ%(#"!'CYASV'$#0R"$H"!'K* '-;()&+A$)C(DUP+LRQB!E0'%1A
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MQE\@03^4V1.X PQHP0Y,@@)L Q8$ 3)^KVI1@(#IP ;0318\QF4<A"=(PN*
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M6 (8// !(&"!0Q X 3"ZL[LFP&!5$2""#'@3@R$L1 DXL)V,[*:H*7(B"@O
M(!6 UH4B[(X,U1B,@V21A!2V00TY$ 04&@2E4G@C#7(HFS9!T(X/T4$.@017
M_38 !QP2;P@J ,(.R/; B^H@!B19Q!+FP+@@:J -86CF4:#WA22,RBJ<R,4.
MG/F H&B!&B]HE)8D<$0\5*(!)W#"\$A!!2 H0$<X$)\2)&$"'M"!$&!0P174
M8-91V<T+20WF":)@"F2)X $/$$'S_VRB@79 [0=3RP1'3D*%$UQ3<$'!!,SL
M=0-8).$N)@!"#C+U!]5ICG.I,&@15)")%-A@#B!(23R$D)$A,)$S8#  #YR0
M!,-QLF4A.8C7GL""*V3BHB8;J<BXV]V0#8$!';N =\D+L@!LK&,?*^]Z,980
M ]@,  ?0JZ,X< 1R%.*2$&CD9&Y061:\(+[O/.N1T$"-& 1 !%"#;0$T&(8I
MP/)>F"@!68^4-@,080I@J%<$R/"#/7" "*/@VVV*\8!"'DP$F? '?$V@AF_@
MP0.FTTH[H.>$!3CB!;CJ0K>*>8(O1,4$-1B#*1YU@!F, 1-[ $ J'/O9, !B
M#]_YD# S5O\C^)+$"=6 V6A, 4<XD+,V'"AH$A8(@+8)(22VF\&K"E$NR$7A
M"9(X4A96@8,#',"87NP C7E !DP$H0#F^086@F&)C'  #D?(W@KLQIMZD22(
M9;N,#7V2"0/$0,TU0(,.<  '(_4AS"*88PEZ2A43; $&U/A.*@;!B$:\  &6
ML82!<4-DLKXSSB?VT'DX-)4U6*&##P!A<$G%!F9J( :9 R"-;S"&:E"#%.!"
M PA:X.D/."') 4!<%UX$ =44KD,B.$,Q2!& &RRZT6"0,N+<L (H(N$D-&:#
MY!YUA#X0&< 2->L&>!"%)&@@ P'X !$**!6$R2<PDS1!/++@ZA;_5%,0Q\@K
MX  :CR< &@ W&$4@]B HC2:AUS'ZP!::)IMP2J8P)'=F)2]P278(YI&5Z0$2
MH, UZ$4AS$=P@AZZ=0")(M$#:@AED'.@@%5(0@3LZ$5O5(.)]L4W.EEZ !#0
M$ </0$ "3YK*F[ZQ3=!D,0L[^LT32"TCPP "E@ PP1GL<)TCP',#Y3F/9*+7
MB&&*&@8F^W9$Y7$&?P0\%60@,@=4<PM(Q(P,EF %X6M2]B5'(0N/FD$/E@""
M#+3-$Y-LN@XZ1*A<Z$$C?[6Z1$Y@ R+K.D;%S(110'.O6E6B1UEP!*8KJ(6H
M ,!K>FA!.^" /4$X'DI2,D4QOA.!52Y^__)HN(M/4H'M,VW[1=^B R:T]*&=
MEXX-Y/BEH **T3_4I!$;B"]D5N$^*'WH#V3]F27XAAM'02H\6-AD'V$<:$Z%
MQ-,WZ$.[IXX&AOKD2*IA#UK ;M N!N @ (Y /'"@D$1MD)XCPDC-)UBJ&L!@
M"+9@"2)*W R@U*8"C6!!*]1NVWKN W+A9;*CA@CC=JP)ECA,I@CC2,0@#B0A
M)3JL_&+$!&[@OB1A-CJ,\V[##S("]=B+"-DK ""F8RBF")=01A#@##A&8M2+
M":?08 Z  ^0ALWK $MKM@^YK!4*#_#( #N(BI"CC9ZH!$CX \B"A6>9A$59K
MZTH!+3R "M0AFO^JH *,P B<  V8X \6P^J,#-M00J^>X )>007@@52T+F$.
M(  RZTBTP!,TH S^9@ ]L ;&YX=&P10N( 0JH (NBG0"  B^(:2VA P*!P&8
M[*QNI@<$@:W\@13:@1%E!!ZP4!YJP 8$ 1+R:A24@"?4;I4,@AW@Z8K4C@T,
MC7-$C@C0[I',X&^6YV^L8RK S+.0 S(PZ';^1@@@:I-( JE  'NP( [<(0_W
M< GV( 9*81'F@ DNK=QLYRH.XU$PT0;X1@0N8Y<ZAP@6@1HZP$B\ ?2*Y 1^
M,>CHP!3XP!V,H *L1A! @!2P8^X:9(."[0A*R0.F@J6R8 ^&P!+)R@3_8@K'
MF"L0^  /&=(&%N!W,G'$(& BOB$)D,$.5"  2.4J!D$.0* -!D%[**-1-. *
M+J,18H"@HJ 7SJ0@.]$=/E$+JV$34D!2-BF^V(%U%";!;,\#S" *+&$"@)$'
MB  /5L \ $<2/H[S ( -1@ L!,4\T$,JJV*#$",##J"1I!+S)JF2 O'E'*E@
M1&#FPL\#B< &#,S%E*"GM/*@^NNL(D 68  82@L(YJ (. !JA* 0*N 348 .
M(.H*V.'W8HZ"@* 70BX@3U TM3%&3 L-=N!R$&TJV, )QH,M7VXP'B09KM';
MU"$.]D"C&. 6JN /8H #)B@3K$!Y.$ $/D$5_Q<.KN)(H!I$*R.D'29O"8X!
M>(A@-#L@%6;)X!S$;2SP1$K@D7YR;1H1'B!10:QH(R&!K%+A#35@(GS'?32J
M%_@R+^B@)T.#"'!A))U@"9@ #S_1!H0@KHA@?(8) N!D 9@@#RM ,S/O!5+!
MDJ;"L ;!$3R $X(0! (@ N+ASWJB"L_S =H %(0@I.:*?S*)+_N(R&+M-"DR
M#-Q@>6+4\CQ0/RYTY*"L6>)O _@'TA:@3>! -1AA#A8R#Z,@ U]A=3 !#/SA
M 8;38(QD$%XF-%CR.HI).1NA <A "YY@*?-00:PN)%D) "R#(Z\T# O&!.S+
M.2! /;:I,G@-+ZB03O]%9@BT0+SJE G/"PH]1D_K-#G^ 13[8!*\X(G85"K&
M)#)>R I2;6T8TQ(@X:.R(%#B VK@=-?"S@-280RD(!]VA5@R)7QRX9<:()QF
M"AK5Y X8= ,B4F$@(#D<8%#WP0O @A.:X"%]% B<P!&N8 MR(!^\@ )TA5W^
MC0.LE"LZE!#T"6KBC,_\X#Z\E 5VKPHCX![RL ?41'E>0"\<(5%E1CX;2PDF
M(S0N=2MBQ%3<X!CXYV<H]0(IM?.Z252@9"^O]*<2P(Q"X]R4(&M@85=T95@%
MX2XB:1\LX)I" +ZLX@AL ,8H(TIL@+# ;J!PT HL(19(X29SDBN>Y1[_(*?_
MJ.-?+2 CRG/7JD$\?4T6 D'BSF(?:8I2ST80ZE$$O\$@]((&MN%?F8,:&L *
MQJ=9C"Q>\/4=8T L2D()Z@!:&B$CIT*W/&%E&H\B_^3YR"$?/G57TB C5@GE
MRG41&N-5S6"M0" \- $%L( %F(@:6D ET"(U+ [CP@,/6F V!8-D(0G8G(8V
MFV7@@FTQ-($'SR,.2-9,)S;(QN<*$H\5"LD,&A,2'J /OH$5VN "=J 4;.H?
M_* $-"!!=2-G*2#SK@ [0\XJJ""/,(Z@U&@/&H#7ZA9ZR& ?W (?5D %2$4!
ML6 #2*4M,6@&ON +#$X^_. 66J/Y6D(/+N#2Q"(Z_XJ#\,C@%H@AUA#7.;,@
M[23@09)@$Z93%A[R\DXD"&) Z78@YLS#9(?@H4J ?W3+#;SC51-"4(V@#YC"
M5M00#2&%G+8I G*! 6QCZX# 9$DV2K*')\1D"V@V/^@ 9 $V=U[-0%W(0T!(
M#*P68)NF 6Y@$7K# _=5 P;N]V)@.[TV8P[@#&2U L9  ?8&!WZ2?^"V$N"
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M.) U+.C  X_,02 <40DS],"+IWK %I* B4H$ "2.*%=,)L *.)A!,0D2#!;
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MNRW!S><8&E7H$E7TC<6T(TKN(P@6L8 #)V*A5_+@0*0#\$;-VJL,=)SO$(B
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M&3)L0U!",A(P&0]BST2L(LF0(%H"$B9*;:LF0W 0"A2!LU@Q V25?;'[2"[
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MX0]T&X%<,  2V+;$*E*=H#",0("_?DU)S^"!*W53#\@H@S=DRP$ R.,,Q2@
M3^6(B54AP 1J,.74FCE!"$SFN!ZX@1^Z4,;[W*,^R\ED"PJ]@B12@0S5&*4:
M+-&%/!Y@!C9(PAX0\($SU$<H'_ #%IB0Q/0Z<;_Q3O5%0IJ!52=AN $@H7\D
M05(>D(%9+[#<"<HLB:SX0-X./\(JEXZB5,""U,.Q 1JV^)SX*D6."736![90
MC75-B @V8'D 1(#S)@_Z!DX0;@-2_P&#'6Q )%NPP19OT =3Q#/1BZ8Z&;)
MC18@'0C5,)8(,N& QF?DLJ3PF=2?X+%M'@$)J[/<!U"-@,ED 1(/.,$8KFZ"
M&PJ"&@4@#!H$(IQ4P!H2^ Z*!$1P!G^$Z#Y 0$-5@&5%.(0":.K[]@D^+PF1
MG!HD0EL\IT3 CNPQGPH&L'E)XX$%0I8JY@@PFDF%2W (J,$&Q58#';J@ 6A[
MG*<E=7HMA7*#;R2!-,I5PM;S381OT+H=L?$'.T ]&"B$%? 927*O#6@*5?$
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M %?$@TK0T$VXP[H02T; &OK+U$TU@E%@A-LKJ3Y@A'WP"(L$,2)@J-=@@R_
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ME>R_*G!+D\P,8$FJ !C/1?FP _@ !]C'C(8N#354TS;A7:J&0@@!?Y!1Q^P
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M0):"@'"%P"# "N<* 0#E1S6.<  E&B6(J*L!HIIW0$)S'"<S&5+$H8%>?"$
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MPEU&@CA,2")[;=V :^/*A Y,6"T H (1L@"%%33 O[[Q@&'TL(+<EF(4.]"
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MO.):.0 &X",?BW-\)*;<3RH[WO%!0:Y 8TJ!#81@ 0KH 0QV*'06GF )%\A
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M1K08(*ZA'6!0X& *4/0 &NA :"";%0##$H$%&WP!%AS;:+C%AQ$+T*$@&*A
MA4B1@?D1#FZ#T$6!%BP!",2.-^3! F"B%$[2CX!'#%K '(!!)!ZD$P >(US
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M@#]\A0@\ &&&0!7800;P9JT0YBL8%B\VA'#^0V'N94^JS&*"IAW8YH=U#GG
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M[/$ !E@F2%#!&3A(KE)!QW19NH*F/W2 T,P !KQ<'W:HH29L"SA.;>##A:H
M)CWH>R9K6,C#KO;H$/P#)-T1@\;;.+2 T* (IL9G9@Q!#SBJ![A41FS!&[0)
M6OXL?;B'Q@G ? #M)N&'68:<T2[M#*"$02XMU$9MQZ$H)A">U/H'%0S!0H*0
M]LC9_]5RDHU^K=B.+8E&@0<N;=C61]J.;7I,"MM>;=BNK7I(@-RV1]"^[=)"
M@+<HP<9X9=VJ!Q"$P";@;=2&97R$$N&B1UGNAS\D+L?UXR9\GN-.[MC.@!I
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M>'@(H, ;,(%OT8=V:8)$'^07Y(Z$,XE9 PA!6,+V;4!LIS22S4$KBD2BD(,
MZ,$>W*@?^$ :!(%,/_8]U#A-$)# BAP$1,L3A, *@/8!0,@(&#@*H, %C,#2
MH<\XO %P[O%63G9(S, 6[!)Z<T=N>(+5C@3$<%:5C])C]  *:  YQUA35,>?
MFP>F/<6@'QC_>816L%V=GX>%C "4U3(U-DD Z(5DY+< "ZT%MVX&O^_M_G8.
M%([%F< 1G%AUFP"="$MCB 4FZ URR\[_C+.MP7A#HRU6A+0@@$2+J\\ $< Y
MVQY %[FZ\2*9UF$Z?<Q $PB")<P!MV@2'*0"K;?T3\!%-;31CP#!9D#%8-D
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MDB> 4J+PQ /;2N.J);!RH@*(7N+8@,'#:'JB! Y,((.0&>%(;K$#3$Q0M?^
M#%+((8DLTLB3),!@ 0&81.'()Z&,DC$#9&!2@ JDS%)+(B&8(8<D]@#@AC?F
M0,$2!1C10P,.Q))'C1S0G&,%_82$X(11N@!F% L4B&,%$N7JX4P+E&"A@\.(
M^(&:#."@X@1+]LGC%E!8K(2TA40HQ89]++@#C!@0B&"+'$C()XTX^C() C5
M(02&?>KB(%,G9$!3_X<6BI.)ASX4L( 0'3J C@=08%! D AMBT"6;X 18HHX
M<&B AS 44( 0/F!1 H1+(X@B"SX@?48/0T6P8H<]2#P@E47 V*!!(";A8IM
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M/ H1FO]6=5#WEQ] *P)A=T0,." /$X0!&"48_\$#.U@ID@$-:I+5":Q' ]C
M$B(G)\YO8:(""$9 #RQE!JQ@&^;@.4CO!_0 !\P ]SP@=F[ !N0F*NC($W)-
MMK[# Z1E$ (A?U)HTH(O#$1GBP:AN"K!!-3 !J2/HN@B" +@"$8A#T#@!0*
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M9I) <X/BP6 8 BC18Z."<N004':R?W!W \#-$FKG/W"W 8G #8)@2GEL TZ
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MI7CT"Z:%#3]XN[7G<<,C)G&LA4"$:H8;3O#X- @D[4N5$'B$>5:-P0\&#!;
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M(IL002A@($FV6!5JC&VLTPZ  2TL#?\%CJTLT0Z0M*4US;*<'5J&8)&$/0#
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M="O;U8-/J' "*C.<W/-DC5!")E/@J.$'.%;R1>9V@!ND^D(^[@6MV+P$:9N
M!TZX^ R^\ ,-!, U:,#.IXF2X5T]H!2P>$K*M/&-))0X/UH_ 0R@L(( "$4(
M6(C0#,* ACB@9SY?$-FYK@5*>1R!R?=)[BCPX$_60* CQ(B1KL/Z@@S90([T
M1 )TUWL"ATOB!9S(12!P?*(:\$&*F@$P$C0AQK)V8$D*9X'A1X=LYAS\!%E0
M"!Q20886KWS9F#@&2$I!!WW4%0YL@($F)O])D:V=+&4T-]++K%S3!7 >YC X
M3V>?_WR?+4UHT*^^2I"F-*!MUOK<9TN@60J (WBE$OR16=>V]]H1?.,'P/@!
M)N9,A1J P?0FPB2K(+#) ,'A SV8P \F  P3\ ;%@ .;)#;S$5P!R >3( @L
M5!;4\09?P # @ DC4 P;@#N*(T,4\3CODQXGH'[L!PP[  ;@TG [\ .X\ -$
MU@'R %PCP'X_\ 9@L + ]"J;  ];L08] (/   RXX (=TSBR(PL^( ?J1X$E
M&"XF4 HYL 1S@!XETBD[P (&L 6 0! -P0Y?\&W\IX( N ,C4 78)A_ I07L
MQP=.( 2F( DP%C[_$+ 1H>$(7[,3(Z" HS %+J$U"O(#,3B#'@ 'G)$U!_!!
M/8B&M/(LUX8 0S0"#+ #.P *0A!!'(!)"X%_#E0 :]8#[0>&(\ "]_$!X]"#
M;P ,+J 'A6<B/+")$P" ?+ #*P!*&K4!H;-"W&83/!%X7A0/25 "5_ );.>#
M$[ #%[ !''!-_Z)D(H(F1[2!Q_-2)! ("P" /L@$C$0I44"*87@!G]@0I8 "
MQ\ !FO%;@R %:< (/NB#5/@"\C 5_Z>".R!J'(A&QU .6X%L%Q" P, 'FM!'
M#[AS#"",%^ $," J!4!J/W >5\6$BT (!L(#]>%4L95C)_0#W]!^(W !_QIP
M3M+! ^H !91&$;.C!:QP!5K$0/V!-XL8!5FP":"4.Z/$(:ZQ (0@@"/@ @.F
M0"/0#X0 #!<P GB$8V;@%.K"@34 "XU0&.J#"5ZC9&;2 @?P 4W0B!. "X]8
M!1F@1S40@#$HAN3'A"M5""P 1,@A O(4%=ZD ?O7 U]@D7R "S!@3B;R 4;
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MG48%I:"3*[AQ$K9TB4H(8% %G2HMJK@'\M)-XV!L<(!LWT"E1G !8# V ("
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MH3)2!5!!';_W&\CV>[PJIM#*!^X@J*SR0L$@&TQ0 >/P!2SP LJ!#P^CI5$
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M=(='0(@X;$"K2$B"B5$ *_(A@(=?"#<^1H$&/>B3)=P1A#M,J>QVF&!>+9
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MAGV=MB)CB/[?#*"">, "XFY?[NXKCA& P.ING/!/H! *\=X)B;N@YJ7GF/4
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MSK7*]R#3%D87&N#LZA$P[."7T-VE203L<-V3_%"-1A3 5*C[B@AJ0 X)K>0
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MQPX8*& !@!C8;'A0Q!5TZ@@CP,/WKI2$$M3N/)5 #-L*$($H?(%2'!D#$SQ
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M'B2-3U%CM03+X>1*YO'!*,B WF!5#]0<AFU2WUF)&HP!(/"305FB.=I!FD0
M&:"!'LP12.S#;6!80H0!&FK>#A2AUC#D!*2?(E8",R93]=Q-$P!#'/X )HP
M.)5:%/R \?W &UR >Q4/$>1 &D@(AK&$86F!%@##[(%!^<V 'Q $D52?#:2A
MY@%#$1S(%$K@ZN&@"A@$,4;!&]3>*,9 .S"C,V)8;XW %^3A"%1!1=)-(QW$
M#KY/0M3 "/1#^OT &-R(SC#  B!C,*3;1O]%@5BHQ %H2]SHS$RNW@Z,8AO.
MQA'0 02YRAEDI6K89!&DA609@:--B6KY@11L RQ*G\3(G$_\0/HQ "8$@>YL
M!%$)#%R<BL91X.])3!1:"3NZHP7&XS9E@ BP ;0Q 8557F]VE00,@5B1#%GY
MIEDAP!E(WLL4Y^/)@QH$X%PBC 2<RA;D( "L 0IH@EU,X4,8FIMPH&>ZBIO@
M0ES2"RE8#;M] P?JA+%9"0\8 0>N85>R!!MTWN%102_-9#\P0#]H00E,9J2D
M9QP4PS*QA,9E1/5] <B=3D0 @SN&V0O @5Q4 2*-8W6B)R)>  M\#0"@W@A@
M'0)47P R0'P:Q)7_T(L)T&=*',045N'Y/)&:->AHGJ-J>J, @H$#H$ 5-D I
M?$$G'00Q7D"> 4  < +F30 3&($F5,%MCD.0!I!Y]1XF#.CCB( V."E>*(]^
M:NEL5D)$I"<B[N>(:L"X.2-[XLC.#%->0(!0P-R(%D/R:<0,)&G9', -**E*
M0 #L\5Y+L@":=),3<&"8CF9Q[ >/?L,.[, *D,+N>!.]_&@/7*ED\  *<" F
M%.![W><>>("RH4 0!%;UK2 'TB5<L!L#Z( &!(!0!. H_%;3J5E-3&$<Q%U)
MC(.WQ43JA6D_M&01Q( GF4@/I"E8C(.!^$83O $(O(\(M,$A"F 1X$  _U@/
M8\$FXFA",7S7N44!OX$D.4JI"L %,=K =[) !]C+% 9@/_#!N$(D$32AOXEJ
M!8S#%[! S]3",13B/41!WU&!<QXI"ER @<"!-Y'0^5#!/;S!&%*)/-3 :[H*
ME'9@D]%0*72J7:A6%%3!K!R<;HQF%1 /E82HKDIIVM'&Q)Y.)C3!=[:HLLD+
M \S!!2#,1N!-("3;RJU!J/Y /=%08H!!)3&0H39K"]!0P3K!H2;7[O16%+1>
MNF;' 6"0K6Z$=.9*>NX KX;G%ZQ (5HI;WJL<[HCO=#0!]SAG;V"OVJ&"12C
M/#V++)REA]V##4BMNJX4N\VLJU1'ZTG,O]S-%_^ 5HE0P49RH!#J)P- Y4&*
MZ!IV !KI3W5JA+LRP&]U2@0QXW."007T +>0@@1AWALHQW)R;LHP7LET;E=%
MGLOX0^B:[NFB;NH^'N*J;NN>C(DX@3],FNO2[LQ42<JPKNL>A29H@IG6+N+-
MAR[8@4]J1.[^[N.)4Q(@[/'>[FS, ._Z+EY8C?$>;U>9P3A@ FR6%?56;_?*
MC 1@P,@,I_<&"%HE)^61;_JJ[_JR;_MF& \D RVZ[_S2;[C4T4T2;_V"3$,%
M2O[J;U>=2CQ@ DK1+SO@[_\6)QN, P+Y+P([<%<- 0,TGOZ.[N0]\ 5C< 9K
M<(!$0"EH0O=M< C3;F+_L("ZB/#&\$ -@,"!G'#*H%[K_53]DK!-M3!7T881
M(&L-ZW"X!$#XCI7^'N?Y[O 0$W$1%Z<(9()!&O$2EQ4$G,$0/"X3YVDI' 83
M;PPS-N[+TJ\$\, 0")\5=PP/8  +@_$.!^<$UV\%*V<9LW$;NW&)<.\;R_$<
MT_$.QW$=X[$(2X !"*< $"?]FJ]:Y?$@$W(A&_(A(W(B*_(B6_'G"H#CT:\:
MERXC4W(E6_(E8W(F:_(F*S)P]O$?SV\0"S(GDW(IF_(IHW(JJ_(JMY4C0_+\
MJC'Z(C $A$\M^^\!A \\<$ >S0DNPT/X]&#K'H#C-+#,+)#TG@XOLW+Y!H!:
M_^!R,3_P'7?O 2PQ-:OI1H0/-/<F+@/S,GOS-X<P6'VR_@:R!3MPE2B/)5B
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MC1&*D1D -J#4^ ,@EGBJT1J^,06'4OKP1&D((J@LB*416ND+%CKPJ!3"-6A
M#2>4H#*"$W+(X[)Y9$D"D@>>[()8:O73H8 (9*D&$@R5WS"M+6#00Y(&1!A"
MG6KX R "8<@"-5K (A?MX040  (, K&' I8B!W'0P & \+J>0" 5.2O""XQ4
M(LNA"PFKV( (V(&&$N!@(2*H 0Q*8+:/V. 'FR@ &_K@A4;HAA0*61,2L(!
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M GAD9%;@X"ZC469@)UIF*LYB;5#09HJ"#4; US($%N*@XP9A >( !3QP$$/
M QI@X10CM<P"+2(@%/9N9H[ "8#))R! >&[N!J+ #;BCM]@DSCP""$;!$2K
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M_"X04+*I9N!X$.@ MG4?TFB(T @JUF1 D#4*X.H%)-$4-BC_-7\@".HB#')
M#KPIH!3@"=+BJ*AAL3:O96;S+"3N"'#3WY04NS3N%C;!!-@ !C+&C!@D"3;(
M2$9ML6Z 335@/;- $TSP>2"()[86"%XE *ISYU0(";CJ!0Z@N:AJ)9S@?U_
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M@*D 5J*;<LB4UYN]V]N]&<(AV=9M;T\BK6PA7^8KYN!V4NO!-.'_*(^" 1@
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M1*JJF$IK>9'>!U( BVW,@04J>$#J(@ +6WXQ(0>0'O4H(S>ZT? RJ>A# KJ
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M!_)' 5X >@>U,_,7DPW34!<#"N=XA;L26Z4P!EY0B@01"I9 00ET DZ@  )
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MTRH ^FD&N4!*":H/^AE!6@J@= @%=V,&9/^ !!F; #YHD1.1 &D LQOS3E;
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M!HP0!S&@FTXPUBT C5*0IW"< ,UJTYD(?%RE<HT0 QY&#E,P!U.C0N0'"V(
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MN]B@+#&4.&BY/A+H @0$( AE%"Q *&64*1P1SL,(_/!!2 &\, T $TZ )8%
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M)" ?"<!C&OA4!@L%H@1O<<C#..2AV<! $)MX%/]@(8A5%" 5=-C&?UR$*T$
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MV<?WP.:$2+IE(VP@MA)6X)HU*: MPTR#"6UEA1P\\PKH34,A[/#J6)," :D
M!060Q!'F;.,]UMD"^X0P:%+/-RN!T,$08-WMP)B@%$39AP7T*YN,6?_@"46
MM0IBW0YO:HQG7FD=%ECP "+DU*N3\ *2.#"WU (@%03I @MB< 5NPX-0HV"E
M!P(@ C5,(HL*-8SM)D&!'&H@8S[8!H$F4KE3X2 \8GC7J_S'L-.L+PVK:$$
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M7J<FXW_VMZ>65Y=\Q<=^H0&(!P]B/.  X.!!"")$".00 *&$ YD>D"H ((!
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MD"A*L+S/IX3*CT".#^C#$TF1$#P#%*'<49E #?P6!4 1"0#"'0* &?2!#PB
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M '$>$B@J%"W!T.DDD!B)T?#(K$A%K?B( EG!,_#9'[3!0-' $R##$!05*"&
M2P#4%4"0!;@I +!#,'8!"\1 &UQ@(/"<&2B.$K# %0R!%53#'.!.6:8"*&1!
M("!###0 UH@!(^S!%;BL#ZA%!G@-V$ "'%!4&NC 'P@$0%%<3H F%Z3<TO;
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M$LA!X]9 16F/#195T7(J%EDD,.#"))0@;XK2/+O )&J0UN30CJ;%85$HW2!
M#6DM)K#+$%")*/& -VS#VP06&2#2"IR%4(>4^L6#\^[%7V!?6(S% 92"$UB
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MCY@!$5" /9584WJ!9Y;-& !P!O#7/3Q:"G!? CRM>>3%)HA4*N0%U.RJ& M
MJRI73\QS%BBG_\P/@:LY+!AH!]3E'4"".9:")<" $# "(>R LGW='L9!"B6.
MI8. VK7U.$FCB/\Z+/SN06 KS"JAA,W &$13;&I'*.7$]53#$U2 )2P (>2
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M:0N46).-,031884'B"#,,!/B@6%0!)+VQ@(]-##!"ACNT !GG:FP0@J_]DR
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M-'; W4I#!0K X=) \#S"BM)@%9209CX/Y"RA N.B#" *"]R- 10 C>1D"?*
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M @3&)?@,%"@ /4;I2LE2$&B, Q2-/QH-B[CD+??1"YX!0R=$0",S$!@306.
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MB@,8QP)*P*/(0 CFP'/$A26P8 =08!) :@\Z0'-^"I\HX")QLT:XQ ]<9"K
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M(&XH0ZA >7+V":CT\2RA%P6$9X2 ;6+C,_1D,N,-;2+ >L=)='>UD T92B0
M XBD&@_91C)I&]VAD7/$.1K@ 6CKUN3A =IA@S.96#PB #+A 4@A  Y 'K),
MK#+Y 1H@ #(95%4B ,CK 1#-(B)@'*+ 5</S !X@$SH@ )K-E#NBE"VY,T39
M9O_E(96+^4_BPP+84@3(BP-L5I?+2S6")I1C )J?])I=^0"<>9150C/@2VMY
M-I-/&0#(^2L@@)Q10YA? &V<69.7MY5%()6%1G9$@ J6*LLNMBG.>2#?^9K]
M! [@@:E((4-,H))5(,L$4)?E005FZYE%5Y=KMCC)ZS#@(9/;(:+?&1XD0 3@
M(://XIU%.0#\Y)O(BQ2P6:RDN9CQMIN3<J"?&98Y@(4PJ0$R :6_B13@09#*
MF5)4^2M,^IB\&97)*Z$W>9QU6B4&.BL](I.S,ITK&@Z.>9@[0Q[*@9!A^0$Z
MH#@AH**56JOQ5JK)JP/*>2!3V9@*S:B9D9O)ZYH7.I/_R\&;LAH!Q)H4J/<L
M4AFE1<"A"?G6(J"A'\"35<*9.<"554,"8KG0D FDO[J7T<:494IVLGH(4-I/
M.AJN9[HC.OJ9PSJ3E\J\SF*@Z_F54SFA.>"NF=2E4V.SQ8L4:!J2WAFE%_J;
MEBJPOY6;"\TLI-F5F^VJ 48>8N"H#X *RJ&<=7FH,>F?01L."%MSA+D ;%8$
M*OF:LYJW8;H=X* ='N"C0[NBV\&98X"V2/ND2?I)@7F#G;D!7%FZQRNP;7:@
M]5F2Y7N^?60(&(#8Z+LI<#79\GN^9Z 4BH%3=H20;>2H4;OA/L55?,TW<N V
M#+-'#AP 4#O";V2?*\+"^UO"_V^$PA>)PS^'PVD$Q#,\Q)L"PT<\2D1<-2@B
MQ16)Q4_\Q9U1Q.\: DB\D5P<QG'\&0- D2GIQ+-Q&[LQQ[UQ0,Y@=9]Q=CYE
M0GOM $HA!6Q@<#97R*5\RJF\RJW\RK$\R[5\RZM\&O$[P_>;&[E\S'E6:::8
MX3@I:0;A;0&+P,G\S>$\SN5\SNF\SNW\SH-$ @R &@7 &C/\D3<)S[5<F%,Z
MS4W:K04]T15]T1F]T1W]T2%=D695 &H5S#6)OR,]TS5]TSF]TSW]TT$]U!M9
M&OG<S_O[QP-=U%5]U5F]U5W]U6$]UKE\TBN]O\-<5V4]UW5]UWF]UWW]UX$=
MDB2IQ_]''- =(I*#/=F5?=F9O=F=_=G[F]9//,R#'-JM_=JQ/=NU?=NSG=2)
M/<-1'=.Y?=S)O=S-_=S1?=&E?<2I/=W=_=WA/=[E?=YA-9$7N<]/W-C%G-[Y
MO=_]_=\!/N MPKZ_W-8O?=\%/N$5?N$9ON%W?<?OW=3S.]P1WN$M_N(Q/N,U
MGLZ]G%:G_>!Q?>-%?N1)ON1-OI#UO-3S_>"1_>1=_N5A/N9E/DC6W=*!?.9Q
M/N=U?N=)WML9><0IOMIY?NB)ONB-/MUKWN!O_NB9ONF=_NF#/9)4OM@/7NBA
M_NJQ/NNU'M*3/K_;?>O!/NS%?NRYW.?Q'>BU,=7)?NW9ONW_W?Z0NYZ^;_WM
MZ;[N[?[N+\G>O[V_];WE\?[O 3_P!9]&"-[CV;WJ!S_Q%7_QW1[B]W[BTU[<
M&7_R*;_RF;[C*?WCE][R.;_S/=_E4_[QZ5O?K?[S3?_T43_@XWZ^OS[U7?_U
M8=_=S5[BZ3OH8__V<3_WKWWUY7ON=?_W@3_X<UWJ17^^^U[XD3_YE=_3>5^2
M6W_YH3_ZI9_.9]_'([_BIS_[M7_[J;SY&_GYN3_\Q7_\1YW'?_[/$9_\U7_]
MV5]6[]OP;5[MVW_^Z;_^$\GQS__4K[_T[;___?__ 0* P($"AV@1@/ "P84,
M&SI\"#&BPP &9" 4X$^BQHT<.WK\_P@RI,B1)$N:/(DRI<J5+%NZ? DSILR9
M-&O:O(DSI\Z=/'OZ9"C!P$&$*'Y^/%#QHCNC3)LZ?0HUJM2I5*M:O8HUJ]:M
M7+N>'++@HL*M%"TBK. UK=JU;-NZ?0LWKMRY=.O:A2C!X,6B6Q&<,2L [=W!
MA L;/HPXL>+%C!O'!2N6:]F+@AU;OHPYL^;-G#M[_FSS (:A OAJ10JX,NC5
MK%N[?@T[MNS9,R$GE)ST+.W=O'O[_@T\N/"M>4F;SNHW]?#ES)L[?PX]NF_;
M L9JG8PPH_3MW+M[_PX^/%0)&,(2Y8I:J?CU[-N[?P]__1 &D<GF#AP_O_[]
M_/O[7QQ >?][<94<9?\=B&"""B[(X$YZW6:?<@U.2&&%%EXX85#&H7>?:AA^
M"&*((HXX''76984=?B2NR&*++KZH6'$#]O67@3#>B&...NXHE8FX :8=CT(.
M26211H8DVH9;I8?04D<^"6644N;H8X0V3HEEEEIN>:",Y]$H(9=BCDEFF=%5
M>5V'9J[)9IMNLD:>>:5Q&.:;=MZ)9YYUS5=?FG7J"6B@@@X*58!R'H=5@;H1
MRFBCCCX*TX/5_7A1D)!>BFFFFC:DX8RGW>?DIJ*.2JJ@:**H9JFJKLKJF%[.
M">:5K<Y*:ZU"GHI5BA[:RFNOOF*8I*=9,:GBK\8>B^R!N%ZE:[+_SCX+K7BO
M(GJ5HL5&BVVVV@:WK%4I6KIMN.*.^UF<PF)%;*CDKLMNNXKQ":&?LKI+;[WV
MMF7HN=76N.B]_OX+L%62GIAKJ@$?C'#".G7ZY:=_*@QQQ!*CU&U5S4Z,<<8:
M;S0M@?Q>NW'((FM<,57?CHQRRA 'V_"PH*H,<\S^ECS5Q3+?C'.X'<?:;\X^
M_YPLS5+9#'311M-J;LOH&GQTTTZ/"N^D5O;\=-56,YJOTOL^?'777MLY,*79
M?4UVV6PR#*O#ZIG-=MM:"AT5T6[/3;>0.VME[:YU[\UWBW 7RG3?@@_^(<MI
MN\PUX8HOGN#?3\G->.22ZW<W<A_K/7GF_YJ'Y[A3)V\.>NC=)7WXTH"I*WKJ
MJI=(7[RH)KYZ[+*_EG7I6\\[>^ZZ@Q;VU"#O#GSPEJ%-K57$8BY\\LH3UGE3
MD"\/??1Q59[HY=)?C_U;S3/U>?;>?S_L:/H:_S+XYI_?HYP$,QLX^NZ_GQ/U
MMU,-?_WVQ[2]4<_?SW__)9%>O*H<SW\$+"!)HK8^;[7/@ QL8$-J%T"JY,V!
M%*S@0GHGK[%9<(,-)!Z=UL;!$!(P?S_9GPA/>#[Y666"*&PA_$CH$Q.Z<(;1
M,UP$IS) &NK0>S#LB0QW"$3=J; J+ RB$9/70YYT[XA,S!T /]BD)DHQ=P@4
MV^^FB$7-0=!CL/_+HA<7A\'7X>Z+9"2<!Y>TP#*JD6])W,D/UPC'L@U1@M:+
MHQWKUD:=+/&.?"2;#:$H -3U<9!7RV-.WDC(1.9LCE,IHB(?>31#X@21D*SD
MR)Z(QBY:<I,CJZ+OD,?)4&ILBSR[HBA/F;$P%@Q(J&SEQLZHMBBZ<I83D^1-
M*$G+7+*+D5)QI"Y_.3/U61&4P"RFN/Z8R3$:<YGBLJ5-<,G,:!J+EU'QI32O
M&2UGUF2/V.PFLC 9RT!Z<YS.\F0&34G.=+:*E'BKHSK?62M5LD^3\*PGIF")
M.&7:<Y^8TB9-H,G/@.:)FE"QID /RBA_SH2;"&THH) 93D$Z=*)X4BC_20(0
M  ZT R( I:A'LT10FT3@#/X80@P"@  $,,2@'VUIF2PZDE0TX1E/*(8'.  !
M"2RDHR[M:9' :914A$ '0ZA $T90!!5P0*4"R:%/GRHF<P;5'9 X !4,, YW
MH" $=NC 1MN11JB*]4CL#&H%(,%4$62B!Q<  PXV"@=WCG6N4))G3]C@#T@P
M1*TQ*   &$K7P.X(GS\1P14VT) #;!0 03F=8!]+))B*Y "*C0A%A*!/R&IV
M12%U"DLW"]H1278D!T! :0_P5YTRE:>A;2V"(&J4")3B#1=X0S#>0%O:KL"O
M3G6M;T$T6I#(=@07<$<%*F#<"MBA!5\-ZV^?_ZN@SM+D #Q  0LZP &,:I>I
MGX6N=Y4E3*=8M1BD> A@OXM>_@"5*1)HQV(; H'RI7>^_Y'J*C-+W_RNIZPU
MHT(&OBI7_0K8/79]"@1XL 409."OSAVP@[=#V*'Y=Z/QI>>#+^R<X*8$ @-A
M+88_3!OI,J4= 0:QB9NC88_H- !_;3&+=2J0\YYXQKV![4]D>UO<YEBW?@6
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M<#?%U# Q-AA4$ -YD"( #W"V!CKPUS^+>]Y7N79$J-L'/E0AN2C@M:]E3.^
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M&&Q-B!-/2(-@Z')=N!%?:(:DMH)9*']K&&Z;9S$_"(?B=H-4088#6(<3UX.
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M*@I@I(^JM!(2H1\7?/A)LQ#G!8&)@"5-L<N8S6 0"G#.5.L7B!*\ Q;!*:H
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M9U*'>6P&(_[C 7)' E.4X .#D,(VGG SG%U@!9F4R %$\(![Y+*#)7C!S3M
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MI+>) +GAG8:8A^ K+L^ $=PROJ:X@:VPI2>TQ1AXOL (#<8HH^<1@9#S@CE
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M/[A!G70"+'F3 _BQ#.N   B2D?2"//@&/\R;L3L!4/BWYF"!AKBX9F$.!E
M+MR;$W :NKD%7/"L/;B":'B&/Y*R,MN#AN !VS"L9UB >Q((B3 !^O"7S^J
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ML(,WF@@3^ #%O0 PL /"$X&#35@3RX04N!DC=%8/D%/$Y=;:*59<75W6!8D
M4$Z6B$#RF<".;%W;O5V@<!B0+0E1$1\%K+#:D(($N(,25 .FZ[WWHXC>_0F*
MU=V1^%WS@5[<G5[J_^T([)'5C:15A&BHZNU>[_U>"TM2]3"JGY%>\#U?]$W?
MET@)"&S."%-?^(U?^?44"* " ?TW&D"G%9C(^>U?__U?B<!(C20?C@0? #Y@
M!$Y@D;"MIFT_%E"!Y%5@"9[@U7W V!4HVC5@"MY@#NY@#_Y@$(9. 58H[=7@
M$#YA%$YA%5YA%HZ>!6M?\X&P6FUA&JYA&[YA',[AB1CA6?V>\-%A( YB(1YB
M(E9?"V9.\\G@'RYB)FYB)WYB*+9 'LY>AHIB*[YB+,YB+1Z?Y%Q.!XMAYT0(
M"=MB,BYC,SYC-'X)6,5> B[A)4YC.(YC.9[C+'Y=+Y9=+G9C.MYC/NYC/_^^
MX>M-.!+VX3\N9$,^9$3^7_:]8# FY$1^9$B.9$F^U2EN8T>>9$S.9$W>9(,[
MXB^60#WF9%$>95(N9?*IY/$I8.XU959N95=^Y9]X848N'QD68UB^95S.95WF
M"%06GP)^XUT.9F$>9E+V9#P6'R4F9F5>9F:6Y%[FGE]N9FF>9FJ.XRZ>9?*I
M91.N9F[N9F]NXC46Y!Z>X6\N9W,^YQ2V8VS.8Q\V7W1^9WB.Y_@-Y(P<9)8(
M >B09WW>9WX&WP#P!R%89_'1YC>8KWX^:(1.:%>%@!#XG@$FGP=@!)9@@']0
M:(N^:(RV0 D(  ;8!MP( 8("!N6@@!W(! #(YXS_3FF57NF(>H *^)X% &;Q
M"08%8 D%&($'\$R'@8X#  "FZ.F?]NFF$&J@'NJ@/FJC3NJB7FJB;FJD9NJG
M=FJEEFJHGNJHOFJKSNJJWFJJ[FJLYNJO]FJM%FNP'NNP/FNS3NNR7FNR;FNT
M9NNW=FNUEFNXGNNXOFN[SNNZWFNZ[FN\YNN_]FN]%FS 'NS /FS#3NS"7FS"
M;FS$9NS'=FS%EFS(GNS(OFP D  ." $+**HW& *"&H(W( T*D $&^ %@ (8)
M2.W55FW7?NW5;FW9AFW6IFW7GNW;KNW<IFW<CFW=]FW>_FW;!N[9[NWA/F[C
M3F[A5N[@;N[B7F[H=N[:_V;NYY;NW:YN[)[NZ,[NZ]9NZR9N[^9N\.YN\AYO
M\T;N[0YO]2YO]/[N]A;O]U[O\Z9N^8YO]J;O^T[O_'9O_)YO_?9O_OYO^P9P
M^.[O 3]P T]P 5?P &_P E]P"'?P^F;P!Y?P_:YP#)_P",_P"]=P7 "&!;"
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1CR-/KGPY\^;.GT./GC4@ #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
